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ABSTRACT
Death of heart muscle cells, manifested as acute myocardial
infarction, is a major cause of mortality in the western world. Although
coronary artery occlusion is the principal cause, animal studies have
suggested that infiltration of neutrophils as part of the inflammatory
response to ischaemic injury, may be significant in the extension of
tissue damage.
As a hypothesis I suggest that neutrophil activation may also play a
significant role in extending tissue injury in man and my thesis
examines the role of the neutrophil in the clinical syndrome of
myocardial infarction.
Firstly, methods for isolating and radiolabelling neutrophils were
developed. These, along with measurement of established markers of
neutrophil activation and free radical activity, were used to assess
neutrophil involvement in myocardial infarction in man.
The single-step isolation procedure developed provided a simple and
easy means of isolating an essentially "pure" preparation of cells with
a minimum of "handling". That this method resulted in isolation of a
viable cell population was evidenced by normal kinetics and uptake into
sites of infection and inflammation in vivo.
Using this labelling method it was shown that there is uptake of
autologous Ill-Indium labelled neutrophils in the heart, in patients
with recent myocardial infarction. The time interval from onset of chest
pain to injection of labelled cells was the only factor shown to
determine the outcome of imaging and suggests that the stimulus for cell
infiltration may be early and transient.
Detection of increased neutrophil elastase by radioimmunoassay and
the non-peroxide diene conjugated isomer of linoleic acid by high
performance liquid chromatography in the plasma of these patients
demonstrated increased neutrophil activation and free radical activity
in acute myocardial infarction in man.
Coronary reperfusion, effected by intravenous thrombolysis, might be
thought to be associated with increased neutrophil activation, but the
results showed a reduction in the intensity of the inflammatory response
as assessed by uptake of radiolabelled autologous neutrophils, abolition
of the late peak of neutrophil activation and a similar degree of free
radical activity between patients treated with and without thrombolysis.
This is consistent with a reduction rather than an exaggeration of the
inflammatory response and conflicts with current views on "reperfusion
injury".
In conclusion, following myocardial infarction in man there is
evidence of neutrophil infiltration, release of neutrophil elastase and
increased free radical activity indicating that neutrophil activation is
an early phenomenon in acute myocardial infarction. However coronary
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Acute myocardial infarction is one of the commonest afflictions of
the westernised world. It is almost invariably caused by coronary artery
occlusion by thrombus, leading to infarction or death of the myocyte.
Animal studies have suggested that the infiltration of neutrophils,
as part of the acute inflammatory response to ischaemic injury, may
contribute significantly to the extension of tissue damage.
The aim of this thesis was to determine if the neutrophil plays a
significant role in myocardial infarction in man.
Before doing so it is helpful to outline the nature of infarction.
1.1.1 ACUTE MYOCARDIAL INFARCTION
Historical Background
Although angina pectoris was recognised in the 18th century (Heberden
1772), the clinical syndrome of myocardial infarction was not known
until the 20th century.
In the intervening period, Weigert, a German pathologist, described
the similarities of infarcts of the myocardium to those found in other
areas of the body. In his paper entitled "Ueber die pathologischen
Gerinnungsvorgange", he documented the gross and macroscopic appearances
of myocardial infarction, and also the healing process which resulted in
the formation of scar tissue (Weigert, 1880). By 1894, Gibson and Muir
described two patients in Ward 22 of the Royal Infirmary of Edinburgh
who sustained "morbid changes which the muscular wall of the heart
undergoes, in a consequence of local nutritive disturbances", noting
this was the condition myomalacia cordis, described by Zeigler, (1880).
The clinical syndrome of myocardial infarction and associated
pathogenic mechanisms were first described in the early 1900's by two
groups at around the same time (Obratzsov et al in 1910; Herrick 1912),
although the main credit in the western world is usually given to
Herrick. In their paper, Obstratzsov and Stratletskov presented post
mortem details of five patients with acute myocardial infarction, with
coronary thrombosis evident in only three of the five. Herrick, in
describing this syndrome postulated even at this early date that "hope
for the damaged myocardium lies in the direction of securing a supply of
blood so as to restore as far as possible its functional integrity"
Although these papers excited the medical community, the exact nature
of the cause of myocardial infarction was unclear. In the 1920's,
several studies revealed many instances where severe atherosclerosis was
apparent but coronary thrombosis could not be detected following
myocardial infarction. Particular examples of this include comments by
Friedberg et al, (1939) on the possibility that myocardial infarction
may occur in the absence of coronary artery occlusion.
Such confusion eventually led clinicians and pathologists to suggest
that myocardial infarction could not only occur in the absence of
coronary thrombosis, but that coronary occlusion may be the result
rather than the cause of acute myocardial infarction (Baroldi et al,
1976).
The debate continued for several decades. Two important factors
generating much of the confusion regarding the variable importance of
coronary thrombosis in various types of myocardial infarction occurred
because the distinction between transmural and non-transmural and the
pathogenesis of sudden cardiac death had not been clarified.
It is now generally accepted that the initiating event in acute
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myocardial infarction, is a critical reduction in the lumen in one or
more coronary artery. The detailed and painstaking work of Davies,
(1984) clearly showed the role of coronary thrombosis in the
pathogenesis of acute myocardial infarction. Similar studies have been
reported by Falk et al, (1987).
Thrombus is commonly formed on the surface of a ruptured or fissured
atheromatous plaque and this thrombus produces occlusion of the coronary
artery leading to downstream anoxia.
1.1.2 Definition
The term myocardial infarction refers to the death of a part or all
of a region of myocardium. It occurs when ischaemia has been
sufficiently prolonged to induce irreversible injury of the affected
cells so that necrosis occurs even after the restoraton of blood flow.
Much that is known of the course of myocardial infarction and the
subsequent healing process was learned from experimental animal models
in which temporary coronary occlusion was followed by reperfusion
(Jennings et al, 1960; Karsner et al, 1916).
In anaesthetised open-chest dogs, myocytes rendered severely
ischaemic were shown to remain viable for at least 15 minutes (Jennings
et al 1960). If perfusion is re-established at this time, then
infarction may be avoided with an eventual recovery of cellular
metabolism, ultrastructure and contractile function. When coronary
occlusion is extended beyond this period of 15 minutes increasing
numbers of myocytes become irreversibly injured and by 40 minutes much
of the ischaemic subendocardial zone will be irreversibly injured
(Jennings et al, 1960). As the duration of coronary occlusion increases
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a "wavefront" of cell death will gradually progress from the
subendocardium to the subepicardium. Similar patterns of cell death are
seen in other species such as rabbits (Connelly et al, 1982), pigs
(Klein et al 1984) and baboons (Geary et al, 1982).
From these and other studies it is recognised that following coronary
artery occlusion, ischaemic myocytes do not die instantaneously, that
mildly ischaemic myocytes may survive indefinitely and within the region
that undergoes infarction, not all myocytes die simultaneously (Reimer
et al, 1979). These concepts are crucially important and form the basis
for experimental and clinical efforts to design therapy that limits
infarct size (Hillis et al, 1977).
The events involved with healing of experimental myocardial infarcts
were also characterised in canine models and correlated with histologic
observations. (Karsner et al, 1916).
The nature of the subsequent healing associated with myocardial
infarction in man was examined first by Levine who correlated the age of
infarct with gross histologic findings (Levine et al, 1929). Although
this paper proved a valuable start, insufficient cases and lack of
detailed, examination provided limited conclusions. Ten years later, the
definitive pathological study on the process of healing after myocardial
infarction was conducted by Mallory et al (1939) and is the basis for
the present day understanding of the events following infarction.
1.1.3 Myocardial Infarction in Man
Mallory concluded from his studies that the speed of healing of
infarcts in humans was similar in most respects to that of experimental
lesions in animals except that it is slower (Mallory 1939).
In man, the site and the extent of infarction is governed by a
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multitude of variables and include the site and severity of the atheroma
in the arteries supplying the zone of infarction, the dynamic nature of
the occluding thrombus, the presence of separate lesions in other
coronary arteries, collateral circulation and myocardial oxygen demand.
Irreversibly damaged myocytes do not regenerate, so are removed and
eventually replaced by scar tissue. While the ischaemic death of the
myocyte is rapid, the process of repair is longer and may require up to
4 to 6 weeks. In commenting on the speed of healing after myocardial
infarction Mallory concluded that it "is in part dependent upon the size
and position of the infarct and in part due to the state of the
remaining myocardial circulation" (Mallory et al, 1939).
As the endogenous degradative enzymes of myocytes are insufficient to
effect complete dissolution of dead myocytes, removal of necrotic cells
depends on the influx of polymorphonuclear neutrophils and macrophages
as part of the acute inflammatory response to tissue injury (Bing
1971/2).
The presence of marginating polymorphonuclear neutrophils within the
microvasculature and in the surrounding interstitial tissues may be
observed within the first few hours of infarction. This infiltration
starts peripherally, spreading centrally from the epicardium to the
endocardium. The number of neutrophils present in the tissue increases
with time and reaches a peak at around 3 to 4 days. At around 48 hours
those neutrophils reaching the site of infarct do not recirculate and
undergo degenerative changes in-situ. By the 4th to 5th day the influx
begins to subside with macrophages becoming more prominent (Mallory et
al, 1939).
The progressive removal of injured myocytes continues and is followed
by ingrowth of new capillary buds and fibroblasts and within the tenth
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day a distinct rim of granulation tissue is present. Between the 2nd and
4th week, 'organisation' of the infarct takes place and the process of
repair is generally complete within 3 to 6 months.
1.1.4 Harmful Effects Associated with the Acute Inflammatory Response
The acute inflammatory response as it relates to myocardial
infarction has not been widely studied. It is essential for the
resolution and repair of the infarcted area but recent studies also
indicate that the inflammatory response, or some facet of this response,
may cause additional injury to reversibly damaged myocytes and thus may
extend the ultimate size of infarct. It is therefore relevant to
describe the events constituting the inflammatory response, particularly
those aspects, which when poorly regulated, may potentionally lead to
extension of tissue injury.
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1.2 INFLAMMATION
The inflammatory response is an integral part of the host system of
defence against damage and has been well characterised (Wilkinson,
1974).
It was first recognised in ancient times by the appearances it
produced in the skin and other surfaces of the body. Its manifestations
were described by the Roman encyclopaedist Celsus (30BC-38AD) as "Rubor
et tumor cum calor et dolor - redness and swelling with heat and pain"
These changes are still known as the cardinal signs of inflammation.
The first clear statement on the modern concept of inflammation was
given by John Hunter (1794), who after first hand study of injured
tissues concluded that "inflammation itself should not to be considered
as a disease, but as a salutary operation consequent either to some
violence or some disease". All modern definitions since then are
restatements of this basic concept.
The earliest workers to examine living inflamed tissue were a group of
British pathologists, Thomson (1813), Wharton-Jones (1842), Addison
(1843) and Waller (1846), who between them described all the essential
features of the early stages of inflammation. Their accounts however,
were largely ignored and it was not until 1882, when Conheim provided
one of the first microscopic descriptions of inflammation in injured
blood vessels in thin, transparent membranes, such as the tongue and
mesentery of the frog, that the basis of the cardinal signs were
generally accepted. His descriptions of the initial vasodilation,
changes in blood flow, the subsequent oedema due to increased vascular
permeability and the characteristic leucocyte migration are still valid
to modern medicine.
Today it is known that any event causing tissue injury may invoke an
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inflammatory reaction, which may be considered not as a single process,
but rather a number of inter-related processes.
The inflammatory process is generally thought of as an immediate
reaction to injury which gives rise to an acute inflammatory response.
In contrast, chronic inflammation results from injurious stimuli that
are persistent, often for weeks or months, leading to a predominantly
proliferative (fibroblastic) rather than exudative reaction.
Because acute inflammation associated with invasion of the tissues by
pathogenic micro-organisms is so common, for a time inflammation was
synonymous with infection. But it is now clear that in addition to
infective agents, inflammation may be initiated by any form of tissue
trauma be it mechanical, chemical, thermal and in the context of this
study, ischaemic.
Following tissue injury, the host will mount a characteristic acute
inflammatory response. Despite the diversity of the damaging agents and
tissues involved in inflammation, the same chemical mediators are
released and so the immediate inflammatory response is similar. The
extent and intensity of the response is dependent on the severity of
injury and reactive capability of the host.
1.2.1 Mediators of Inflammation
Although injury precipitates the inflammatory response, it is the
subsequently released chemicals that mediate the response. These
mediators, which are large in number, can originate from plasma, cells
or damaged tissue.
A large number of mediators exist, however most workers accept that
those most closely associated with myocardial infarction are split
products of the complement system and products of arachidonic acid
8




1. Vasoactive Amines Histamine, Serotonin
2. Plasma Proteases a) the kinin system (bradykinin, kallikrein)
b) the complement system (C3a, C5a, C5b-C9)
c) the coagulation/fibrinolytic system
(fibrinpeptides, fibrin degradation products)
3. Arachidonic Acid Metabolites
a) via the cyclo-oxygenase pathway
(endoperoxides, prostaglandins, thromboxane)
b) via the lipoxygenase pathway
(leukotrienes, HPETE, HETE)
4. Lysosomal constituents (neutral proteases)
5. Oxygen-derived free radicals ^*2'
6. Cytokines (IL-1, TNF)
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The acute inflammatory response itself can be divided into three
major components; the vascular response; the formation of exudate; and
the cellular response.
1.2.2 Vascular Response
a)Alteration of Blood Flow
Immediately after injury, the vessels at the site of inflammation
become dilated. As a consequence of the local dilation, there is
increased blood flow and delivery of increased numbers of leucocytes to
the tissue site. The resulting hyperaemia and subsequent stasis of the
circulation produce changes in the intravascular pressure and
orientation of blood cells in the local microcirculation. Both leucocyte
accumulation and vascular leak were shown by Rampart and co-workers
(1986) to be markedly enhanced in the rabbit by local administration of
vasodilators when combined with neutrophil chemoattractants such as C5a
and formyl-methionyl-leucyl-phenylalanine (FMLP).
A number of factors contribute to the stagnation of local blood flow.
As hyperaemia develops, the capillaries and venules become abnormally
permeable to the escape of fluid, resulting in increased blood
viscosity, with increased red cell packing producing further resistance
to flow and so the outflow of blood from the local site is further
impeded (Atherton et al, 1973).
b) Alteration of Vascular Permeability
Increased vascular permeability, with the escape of plasma proteins
and leucocytes is known as "exudation" and is a major feature of all
inflammatory reactions.
The morphologic basis of exudate formation has been studied
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extensively in recent years. Under normal circumstances, the endothelium
provides the major barrier to permeability. According to Pober, (1990),
increased fluid permeability associated with the inflammatory process
may be caused by alteration of endothelial integrity in 4 ways. This is
suggested to occur by endothelial contraction; cytoskeletal and
junctional reorganisation; endothelial cell injury with retraction,
lysis and denudation; and endothelial denudation without lysis.
Regardless of which of these contributes to vascular leak, the nett
effect is to cause a reduction in shear force and thereby favours
leucocyte interaction with the endothelial cell surface.
1.2.3 Cellular Events_
The massing of the leucocytes, principally neutrophils and
macrophages, may well constitute the most important phase of the acute
inflammatory response (Wilkinson, 1974). These cells engulf and degrade
foreign matter, bacteria, immune complexes and the debris of necrotic
cells (Gallin, 1984). The release of their granular contents in
combination with the respiratory burst products contribute in a number
of ways to the defence response (Weissman et al, 1980). But as will be
demonstrated later, during these defensive reactions neutrophils also
release chemical mediators and toxic radical species that may themselves
prolong the inflammatory process and so increase tissue damage.
a) Margination
Since Dutrochet first reported that leucocytes adhered to the vessel
and emigrated to the tissues, the interactions between leucocytes and
endothelium have attracted great interest (Dutrochet, 1824).
Margination of leucocytes in the blood vessels is thought to depend
on two separate processes: reduced shear forces (Atherton et al, 1973)
and increased adhesive interaction between the leucocyte and the
vascular endothelial cell surface.
The mechanisms by which neutrophils adhere to endothelium during
inflammation have been the subject of much attention recently. Such
exciting advances allow us to begin to understand these fascinating
mechanisms and merit a brief description at this point.
Not only is adherence the first critical step in neutrophil
migration, but also in many diseases this may prove to be the site of
early inflammatory injury. The adhesion of formed elements of the blood
to the endothelium and to each other is mediated by a family of membrane
proteins called "integrins" (Weissman, 1989). Three groups have been
described: receptors for extra-cellular matrix proteins such as
fibronectin and T lymphocyte receptors known as the very late appearing
antigens (VLA); platelet surface glycoproteins Ilb/IIIa and the
vitronectin receptor and the lymphocyte functional antigen (LFA-1)
family of leucocyte adhesion molecules.
The LFA-1 family of adhesion molecules includes three heterodimeric
glycoproteins which have a common 95kDa beta chain (CD18): LFA-1, Mac-1
(or Mol, gpl65/95 and CR3) and gp(150/90) whose alpha chains have been
designated CDlla, lib and 11c respectively (Sanchez-Madrid et al, 1983).
The expression of these three molecules varies according to the lineage
and the stage of maturation of the various haemopoeitic cells.
In addition to mediating cell-cell adhesion, MAC-1 functions as a
receptor for iC3b (CR3) and thereby mediates phagocytosis of opsonised
particles (Ross et al, 1985). MAC-1 is probably the major neutrophil
adhesion molecule involved in heterotypic (neutrophil/endothelium) and
homotypic (neutrophil/neutrophil) adhesion. It is constitutively
expressed on the surface of resting neutrophils at a density of 10
000-20 000 molecules per cell (Ross et al, 1985)
Several stimuli such as complement components, concanavalin A,
formyl-methionly-leucyl-phenylalanine (FMLP), phorbol myristate acetate
(PMA) or calcium ionphores increase leucocyte adhesion to endothelium by
acting principally on the leucocyte (Tonnesen et al, 1984). This is
effected by an "upregulation" of receptor expression at the surface of
the plasma mebrane by 5 to 10 fold. This increased expression is the
result of translocation of preformed receptors from an intracellular
source known to co-sediment with the specific granules (0'Shea et al,
1985).
Recent studies have shown that in addition to neutrophils,
endothelial cells play an active role in all phases of immunologic and
non-immunologic inflammation (Wallis et al, 1986). This contrasts with
the earlier view that vascular endothelium was merely a passive barrier
separating the blood circulation from the tissues. With the advent of
tissue culture and associated techniques (Jaffe et al, 1973) it is now
known to be a distributed organ with a wide diversity of function.
Tn its unique position at the interface between the blood and
tissues, vascular endothelium participates in critical haemostatic
functions, including the maintenance of a non-thrombogenic surface,
regulation of vascular tone and permeability and the modulation of
immune function (Cotran et al, 1987).
Much of the new information regarding endothelial function in
inflammation has come from studies of the effect of cytokines on
endothelial cells in culture.
Interleukin 1 (IL-1) and tumour necrosis factor (TNF-alpha) are
products of activated macrophages. Lymphotoxin (LT or also known as
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TNF-beta) is a polypeptide which is secreted by activated T lymphocytes
and has similar tumour killing activities as TNF from activated
macrophages (TNF-alpha or cachetin), (Le et al, 1987).
IL-1 has two gene products; IL-alpha and IL-beta, which have limited
structural homology but have identical biological activities. The TNF
gene has also been cloned and has no homology with IL-1 (Pennica et al,
1984). TNF and IL-1 have similar inflammatory properties.
These three cytokines have similar effects on cultured endothelial
cells. Among these effects, IL-1 was shown to markedly increase tissue
factor-like procoagulant activity in both human umbilical vein
endothelial cells (HUVEC) and saphenous vein endothelial cells (SAPEC)
(Bevilaqua et al, 1984). This increase was found to be transient and was
maximally expressed 4-8 hours after the cytokine treatment. Proof that
RNA and DNA synthesis was required for expression was demonstrated by
inhibition in the presence of actinomycin D and cycloheximide
respectively. It was later shown that TNF had a similar effect.
In addition, IL-1 and TNF were shown to increase secretion of tissue
plasminogen activator inhibitor and reduce the activator itself and so
the fine balance between anticoagulant and pro-coagulant activity may be
tipped towards fibrin deposition and intravascular coagulation (Nachman
et al, 1986). Indeed, IL-1 infusion in rabbits was shown to induce
fibrin deposition on apparently intact endothelium in-vivo (Naworth et
al, 1986)
The second notable effect of these cytokines on endothelium is the
ability to induce an increase in adhesivity to neutrophils, monocytes,
lymphocytes and other cell lines (Pober, 1987). Again this effect can be
blocked by RNA and DNA inhibitors and is maximal between 4 and 6 hours,
remaining elevated above control levels for up to 24 hours for
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neutrophils and monocytes. The development of monoclonal antibodies
against cytokine-treated endothelial cells has led to the identification
of an endothelial leucocyte adhesion molecule (ELAM-1) which inhibits
binding of neutrophils to IL-1, TNF or LT treated endothelial cells
during maximal adhesion at 4 to 6 hours (Bevilacqua et al, 1987). The
ligand on the neutrophil has yet to be identified but it is thought
unlikely to be a component of the complex CD11/18 (Luscinskas et al,
1988).
In addition to inducing expression of ELAM-1 on endothelial cells;
IL-1, LT and TNF also stimulate increased surface expression of ICAM-1
(intercellular adhesion molecule-1, an adhesion molecule present on the
surface of fibroblasts, lymphocytes and normal endothelium (Dustin et
al, 1986). The expression of this molecule on the surface of
cytokine-treated endothelium is maximal at 24 hours (in contrast to that
for ELAM-1) and is maintained as long as the agonist is present. Recent
evidence suggests that ICAM-1 is the ligand for the LFA-1 molecule of
the CD11/18 complex (Marlin et al, 1987) and that it also may serve as a
cell adhesion molecule to bind to lymphocytes, and possibly monocytes
and neutrophils to endothelium (Dustin et al, 1988).
b) Emigration
This constitutes the mechanism by which motile leucocytes escape from
the blood vessels to the perivascular tissues. The importance of the
recognition of at least two cytokine-responsive endothelial molecules
(ICAM-1 and ELAM-1) in the localisation of neutrophils has just been
discussed.
It was only relatively recently, that the requirement for the
CD11/CD18 adherence proteins for leucocyte emigration was ascertained.
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This was convincingly demonstrated in patients genetically deficient in
this glycoprotein complex, termed leucocyte adhesion deficiency (LAD)
(Anderson et al, 1985).
Further evidence for the requirement of ICAM-1 or CD11/18 complexes
for transmigration across endothelium was demonstrated in vitro using
using monoclonal antibodies to these complexes (Smith et al, 1989;
Tonneson et al, 1989).
c) Chemotaxis
The movement in the tissues towards the site of injury is termed
"chemotaxis". Technically this term describes "unidirectional migration
of cells towards an attractant", or more simply, movement oriented along
a chemical gradient.
Although there was an early interest in chemotaxis, the development
of a micropore filter technique by Boyden, (1962), considerably enlarged
the knowledge of substances found to be chemotac.tic for neutrophils.
Both exogenous and endogenous substances may act as chemoattractants.
Some of the notable chemotactic agents for neutrophils include bacterial
products such as lipopolysaccharide (LPS) and FMLP; components of the
complement system such as C5a, products of the lipoxygenase pathway of
arachidonic acid metabolism such as leukotriene B, (LTB„) and
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hydroxytetranoic acids (HETES), (Vane et al, 1987; Cutler et al, 1974)
During chemotaxis the bulk of the neutrophils granules are at the
front of the cell (Malech et al, 1977), and the granule contents are
discharged at the leading edge (Cramer et al, 1979).
1.2.4 Phagocytosis
Phagocytosis and the release of enzymes by neutrophils and
macrophages occur at the site of inflammatory foci.
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Phagocytosis involves three processes; first, the recognition and
attachment of the particle to be ingested, secondly, engulfment with the
formation of a phagocytic vacuole and lastly, the killing and/or
degradation of the ingested material.
a) Recognition and Attachment
Most organisms are not recognised until they are coated with
naturally occurring "opsonins". The two most common classes of these are
immunoglobulin G (IgG; sub-classes 1 and 3), which are presumably
naturally occurring antibodies against the ingested particle and C3b,
the so-called "opsonic" fragment of C3, which is generated by activation
of complement (Henson, 1971). Opsonised particles attach to two
corresponding receptors on the surface of neutrophils and macrophages:
one for the Fc fragment of the IgG molecules and the other, the C3b
receptor (now identified as MAC-l) (Weissman,1989).
b) Engulfment
The plasma membrane of the neutrophil invaginates when engaged by
opsonised bacteria or immune complexes. The azurophilic and secondary
granules join the newly formed vacuole at its internal border to allow
the discharge of their contents (Gallin, 1984).
c) Killing and/or Degradation
Killing involves a multiplicity of mechanisms, all of which are set
in motion by degranulation (Zucker-Franklin et al, 1964) and the
initiation of the respiratory burst (Sbarra et al, 1959).
Degranulation describes the process of fusion between the primary
phagosome and the granules present in the cytoplasm of the phagocyte.
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These granules contain substances that participate in the killing and
degradation of foreign particles. During this process, these substances,
which remain inert as long as the granule membrane remains intact
(Lehrer,1990), are discharged into the vesicle containing the ingested
foreign particle. The two granule types may degranulate independantly
(Wright et al, 1977), and the contents of each are shown in Table l(ii).
The two main mechanisms by which killing is executed are generally
described as oxygen dependent and oxygen independent. The former is an
energy dependent process which requires a "burst" of oxygen uptake,
glycogenolysis, increased glucose oxidation via the hexose
mono-phosphate shunt and production of active oxygen metabolites
(Babior, 1978).
d) Oxygen-dependent killing
The NADPH oxidase system is a membrane-associated enzyme complex
which participates in the generation of at least three oxygen
metabolites; superoxide anion (O^*), hydrogen peroxide
hydroxyl radical (OH').
The oxidase system is normally inactive but when neutrophils are
activated, electrons are moved from the cytosolic NADPH to the oxygen
rich fluid at the plasma membrane so that:
NADPH
20^ + NADPH -> 202~ + NADP+ + H+
oxidase
two molecules of oxygen accept these electrons. In turn two of the






Although superoxide and hydrogen peroxide may react with other
substrates, the dismutation reaction is favoured as the rate of
association of superoxide is very rapid (Baboir, 1978).
During degranulation, myeloperoxidase (MPO) is discharged from the
azurophilic granules. This alone exerts little bactericidal effect if
any, yet in combination with hydrogen peroxide it can oxidise halide
ions (usually chloride, as its concentration is 1000 times that of the
others) to hypochlorous acid (H0C1) (Weiss, 1989).
The hydrogen peroxide-halide-myeloperoxidase is considered the major
anti-microbial system within the neutrophil. Because of the high
reactivity of H0C1, it does not accumulate in biologic systems but
instead disappears almost instantaneously in multiple reactions with
available sustrates (Test et al, 1986).
e) Oxygen-independent killing
This mechanism of killing and degradation utilises the lysosomal
agents of the granules. Whilst there are over 20 of these, lysozyme,
lactoferrin and elastase are of particular importance in this capacity.
Lysozyme is unusual in that it is divided almost equally between the
two granule types. Lysozyme is a cationic protein of approximately 14kDa
and its enzyme activity is directed against the beta 1-4 glycosidic bond
between N-acetylglucosamine and N-acetylmuramic acid residues which
H202 + X + H H0X + H20
(where X = CI , Br , I , SCN )
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stabilise many bacterial walls (Lehrer, 1990).
Lactoferrin (LF) is a 78kDa, slightly basic glycoprotein which
belongs to the transferrin family of iron binding proteins and is
contained in the specific granules of the neutrophil. Lactoferrin exerts
its bacteriostatic action by tightly binding Fe^+, thus depriving the
iron required for synthesis of bacterial components.
Elastase is a highly cationic glycoprotein found in the azurophilic
granules. Its activity against bacteria lies in its ability to degrade
bacterial cell wall protein and potentiates the lytic activity of
lysozyme (Thorne et al, 1976).
Although all of the above have some antimicrobial activity, the
lysosmal enzymes are generally considered more important for degradation
than direct killing.
1.3 TISSUE DAMAGE
From this short description of those processes which constitute the
inflammatory response it is clear that the over-riding purpose of the
reaction is to permit the survival of the affected tissues and the host
as a whole (Stevens et al, 1984; Wandell et al, 1985).
However, many examples may be cited in which the destruction of the
tissue is not due to the damaging stimulus, but to some aspect of the
hosts reaction to injury.
Of particular interest in this area, is the role of neutrophils in
tissue injury. Its importance as a defence against infection is well
known (Wilkinson, 1974; Lehrer, 1990), however the same processes that
are so important in the killing and degradation of foreign material, may
also act to degrade the surrounding healthy tissue.
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The products with potentially harmful consequences in this context
are the lysosomal enzymes and oxygen-derived reactive metabolites.
1.3.1 Lysosomal Enzymes
There are a number of ways in which the neutrophil, as part of the
inflammatory reaction, may effect inappropriate tissue damage.
During phagocytosis granular products may leak into the extracellular
space if the phagolysosome system is overwhelmed, thus toxic substances
may escape into the space proximal to the cell (Weissman et al, 1971).
Enzyme release of this kind is termed "regurgitation during feeding"
Another mechanism is reverse endocytosis (or frustrated phagocytosis)
which occurs when this process is restricted as a result of the cell's
adherence to a flat surface, with consequent release of enzymes into the
environment. Upon cell death, "cytotoxic release" due to cellular
disruption, may result in disgorgement of the granular contents.
Neutrophil granules contain an impressive array of biological
weaponry, but three proteolytic enzymes; a serine protease, elastase and
two metalloproteinases, collagenase and gelatinase, appear to have the
greatest potential as mediators of tissue destruction (Weiss 1989) and
is presumably due to their inherent ability to degrade architectural
matrix glycoproteins.
Until recently the importance of the two metalloproteinases has been
largely ignored, specifically because collagenase and gelatinase are
secreted in inactive forms (Weiss et al, 1986). Most studies aimed at
identifying the activating agent initially involved the use of cell-free
systems. As the concept of self-activation grew, contenders for this
role included elastase and cathepsin G, but these were found to destroy
rather than activate the proteinases (Weiss et al, 1986). A more
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relevant system for collagenase activation was endorsed by a series of
experiments using neutrophils from normal subjects and those from
sufferers of chronic granulomatous disease. The results of these pointed
to the generation of oxygen metabolites as an absolute requirement for
activation. (Weiss et al, 1985). Further studies by the same group
revealed that normal neutrophils, that were prevented from producing
H0C1, were unable to activate collagenase. Not unexpectedly, despite the
structural distinctness of gelatinase, the same system was found to
trigger the unmasking of the substance's active site. (Peppin et al,
1985).
In spite of these findings, most attention has centred on neutrophil
elastase and its causal role in tissue destruction. The elastase of
neutrophils is a serine protease with a serine residue in position 195
of the enzymes primary sequence, which contributes a nucleophilic
hydroxyl group to attack carbonyl carbons of scissile peptide bonds.
Elastin, the amorphous component of elastic fibre is, as the name
suggests, an obvious target for elastase. However its degradative
activity is not restricted to this substrate and other important
structural targets of the enzyme include collagen types III and IV. Both
are cleaved across the helical portions, randomnly in type IV collagen
but at a single cleavage site in type III (Mainardi et al, 1980), in a
manner similar to that of human collagenases. Fibronectin, a major
cell-adhesion molecule critical to the organisation of many tissues, is
also susceptible to attack (McDonald et al, 1980).
In addition to architectural components, many plasma proteins can be
hydrolysed by elastase. Among these potential substrates are
immunoglobulins (Janoff, 1985), coagulation (Plow, 1975) and complement
proteins (Taylor, 1977).
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The ability to activate the complement system is of crucial
importance in the context of tissue injury, since one of the split
products C5a, is a powerful chemotaxin for neutrophils, and therefore
may attract further neutrophil migration, thus potentiating the response
(Forrest et al, 1986).
1.3.2 Oxygen-derived Metabolites
Reactive oxygen species, including the superoxide radical (0 *),
hydrogen peroxide and especially the hydroxyl radical (OH'), are
formed during the process of neutrophil activation (described earlier).
These species can react with nucleic acids, proteins and lipids, with
resulting damage to the cell membrane or intracellular organelles
(Freeman et al, 1982). Few studies have successfully demonstrated that
the neutrophil uses either 0 " and alone to produce a toxic effect
(Weiss et al, 1981). There is however evidence that these moieties may
play a part in the oxidative inactivation of protective anti-proteases
systems and in this way contribute to the extent of tissue damage.
1.3.3 Regulatory Mechanisms
Plasma and interstitial fluids contain a series of powerful
anti-proteinases including circulating alpha-l-proteinase inhibitor,
alpha-2-macroglobulin and secretory leucoproteinase inhibitor, that
regulate extracellular neutrophil elastase and prevent the enzyme from
attacking extracellular substrates (Fritz et al, 1978)
Alpha-l-proteinase inhibitor, (formerly known as
alpha-l-antitrypsin), appears to be the most important regulator of
neutrophil elastase. This anti-proteinase (MWt 52kD) is synthesised in
the liver and is found in the alpha-l-globulin fraction of serum and can
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also be detected in broncheolar fluids. Serum levels of the inhibitor
rise during inflammation and increased levels of mRNA can be detected in
the liver cells during such episodes (Janoff, 1985).
Elastase and its inhibitor form a stable complex when the serine
hydroxyl of the active site in elastase attacks the alpha-carbonyl of
the methionone residue (at position 358) of the anti-proteinase. Thus
under normal conditions, the enzyme is not free to act on other
substrates (Carrell et al, 1982). The calculated half-life of active
elastase in vivo, is only about 0.6msec and Travis estimated that by
3msec all activity should be inhibited (Travis et al, 1983).
It would therefore seem unlikely that neutrophil elastase would be
present in concentrations sufficient to overwhelm the vigorous
protective anti-proteinase shield.
Strong evidence that neutrophils may not only overcome the
anti-elastase defence but release their granular contents with ensueing
tissue injury, was provided by Opie as early as 1922 (Opie, 1922). He
noted that purulent fluids from sites of inflammation contained free
neutrophil enzymes which were capable of degrading a variety of native
proteins at neutral pH. These observations pointed to the saturation of
the natural inhibitory systems, thus permitting the free enzyme to cause
tissue damage.
1.3.4 Circumvention of Regulatory Mechanisms
A number of suggestions have been made to explain how elastase in
particular may escape regulation by its inhibitors.
Firstly, that elastase may be released in quantities that result in
saturation of the anti-proteinase shield; secondly, that the enzymes are
released in close proximity to the site of damage, thus creating a
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microenvironment of high local concentration of enzyme whilst excluding
inhibitors (Campbell et al, 1982) and lastly, the release of elastase
into areas where the inhibitors have been inactivated by oxidation
(Weiss, 1989). The latter theory is based on evidence that the methionone
residue (358) at the reactive site of the anti-proteinase is sensitive
to oxidation. Free radical species generated by activated neutrophils
have been shown to oxidise this residue with a consequent reduction in
the association with elastase by 2000 times, thus extending the
half-life of free elastase to 1.2 seconds and its potential to induce
tissue destruction.
1.4 NEUTROPHIL INVOLVEMENT IN INFLAMMATORY DISEASE
The neutrophil's ability to release agents that can damage and
destroy connective tissue is implicated in the pathogenesis of an
increasing number of non-infectious diseases (Weissman et al, 1980;
Malech et al, 1987; Weiss 1989).
For example the association of the destruction of the joint with
neutrophil infiltrates has been shown in diseases of the joints such as
rheumatoid arthritis (Weissman et al, 1984) and gout (Malawista et al,
1977).
Neutrophils have also been implicated in the pathogenesis of
respiratory diseases and include adult respiratory distress syndrome
(ARDS) (Stevens et al, 1984) and emphysema (Janoff, 1985).
The pathogenisis of several skin disorders in association with
neutrophil infiltration has also been noted eg. in psoriasiform
dermatoses (Ragaz et al, 1979), autoimmune bullous dermatoses (Glinski
et al, 1985) and pyoderma gangrenosum (Hickman, 1983).
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In addition to the presence of neutrophils at increased density in
specific sites associated with the disease process, detection of
increased levels of neutrophil degranulation products, particularly
neutrophil elastase, indicating a state of neutrophil activation (Plow,
1982), have been reported in non-inflammatory diseases.
In Edinburgh, I have contributed to work detecting increased levels
of neutrophil elastase (measured in patient plasma), in patients with
diabetes mellitus (Collier et al, 1989), ischaemic heart disease and
severe hypertension (Jackson et al, 1991) and Wegeners granuloma (Wathen
et al, 1987). Others have also shown increased levels in ischaemic heart
disease (Mehta et al, 1989) and pregnancy-induced hypertension (Greer et
al, 1989)
Free radical species, which may be derived from neutrophil
activation, have been implicated in the involvement of injury to the
skin, intestine, pancreas (McCord, 1985) and also in inflamed rheumatoid
joints (Woodruff et al, 1986).
1.4.1 Neutrophil Involvement in Acute Myocardial Infarction
Recently, studies in animal models of experimental myocardial
infarction, have shown that neutrophils and their products of activation
may play a part in extending myocyte injury. The following details a few
of these studies which illustrate how tissue injury, associated with
myocardial infarction, may evolve.
1.4.2 The Myocardium as a Source of Chemotaxins
The role of the neutrophil as a contributor to myocardial infarction
after chemoattraction was suggested initially in 1971 by Hill (Hill et
al, 1971).
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This possibility was confirmed by Pinckard and co-workers (1973) who,
using histological techniques, demonstrated complement activation, one
of the most important sources of inflammatory mediators, in animal
models of infarction after 3 to 6 hours of ischaemia.
The importance of complement activation was confirmed when cardiac
lymph drained from ischaemic myocardium was found to contain molecules
of subcellular origin bound to Clq which could activate the complement
cascade (Rossen et al, 1988). Later studies by this group indicated that
cardiac lymph collected after 90 minutes of coronary occlusion in dogs,
was not only chemotactic for neutrophils but could also increase the
expression of receptors that mediate neutrophil adhesion (Dreyer et al,
1989).
In vitro models using tissue culture of myocytes have also provided
evidence for the production of substances that are chemotactic for
neutrophils under conditions of hypoxia (Friedman et al, 1986).
In addition to the myocyte, it was shown that endothelium may also
present a potential source of chemotaxins. In vitro treatment of human
cultured endothelial cells with IL-1 or TNF-alpha, was found to induce
synthesis and secretion of a factor, similar in structure to human
monocyte-derived neutrophil activating factor (NAF) (Strieter et al,
1988), which is chemotactic for neutrophils.
1.4.3 Assessment of Factors Influencing Infarction Size
a) Complement Depletion
The essential requirement for complement, particularly C3 and C5, in
neutrophil recruitment and extension of tissue damage in ischaemic
myocardium was shown in rats (Hill et al, 1971) and also in baboons
pretreated with cobra venom factor (Crawford et al, 1988). The nett
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effect of complement depletion in both studies was a reduction in the
amount of myocardium that eventually infarcted.
b) Neutrophil Depletion
Romson demonstrated that a reduction in infarct size could be
effected in dogs rendered neutropenic by infusion of rabbit antisera to
canine neutrophils (Romson et al, 1983). Results indicated that by
reducing the neutrophil population by approximately 77%, there was a 43%
reduction in the infarct size compared to dogs infused with either
saline or non-immune sera.
Several other studies, including that of Mitsos et al (1986) and
Jolly et al, (1986), also measured infarct size in dogs treated with
neutrophil antisera. It was shown in the former study, that the control
group infarct size was 46 % while the antibody-treated group was reduced
to 31% after 90 minutes occlusion and 6 hours reperfusion. Furthermore,
lengthening the reperfusion period to 24 hours still resulted in a
significant reduction of infarct size (Jolly et al, 1986).
c) Neutrophil Inhibition
Similarly, administration of prostaglandin inhibitors have
contributed to the understanding of mechanisms of tissue injury.
Ibuprofen, a non-steroidal inflammatory drug, was shown to reduce
infarct size in dogs (Romson et al, 1982) and prompted Romson to study
how ibuprofen affected the influx of Indium-labelled platelets and
neutrophils into ischaemic heart tissue. Infarct size was reduced
significantly by ibuprofen treatment, which was coincident with a 67%
reduction in myocardial neutrophil uptake. Platelet infiltration was
unaffected in this study and was later confirmed by platelet depletion
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studies (Mullane et al, 1985).
The apparent dichotomy between the action of two anti-inflammatory
agents, ibuprofen and aspirin, was clarified by Flynn et al, (1984) who
assessed the effects on infarct size in a feline model and on neutrophil
function in-vitro. While ibuprofen administration reduced infarct size
and inhibited neutrophil function, aspirin was ineffectual on both
counts, thus strenghthening the case for neutrophils augmenting myocyte
damage.
Several other therapies for reducing infarct size have been
investigated. Early studies on the administration of prostacyclin (PGI^)
as a means of limiting myocardial tissue death suggested that its
beneficial effects lay in its ability to reduce collateral blood flow to
the ischaemic tissue (Jugdutt et al, 1981), however this effect was
shown to occur in the absence of an increase in blood flow during
occlusion (Melin et al, 1983). The possible mechanisms by which PGI^
produced the reduction in infarct size were evaluated by Simpson et al,
(1987). Intravenous administration of prostacyclin and a PGI^ analogue
(SC39902) were compared in dogs. Both gave a depression in blood
pressure but only PGI^ reduced the extent of myocardial injury.
Furthermore when tested in vitro, PGI^ was found to inhibit neutrophil
activation. Therefore the cardioprotective effects of PGI^ may also be
attributed to inhibition of neutrophil function.
d) Neutrophil Adherence Blockade
The action of cytokines, such as IL-1 released from activated
macrophages, allow the endothelium to actively participate in the
inflammatory process. Although cytokines are thought not to injure
endothelium directly, they may help to effect a predisposition to injury
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from other stimuli. An elegant study on cytokine-treated rat pulmonary
artery endothelium established that pretreatment of endothelium with
either IL-1 or TNF rendered it more susceptible to injury by C5a and PMA
(Varani et al, 1988). It therefore seems likely that endothelial
activation and injury may co-exist in vivo.
Although the specific importance of the induction of ICAM-1 and
ELAM-1 in the context of myocardial ischaemia is not yet fully
understood, studies inhibiting the activity of the MAC-1 (Mol or
CDllb/CD18) complex on the neutrophil surface (Simpson et al, 1988)
serve to illustrate the significance of the adhesion reaction of
neutrophils in the inflammatory response associated with myocardial
infarction. Dogs treated with antibody (904), which binds to the
leucocyte adhesion promoting glycoprotein (MAC-1, Mol, CDllb/CD18), 45
minutes into the 90 minute period of coronary artery occlusion, resulted
in an absolute reduction in neutrophil accumulation with a consequent
46% reduction in the mean infarct size. Moreover this effect could not
be accounted for by differences in arterial blood pressure, heart rate
or neutrophil count.
1.5 FREE RADICAL PRODUCTION IN ACUTE MYOCARDIAL INFARCTION
Because free radicals are by their nature highly reactive species and
therefore difficult to detect, it is customary to measure alteration of
substrates upon which these moieties may act, and so employ indirect
detection.
In special situations electron spin resonance spectroscopy (ESR) can
be used to detect free radicals directly in quick-frozen myocardium, or
indirectly, employing spin-trap agents which react with the free
radicals to form stable adducts.
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Using ESR, several groups (Garlick et al, 1987 and Zweier et al,
1987) have detected a "burst" of free radical activity in isolated
perfused hearts in dogs during ischaemia and particularly during
reperfusion.
1.5.1 Potential Sources
The production of free radical species in vivo occurs not only in
pathologic conditions, but also in the course of normal metabolism and
therefore many sources of these species exist.
The three main sources thought most likely to contribute to free
radical production during ischaemia are the electron transport system,
xanthine oxidase and activated leucocytes.
a) Electron Transport
The majority of oxygen metabolism occurs via tetravalent pathways but
1 to 2% is known to be carried out univalently, thus resulting in
generation of small quantities of superoxide and other radicals (Boveris
et al, 1973). Under ischaemic conditions the percentage of mitochondrial
"leak" increases (McCord, 1988).
b) Xanthine Oxidase
The native form of the xanthine enzyme is the dehydrogenase (or Type
D), although healthy tissues contain approximately 10% of the enzyme as
the oxidase (Type 0). During ischaemia, conversion to the oxidase occurs
by limited proteolysis (Battelli et al, 1972) which, upon reoxygenation,
utilises the substrate hypoxanthine to form uric acid, with attendant
superoxide anion generation.
C) Leucocytes
As discussed in detail earlier in this chapter, leucocytes constitute
a potent source of free radical species through activation of the
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membrane-associated NADPH system.
1.5.2 Free Radicals in Myocardial Infarction
Although free radical activity is believed to potentiate tissue
damage during ischaemia, it is particularly upon reoxygenation that the
majority of the injury by this stimulus is considered to occur.
Consequently models of reperfusion have provided a valuable insight into
the role of these species in myocardial injury.
Reperfusion of reversibly injured myocytes prevents cell death
(Braunwald, 1985) and it is also generally accepted that cells salvaged
thus, require time to recover structurally and functionally (Jennings et
al, 1985). In recent years it has been proposed that myocyte death,
myocardial "stunning" and arrhymias may not be caused directly by the
metabolic events just prior to, but may result more from some
deleterious effect of reperfusion. Therefore "reperfusion injury"
generally refers to that injury that may not have been expected to
occur, except as a result of the reintroduction of the cardiac
circulation (Lucchesi et al, 1989).
1.5.3 Interventive Therapies
The assessment of agents that prevent formation of free radical
species eg. allopurinol or oxypurinol; "scavenge" free radicals eg.
superoxide dismutase alone or in combination with catalase, or inhibit
neutrophil function eg. prostacyclin and ibuprofen in animal models of
infarction have helped to ascertain whether a reduction in free radical
production also limits infarct size.
While there have been a considerable number and diversity of studies
designed to determine free radical involvement in tissue injury
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extension, results have often been contradictory as illustrated below.
One of the first studies to show that superoxide dismutase
administration in dogs limited infarct size was published by Jolly et
al, (1984). The results from several subsequent studies; that of
Chambers et al, (1985), Werns et al, (1985) and Nakazawa et al, (1988)
concurred with this view. In contrast, in later studies superoxide
dismutase failed to reduce infarct size (Ambrosio et al, 1986; Klein et
al, 1988; Richard et al, 1988).
Similarly, studies on the action of inhibitors of xanthine oxidase,
viz alio- and oxy-purinol have provided conflicting views of the
effectiveness of these treatments in reducing infarct size. Allopurinol
administration was shown by Chambers et al, (1985) to limit infarct
size, whilst this was disputed in a similar study by Reimer et al,
(1985). Likewise, opposing data have been reported on the use of
oxypurinol (Werns et al, 1989; Puett et al, 1987). The most important
determinants of the variability of results from these studies was
suggested by Reimer to be due mainly to "the dose or manner of
administration of therapeutic agent, animal species, and experimental
protocol, including the duration of occlusion and reperfusion" (Reimer
et al, 1989).
In spite of this, a substantial body of evidence to support free
radical production after ischaemia exist (Burton et al, 1984; Zweier et
al, 1987; Garlick et al, 1987). The doubts that persist on the exact
role of radicals in myocardial ischaemia mean that although attractive,
much work must be completed before interventions may be used confidently
in man.
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1.6 ASSESSING NEUTROPHIL INVOLVEMENT IN VIVO
Although animal models have explored the factors believed to extend
tissue injury, evidence of abnormal neutrophil behaviour in man is
limited by observational difficulties. While the use of post-mortem
matter is possible in some cases, this material provides a restricted
"snap-shot view" of the pathologic process at the time of death.
Neutrophil behaviour can be studied in vivo by following their uptake
into sites of inflammation using radiolabelled autologous neutrophils.
Alternatively products of neutrophil activation and end-products of
free radical activity can be measured in serum or plasma.
The following section reviews the methods available for assessing
neutrophil and free radical involvement in the extension of myocardial
injury and justifies their use in this study.
1.6.1 Radiolabelling of White Blood Cells
Animal studies, particularly those performed in canine models, have
shown that experimental myocardial infarction may be imaged with
radiolabelled neutophils. A preliminary report demonstrated infiltration
of "'"^Indium labelled leucocytes administered 24 hours after
experimental myocardial infarction, into infarcted myocardium in dogs at
72 hours after coronary occlusion (Weiss et al, 1977). Later these
observations were extended by Thakur and co-workers (Thakur et al,
1979). This study, again in dogs, indicated that discrete uptake of
radioactivity could be imaged, 1-4 days after infarction, but not after
5 days. Furthermore, uptake was maximal in the zones of lowest flow and
occurred 24 hours post-infarction in the epicardium and at 72 hours in
the endocardium.
Following these encouraging animal studies methods for labelling
35
neutrophils to follow the acute inflammatory response to myocardial
infarction in man have been developed.
Several radionuclides have been used to label leucocytes but as the
neutrophil is the principle cell of the response, it is important to
distinguish methods that label any white cell from those that label
neutrophils.
A radioactive agent which is "ideal" for labelling cells should be
specific for the cell type, should neither elute from cells after
labelling ex vivo or in vivo, should cause little or no radiation
damage, should emit gamma radiation suitable for external detection and
lastly should have a half-life suitable for use in clinical studies.
Several radioisotopes have been assessed for cell labelling. The
first gamma-emitting compound used to label leucocytes was chromium-51
51
( Cr) in the form sodium chromate. It was not ideal since it was not
specific for neutrophils, had low labelling efficiency and was also
found to accummulate in the reticulo-endothelial system of the liver and
the gastrointestinal tract in vivo (Eyre et al, 1970).
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Gallium-67 ( Ga) has also been used to detect sites of infection and
inflammation, either by direct administration to the patient or as a
leucocyte labelling agent. The efficiency associated with gallium
labelling of leucocytes is low and variable and also the associated
radiation burden is high (Lantier et al, 1980).
0gm
Although Technetium is an ideal imaging agent at the time of this
00 j-J^
study effective methods of labelling leucocytes with Technetium
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McAfee (McAfee et al, 1976) showed 11"I'Indium chelates to have
physical characteristics superior to tracers previously used for cell
labelling as it emits two gamma photons 173keV (84%) and 247keV (94%)
which are suitable for external detection by gamma camera imaging. A
half-life of 67 hours allows studies to be performed over a period of a
few days without having to administer large quantities of radioactivity
but not so long as to impart prolonged radiation to the patient after
the study is completed.
Indium can be complexed to a number of ligands. Over the years a
number have been developed such as acetlyacetone and
tetraphenylporphyrin (McAfee et al, 1976), but two ligands, oxine
(Dewanjee et al, 1981) and tropolone (Danpure et al, 1982) have proved
most useful for use in clinical studies.
Oxine (or 8-hydroxyquinoline) is a lipophilic chelating agent and
bacteriostatic, used for many years as a topical antiseptic, fungicide,
antiperspirant and spermicide (McAfee et al, 1984). It forms 3:1
3
complexes with trivalent cations like indium (stability constant 10 ) or
did not exist (McAfee et al, 1984). Since the completion of these
studies a lipid soluble agent, Hexamethylpropylene amine oxime (HMPAO),
formerly used to assess regional cerebral blood flow (Ell et al, 1985),
has been used to label mixed leucocyte populations. Although this
leucocyte labelling method has been used successfully to image
inflammatory lesions (Peters et al, 1986), there have been no reports of
its use in the detection of acute myocardial infarction.
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iron, with a nett charge of zero. Due to its lipophilic properties it
readily penetrates cellular or bacterial membranes. Once intracellular,
the complex is thought to dissociate, with indium binding firmly to the
nuclear and cytoplasmic proteins while oxine remains diffusable (Thakur
et al, 1977).
Since oxine forms complexes with plasma transferrin, the cells must
be resuspended in saline to allow efficient labelling. In contrast,
tropolone (or 2-hydroxy-2,4,6-cycloheptatiene-l-one), another lipophilic
chelating agent, which also forms a 3:1 complex with indium, is suitable
for cell labelling in plasma (Saverymuttu et al, 1983).
The relative merits of using the tropolone or oxine ligand of
indium-Ill for leucocyte labelling remains controversial. In vitro tests
of cell function, after labelling with tropolone and oxine, have
produced variable results (Zakireh et al, 1979; Haslett et al, 1985).
Kinetics studies of neutrophils labelled with ''""'""'"Indium tropolone showed
a rapid passage of the cells through the lungs indicating a "healthy"
cell population and was attributed to cell labelling in plasma
(Saverymuttu et al, 1983).
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In spite of this, since Indium-oxine was first proposed as an
agent for labelling leucocytes (McAfee et al, 1976), it is still the
most widely used method for cell labelling and imaging inflammatory
processes.
The main disadvantage of the use of """"""Indium-oxine, as with those
also discussed, is that it is a non-specific label and therefore the
cell of choice must be isolated prior to labelling. Even for labelling
mixed leucocyte suspensions, the bulk of the erythrocyte population must
be removed as they are around a thousand times more numerous than the
white cells in whole blood. Isolation of neutrophils from other
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leucocyte types, particularly the lymphocyte, is also desirable since
there are reports that radiolabelling this cell type may have several
detrimental effects including induction of severe chromosomal
aberrations (ten Berge et al, 1983).
1.6.2 Techniques of Isolating White Blood Cells
Simple centrifugation of anticoagulated whole blood results in the
formation of a "buffy coat", but as only around one third of the total
leucocyte population are recovered by aspiration of this layer (Roy et
al, 1971), alternative methods to improve this have been investigated.
Erythrocyte sedimentation is the most widely used method of obtaining
'mixed' leucocyte suspensions. In 1968 Boyum, developed a simple method
of hastening the spontaneous settling of red cells at unit gravity by
the addition of an erythrocyte clumping agent. Several such agents
including 2% methylcellulose, 6% dextran and 6% hydroxyethyl starch have
been used successfully for this purpose (Pfeiffer et al, 1982; Danpure
et al, 1982; Segal et al, 1978).
To further purify the leucocyte-rich plasma suspension obtained from
erythrocyte sedimentation of whole blood, density gradient (or
Isopycnic) centrifugation is often employed. This method of cell
separation is governed by Stokes' Law, which states that the rate of
sedimentation in a centrifugal field is zero when the cell encounters a
medium of equal density. When isolating cells on discontinuous density
gradients, the cells migrate until they reach the interface of a
solution equal to or greater than their own density; hence, cells of
different densities come to rest at different depths.
Since Boyum (1968) showed that Ficoll (produced by the
co-polymerisation of sucrose molecules with epichlorohydrin to give a
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polysaccharide with an average molecular weight of 40kD) could be used
to isolate lymphocytes, researchers have tried many modifications of
this for isolation of other leucocyte types.
Perhaps the method most widely used is separation on a density
gradient composed of a polysaccharide like Ficoll, in combination with
iodinated gradient solutes. Gradients of glycogens, dextrans and other
materials have been used, however the commonest is Ficoll (Pharmacia ,
Uppsala, Sweden), and is generally used in combination with iodinated
gradient solutes. Most iodinated compounds used as gradient media have a
structure based on tri-iodobenzoic acid to which hydrophilic groups are
attached to increase the solubility of these in water eg Hypaque,
Isopaque, Metrizamide and Nycodenz (Nyegaard and Co. Oslo, Norway).
A refinement of the Boyum technique was described by English and
Anderson (English et al, 1974) and involved the separation of leucocyte
rich plasma on Ficoll-Hypaque density gradient media comprised of two
layers (specific gravity 1.076 and 1.120).
Isolation of cells can be achieved in a single centrifugation step
using a single density solution of Ficoll-Hypaque. Ferrante and Thong
(1978), found that a mixture of these two components with specific
gravity 1.095 caused leucocytes to separate into two bands on
centrifugation: lymphocytes in the uppermost and neutrophils in the
bottom layer. In later experiments, the density for optimal resolution
was determined to be slightly greater, at 1.114g/ml (Ferrante et al,
1980).
Percoll (Pharmacia, Uppsala, Sweden) is another media used for
density gradient centrifugation. The density of this mixture of silica
particles of 15-30 nm diameter, coated with polyvinylpyrrolidone (PVP)
can be varied over a wide range by adding balanced salt solutions,
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sucrose (0.25M), or even plasma. In one such variation of the use of
this material, Percoll is diluted with physiological buffer or platelet
poor plasma to three densities: 1.1, 1.0875 and 1.0697 and a tri-layer
gradient prepared (Dooley et al, 1982). After centrifugation, the
neutrophils are found in the middle of the gradient between the
lymphocytes and the contaminating erythrocytes.
Until a radio-pharmaceutical with total specificity for the cell of
interest is developed, isolation procedures will continue to be
required. These methods must therefore result in isolation of a "pure"
and "functional" cell population.
In this study two methods for isolating neutrophils from whole
blood were compared in terms of efficiency, selectivety, ease and
duration of execution and finally on the "activation status" of the cell
isolate.
1.6.3 Clinical Applications
The results of early attempts to image autologous radiolabelled
neutrophils in patients with myocardial infarction were poor. As part of
a larger study of inflammatory disease, four patients with acute
myocardial infarction were studied using this technique, however uptake
of neutrophil-associated "" Indium in the area of infarction was not
demonstrated in this small sub-group of patients (McDougall et al,
1979).
In a later study, factors which influenced the outcome of imaging the
inflammatory response to myocardial infarction were assessed in a larger
group of 36 patients. "'"''"Indium activity in the myocardium, representing
neutrophil uptake, was evident in 21 of these subjects (Davies et al,
1981). Although several parameters, including serum creatine kinase,
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infarct site, use of anti-inflammatory drugs, were evaluated, only the
age of the patient and the interval between infarction and the time to
injection of the radiolabelled neutrophils played a crucial role in the
outcome of imaging. These studies addressed the possibility of using
labelled neutrophils to demonstrate infarction, however with the
99m
development of improved infarct imaging agents such as Technetium
pyrophosphate, investigators abandoned the use of labelled neutrophils
for the diagnosis of infarction (Klein et al, 1978).
My objective was to determine if improved isolation and labelling
techniques would allow the study of in vivo behaviour, of neutropils in
man after myocardial infarction.
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1.7 ASSESSING NEUTROPHIL ACTIVATION
There are a number of ways in which neutrophil function and
activation status may be assessed. Evaluation of neutrophil locomotion,
usually directional (chemotaxis), or interactive reactions such as
aggregation or adherence, are often useful tests. Also measurement of
products of the neutrophil respiratory burst (superoxide and hydrogen
peroxide) and degranulation (lactoferrin, myeloperoxidase, elastase) may
also serve as a valuable measure of the activation or competence of the
cell population.
Many of these tests are used by specialised haematology laboratories to
identify diseases in which neutrophil function is abnormal. For example,
defective neutrophil adherence and hydrogen peroxide production is found
in leucocyte adhesion deficiency (LAD) and of chronic granulomatous
disease (CGD) repectively (Wilkinson, 1974).
The following techniques may be used to assess neutrophil function.
1.7.1 Motility a) Direct Microscopic Examination
The motility of neutrophils may be observed by light microscopy.
However as this technique only allows the assessment of a single cell
population at a time, dose effect relationships and other multiple
preparations of cells are impossible and hence has limited research
applications.
b)Agarose Technique
First introduced by Cutler (Cutler, 1974) and later popularised by
several groups since then (Nelson et al, 1975).
This method allows measurement of directional (to the chemotactic
source) and randomn locomotion (vehicle substance) of neutrophils in
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agarose towards "wells" containing the test substance. An inherent
problem of this method is that the concentration gradient of the test
substance will vary during incubation, as the factor will itself diffuse
through the agar.
c.) Filter Techniques
Based on the principle of active neutrophil trans-membrane migration
towards chemotactic stimuli, the Boyden Chamber (Boyden, 1962) and the
raft modification of Addison and Babbage (Addison et al, 1976) are the
two main methods used. While the raft modification allows multiple
determinations, these methods remain lengthy and labour intensive.
1.4.2 Neutrophil Adherence
The adherence reaction of neutrophils may be assessed on artificial
substrates such as nylon wool (MacGregor et al, 1974) and other plastics
(Yakuwa et al, 1989; Oez et al, 1990). The advent of in vitro tissue
culture methods (Jaffe et al, 1973), providing a more physiological
interface has also allowed the role of endothelial cells in neutrophil
adherence reactions to be investigated (Miller et al, 1988; Toothill et
al, 1990).
1.7.3 Neutrophil Aggregation
These tests were derived from existing platelet aggregation
technology and are therefore based on the assumption that, like
platelets, neutrophils can adhere, aggregate and undergo a release
reaction. The two main methods employ light transmission (Yuli, 1984)
and electrical impedence (Russell-Smith et al, 1982) which relate to the
aggregability of the neutrophil population under test.
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1.7.4 Products of the Respiratory Burst
The ability of neutrophils to generate these products may be used to
indicate neutrophil competence.
a) Superoxide Production
Generation of superoxide may be determined by measuring superoxide
dismutase (SOD)-inhibitable cytochrome c reduction (Baboir et al, 1973).
As many electron donors can reduce cytochrome c, the inclusion of SOD
confers specificity to the assay, as only superoxide is destroyed by
SOD. Methods of continuous recording changes in absorbance are tedious
and permit sequential analysis of a limited number of samples, however
the development of a rapid microassay allows simultaneous measurement of
hydrogen peroxide (Pick et al, 1981).
b) Hydrogen Peroxide Production
Hydrogen peroxide production may be measured by the loss of
fluorescence of scopoletin following exposure to hydrogen peroxide in
the presence of horseradish peroxidase (HRPO) (Root et al, 1975). While
this method is very sensitive it requires the availablity of specialised
equipment and as a result a simpler method that involves measurement of
HRPO-dependent oxidation of phenol red (Pick et al, 1980) is generally
preferred.
1.7.5 Detection of Neutrophil Granule Release
Detection of extracellular release from neutrophil granules may also
serve to indicate the activated state of the cell population. Assays
that measure beta-glucuronidase (Mitchell et al, 1970), myeloperoxidase
(Baggiolini et ail, 1969) and elastase (Beith et al, 1974) provide
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evidence of primary granule release. Lactoferrin, degranulation of
secondary granules (Quie, 1983), while lysozyme (Shugar, 1952) may be
used as a marker of release from both granules.
The two main limitations of the use of most of these methods is that
almost without exception these tests require the isolation of
neutrophils from whole blood for subsequent testing and, since the
process of isolation itself may lead to altered function then the
results of such tests must be interpreted with care. Secondly large
volumes of blood are usually requisite for neutrophil isolation
(40-50ml), and are not ideally suited for repeated assessment over short
time intervals, as in the case in myocardial infarction and in other
such acute events.
A more convenient approach would allow measurement of markers of
neutrophil activation or degranulation in small volumes of blood without
requiring neutrophil isolation so that unnecessary disturbance to
patient care would be kept at a minimum.
1.7.6 Neutrophil Elastase Release
Since elastase is found in high concentrations in neutrophils
7
(4.6ug/10 cells; Plow et al, 1982) with little additional contribution
from other blood elements, and in view of its degradative potential in
vivo (Mainardi et al, 1980; Taylor et al, 1977), this enzyme is
considered most appropriate for diagnosing and monitoring inflammatory
conditions (Ohlsson et al, 1978; Janoff, 1985).
Elastase is synthesised primarily at the promyelocyte stage in the
development of the neutrophil and is stored in the cytoplasmic
azurophilic granules of the mature cell. The enzyme is a single chain
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polypeptide of molecular weight 33kD, with a strongly basic isoelectric
point (pH 10 to 11). It has several iso-enzymes and is active at neutral
pH (Ohlsson et al, 1974).
Elastinolytic proteinases have also been identified in platelets and
monocytes as well as in neutrophils (Janoff, 1985).
The enzyme in platelets is present in small amounts (Robert et al,
1970) and although not very well characterised, appears to be an
elastase distinct from that of the neutrophil on the basis of
immunologic criteria (Legrand et al, 1975).
Human monocyte elastase is antigenically and biochemically similar to
the elastase of neutrophils, but on a per cell basis, monocytes contain
considerably less elastase than neutrophils and is located at the plasma
membrane (Janoff, 1985).
1.7.7 Methods for Detecting Neutrophil Elastase
Methods of measuring neutrophil elastase in its free and complexed
form have been developed.
Activity assays measure free elastase by its ability to degrade
chromogenic (Hart, 1984) or fluorogenic substrates (Toothill et al,
1990) in the absence of inhibitors and therefore are more appropriate
for detection in cell-free systems than for use in plasma.
Immunological detection by two different methods, one a standard
radioimmunoassay (RIA) (Greer, 1989) and the other, a double antibody
enzyme-linked immunoassay (ELISA) technique (Neumann et al, 1983) does
allow for in vivo detection of neutrophil activation in plasma, sera and
other biological fluids.
Plow first described the immunological detection of neutrophil
elastase as a marker of neutrophil activation (Plow, 1982). From his
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studies he concluded that "normal plasma appeared to contain a basal
level of leukocyte elastase-related antigen that could not be attributed
to in vitro liberation of the enzyme from leukocytes". Since the
presence of calcium ions was found to result in extracellular release of
elastase (without cell lysis) the choice of anticoagulant was shown to
be an important determinant of the plasma level of elastase.
Consequently, citrate or ethylenediamine tetra-acetic acid (EDTA), are
recommended as the anticoagulants of choice.
The ELISA technique described by Neumann and co-workers in 1983 was
subsequently developed by Merck, Germany. This method .measures elastase
in complex with its natural inhibitor alpha-l-antiproteinase. The
availablity of this prohibitively expensive detection system however
post-dated this study.
Therefore despite inherent disadvantages of the use of radioisotopes
in detection systems, the radioimmunoassay used here provided a simple
and specific assay system which could detect the free enzyme as well as
its complexed form. This standard RIA employed polyclonal rabbit
antisera raised in-house. The antibody was specific for neutrophil
elastase and did not cross-react with either monocyte or platelet
elastase. This assay system provided a simple means of assaying large
sample numbers with a high degree of sensitivity and precision (Dawes
1987) .
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1.8 Measurement of Free Radical Species
1.8.1 Free Radicals: Definition
Most chemical reactions occur via heterolytic fission and formation
of covalent bonds. However homolytic fission can also take place, thus
generating species possessing an unpaired electron, that is a radical.
Electrons in atoms or molecules occupy regions of space known as
"orbitals". The maximum number of electrons is two and these spin in
opposite directions. Therefore a free radical may be defined as " any
species capable of independent existence that contains one or more
unpaired electrons" (Halliwell, 1989).
There are a number of ways in which a free radical may be generated
from neutral molecules; by photolysis, thermolysis, via redox reactions
mediated by inorganic ions, metals and electrolysis that involves
one-electron transfers.
Free radicals, thus generated are highly reactive species and have a
very short life span; in the order of magnitude of microseconds. These
species may react with other molecules in several different ways. The
interaction of two free radicals may result in the formation of a
covalent bond, shown below;
X- + X' X-X
Alternatively, a free radical species may donate its single electron or
may abstract a free radical from another molecule. As a result a
non-radical molecule may itself become a free radical species and
demonstrates the ability of these moieties to generate free radical
chain reactions (Slater, 1984).
The existence and chemistry of free radicals was first studied by
49
radiation chemists. The products of free radical initiated chain
reactions and their applications in every day life are numerous. For
example a free radical initiated polymerisation reaction is used to
R
manufacture Teflon , the non-stick coating for frying pans. Probably one
of the most common chain reaction known to modern man is the oxidative
breakdown of alkanes in the internal combustion engine.
In the mid 1950's, Gilbert first suggested that damage to living
organisms under conditions of high oxygen concentrations, could be
attributed to the formation of free radicals (reviewed in Gilbert,
1981). It was not until several decades later that the identification of
an enzyme that was specific for the removal of radicals (McCord, et al,
1969), now known as superoxide dismutase (SOD), led to general
acceptance of the theory that oxygen free radicals may mediate damage to
biological systems.
Free radical reactions are vital for the normal operation of a wide
spectrum of biologic processes. Endogenous sources of free radicals
include those which are generated and act intracellularly, as well as
those formed within the cell and released into the surrounding
environment. Sites of free radical generation encompass all cellular
constituents including the electron transport system in the mitochondria
and peroxisomes. Exogenous sources include tobacco smoke, certain
pollutants and pesticides (Slater et al, 1984).
Several regulators of free radical activity exist. Superoxide
dismutase, catalase and glutathione peroxidase are among the
intracellular enzyme systems which control the levels of superoxide and
hydrogen peroxide. There are also several naturally occurring agents
that directly scavenge free radicals which react to produce less harmful
radical species. These antioxidants include vitamin E, vitamin C,
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beta-carotene and thiols (Machlin et al, 1987).
Under normal conditions these and other regulatory mechanisms
maintain the balance between radical production and destruction, but in
pathological conditions perturbations of these mechanisms may occur
leading to free radical-induced tissue damage.
The reactive nature and lack of selectivety in targetting potential
substrates, does not help to confine free radical activity in vivo
purely to physiological ends. Polyunsaturated fatty acids are found in
all cell membranes and are particularly susceptible to oxidation by free
radicals (Burrell et al, 1989). Damage to proteins (Dilley et al, 1984),
nucleic acids (Hoffman et ail, 1984) and lipids (Lunec et al, 1979) has
been attributed to the action of free radicals.
1.8.2 Methods of Detection
The short half-life and instability of these species makes their in
vivo measurement very difficult and was aptly described by Dormandy as
the "diagnostic block" (Dormandy et al, 1983).
Consequently, almost all the methods of detection involve indirect
measurement of products of free radical interaction.
The exception to this is electron spin resonance spectroscopy (ESR)
which allows free radicals to be detected directly in tissues. This
technique has been used in the field of pure chemistry for a number of
years, but only recently has it been applied to biochemical and
biological systems.
The principle of radical detection is based on the application of a
magnetic field which reverses the spin of the radicals. Thus ESR
measures energy changes that occur as a result of the change of spin
direction, not unlike that employed in nuclear magnetic imaging (Symons,
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1982). However until this detection system can be adapted successfully
for application in humans, as in the case of nuclear magnetic, resonance
spectroscopy to magnetic resonance imaging, this will be useful only for
in vitro studies and animal models (Hess et al, 1981; Garlick et al,
1987; Zweier et al, 1987).
Most other methods for evaluating free radical activity rely on the
measurement of alteration to proteins and peptides (Henricksen, 1976),
nucleic acids (Henricksen, 1976), and lipids (Iversen, 1985) as a
consequence of free radical interaction, or alternatively, the
concentration of regulators such as superoxide dismutase (Misra et al,
1977), caeruloplasmin (Menden et al, 1977) and plasma and red cell thiol
levels (Ellman et al, 1959).
Methods of measuring alterations of lipid structure under the action
of free radical attack, have been the most common means of assessing
free radical activity (Dormandy, 1983). Polyunsaturated lipids in cell
membranes are particularly sensitive to free radical attack; these
molecules consist of double bonds which are interrupted by methylene
groups. The hydrogen bonds of these groups are relatively weak and may
be easily abstracted by free radical species. After such an abstraction,
the resulting sequence of events may proceed in several ways.
In situations of oxidative stress, auto-oxidation may result. This is
one of the main free radical reactions in vivo and is the low
temperature oxidation of organic compounds by oxygen or oxygen free
radical products. Here, oxygen is considered a biradical ("0-0"). The
initial stage is commonly the formation of hydroperoxides
eg R-H -> R00H
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so is in effect a nett overall displacement, though the actual pathway
involves a hydrogen abstraction and 0^ addition.
Alternatively, in vitro experiments have shown that isomerisation of
the lipid radical (Iversen et al, 1984) through the stabilising
delocalised orbitals, may occur in the presence of protein.
All of these products, including the parent molecule, linoleic acid,
have the property of diene conjugation and so absorb light at 230-250nm.
These products may be detected by the thiobarbituric acid test (TBA)
(Yagi, 1976) or diene conjugation (Iversen et al, 1985).
a) The Thiobarbituric Acid Test (TBA)
This is one of the oldest and most frequently used tests for
measuring the peroxidation of fatty acids, cell membranes and food
products.
The principle of the test is that lipid peroxides react with TBA with
the subsequent development of colour. This pink colour is due to the
formation of an adduct between TBA and malondialdehyde under acidic
conditions which can be measured at 532nm.
The early TBA reaction, while simple and sensitive (Berheim et al,
1948), had low specificity. This was improved by including a
modification that isolated lipid peroxides from other TBA reacting
substances (Yagi et al, 1976). Since then further modifications of the
method have been made so that measurements on very small samples are
possible and also interference by common biological substances such as
bilirubin, glucose and sialic acid is reduced (Yagi, 1982).
In attempts to reduce interference in the measurement of the
thiobarbituric acid adduct of malondialdehye, several modifications to
the detection systems have evolved; using high performance liquid
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chromatography (HPLC), (Wong, 1987), fluorometric (Yagi, 1984) and
spectrophotometry methods (Bird et al, 1984). Nonetheless doubts on its
specificity and interpretation of results still persist.
b) Diene Conjugation
Diene conjugated isomerism was studied by Cawood in serum, bile and
duodenal juice and identified the major products of free radical
activity in a number of systems (Cawood et al, 1983). The use of
ultraviolet radiation in the presence of protein helped to identify two
of the diene products, linoleic acid (18:2(9,12) or (PL-9,12-LA) and the
non-peroxide diene conjugate (18:2(9,11) or PL-9,11-LA'). The latter
isomer was shown to account for over 90% of the diene conjugation in
plasma, tissues and fluids (Cawood et al, 1983).
On the basis of this work a method for measuring the diene-conjugated
derivative of PL-9,11-LA' in the phospholipid fraction of serum was
devised (Iversen et al, 1985). This method is based on enzymatic
hydrolysis, protein precipitation with final analysis by HPLC and allows
measurement of the parent molecule PL-9,12-LA and its isomers.
As with the TBA assay there are critics who question the relevance of
the use of the diene conjugation assay since the mechanism by which
PL-9,11-LA' originates in man has been questioned (Thompson et al,
1985). The dietary composition of fatty acid is known to affect the
pattern of fatty acids esterified into serum phospholipids (Holub et al,
1978) and may be reflected in tissue and cellular phospholipids, however
such an effect has not been reported (Iversen et al, 1985).
While each method has its limitations, where several of these methods
have been compared there is generally good correlation (Burrell et al,
1989). Therefore despite the problems associated with these indirect
methods of measurement, both are, and continue to be used widely in the
measurement of end-products of free radical interaction in human studies





Procedures used repeatedly throughout this work are described in this
chapter. More specific methods are described in the relevant chapters.
2.1 ISOLATION OF HUMAN NEUTROPHILS FROM WHOLE BLOOD
2.1.1 Materials
Mono-Poly Resolving Medium (M-PRM, Flow Laboratories Ltd.)
Phosphate buffered saline, pH 7.4 (PBS)
Preservative-free sodium heparin injection BP, Leo Laboratories Ltd.
2.1.2 Method
All separations were carried out in a laminar flow cabinet using aseptic
technique.
From each subject, 60ml of venous blood was collected via a 19G infusion
set into a sterile syringe containing 300 units of preservative-free
sodium heparin.
In duplicate, 25ml of blood was carefully layered over 12ml of Mono-Poly
Resolving Medium (M-PRM), in sterile 50ml polypropylene centrifuge
tubes. Any bubbles generated during this transfer were burst with a
sterile needle. The tubes were spun at 400g for 45 minutes at room
temperature. Differential cell migration during centrifugation results
in formation of two distinct white cell bands. The upper is composed of
predominantly mononuclear cells and the lower, mainly polymorphonuclear
leucocytes, with the erythrocytes forming a pellet at the bottom of the
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tube. Figure 2(a).
From the top platelet rich plasma layer, 10ml was collected and spun at
lOOOg for 10 minutes to provide platelet poor plasma (PPP) and laid
aside until required.
The remaining plasma and the mononuclear leucocyte band was carefully
removed with a sterile pasteur pipette and discarded. The remaining
polymorphonuclear leucocyte band was gently aspirated and transferred to
a 40ml volume of phosphate buffered saline (PBS) and spun at 400g. The
supernatant was aspirated, the cells resuspended and washed twice in
PBS. The supernatant was discarded and the cells resuspended in PBS
(10ml) for radiolabelling. An aliquot of the cell suspension was taken
for a manual leucocyte count.
2.2 MANUAL LEUCOCYTE COUNT
2.2.1 Materials
New Improved Neubauer chamber (0.100mm)
Cover glass (22x25mm) BS748, Weber Scientific International Ltd.
2% acetic acid coloured pale violet with gentian violet crystals (1:20)
2.2.2 Method
Manual cell counts were performed on whole blood and the cell isolate as
follows:
A 1:20 dilution of either whole blood or the leucocyte suspension was
made in 2% acetic acid coloured with gentian violet crystals and allowed
to mix thoroughly for 10 minutes. Each side of the counting chamber was













M-PRM mono-poly resolving medium
PMNs polymorphonuclear leucocytes
RBC red blood cells
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for 15 mins to allow complete lysis of contaminating erythrocytes. The
leucocytes, with their nuclei stained deep violet/black, were counted
3
over an area representing (0.4 mm ). This was done on each counting grid
of the chamber to improve accuracy.
9
Cell numbers were expressed as N x 10 /litre.
2.3 LABELLING NEUTROPHILS WITH —INDIUM OXINE
2.3.1 Materials
^""^Indium oxine (1ml, 20-40 MBq) , Amersham International pic.
Phosphate buffered saline, pH 7.4, (PBS).
Autologous platelet poor plasma (PPP)
2.3.1 Method
All procedures were carried out using aseptic technique.
The isolated neutrophil population was resuspended in 10ml of phosphate
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buffered saline (PBS), in a 15ml conical tube. Indium oxine solution
(lml) was added dropwise to the suspension and incubated undisturbed for
15 minutes at room temperature. Autologous platelet poor plasma (PPP,
3-4ml), isolated during the separation procedure, was added to the
labelled cell suspension and centrifuged at 250g for 10 minutes. The
resulting cell pellet was resuspended to 5ml with equal volumes of PPP
and PBS. The activities of the cell pellet and supernatant were measured
in a radioisotope callibrator (Capintec Inc, ARC 120, Montvale, New
Jersey, USA) and from this the labelling efficiency was calculated.
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2.4 HUMAN NEUTROPHIL ELASTASE RADIOIMMUNOASSAY
This assay was developed by the Scottish National Blood Transfusion
Service (SNBTS)/MRC Blood Components Assay Group, in Edinburgh under the
guidance of Dr J Dawes.
This was a standard, specific radioimmunoassay which used rabbit
polyclonal antisera raised 'in-house'. The antigen was purified from
human neutrophils obtained after leucopheresis. The antibody was
specific for neutrophil elastase and did not cross-react with
pancreatic, monocyte or platelet elastase. The assay measured neutrophil
elastase equally well in its free form or complexed to its natural
inhibitors alpha-l-proteinase inhibitor or alpha-2-macroglobulin.
Results are expressed as ng/ml.
2.4.1 Sample Collection
Whole blood (5ml), was collected into a tube containing 3.12% trisodium
citrate in 5% HEPES buffer, mixed thoroughly and centrifuged at lOOOg
for 10 minutes at 4°C. The plasma fraction was carefully aspirated and
stored at -20°C until assayed, usually within a week of sampling.
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2.4.2 Materials
Rabbit anti-neutrophil elastase antibody-
Donkey anti-rabbit immunoglobulin immobilised on
Sepharose, made by the Cyanogen Bromide method
125
Human I-granulocyte elastase (used at lOng/ml in
Assay Buffer) labelled using the Chloramine-T method
0.05M phosphate pH 7.4 (PO )
0.6M NaCl
2mM di-sodium EDTA
130ug/ml heparin (porcine), Sigma Chemicals Ltd.
20U/ml aprotonin
2% heat-inactivated horse serum
10% sucrose solution in 0.05M PO , 2% heat-inactivated
horse serum, 1% Tween 20.
Quality Control Fresh frozen plasma of assigned value.
Standards Fresh frozen plasma (20ng/ml), doubling dilutions from
neat to 1/128.
2.4.3 Method
All sample dilutions were made in assay buffer (see materials).
Plasma samples were assayed at a 1/10 dilution. Doubling dilutions of
standard fresh frozen plasma (20ng/ml) from neat to 1/128 were used for
the standard curve.
To 50ul of standard or sample, 50ul of anti-elastase antibody (used at
125
1:6000 dilution) and 50ul of I-elastase (lOmg/ml) was added and made






mixed and incubated overnight at room temperature. After the addition of
donkey anti-rabbit immunoglobulin immobilised on Sepharose (1ml at a 1:6
dilution) and vigorous shaking, the bound complex was separated from
free by sedimentation at unit gravity through a 10% sucrose solution.
The samples were counted on a NE1600 gamma counter. Results are
expressed in ng/ml. Figure 2(b) shows a typical standard curve for this
assay.
2.5 MEASUREMENT OF LINOLEIC ACID AND THE NON-PEROXIDE DIENE CONJUGATE
The molar concentrations of linoleic acid (PL-9.12-LA) and and its
non-peroxide diene conjugate (PL-9,11-LA') in plasma were measured by
high performance liquid chromatography (HPLC), after enzymatic
hydrolysis with phospholipase A^ and solid-phase sample preparation as
described by Iversen et al, 1985.
Plasma was obtained from heparinised blood samples. PL-9,11-LA'
concentration was measured by HPLC, using a sherisorb 0DS2 column, a
mobile phase of acetonitrile/water/acetic acid (85:15:0.1) at a flow
rate of 1.5ml/min, and ultraviolet (UV) detection at 234nm. An internal
standard of PL-9,11-LA' trans isomer was used.
Plasma (0.5ml) was incubated for 15 minutes with TRIS buffered
phospholipase A^ to permit enzyme hydrolysis, then the proteins were
precipated by the addition of methanol containing the internal standard.
After centrifugation, the supernatant was passed through a
preconditioned "Bond Elut" column, then, after washing, was eluted with
lml of propan-2-ol/acetonitrile (2:1). Aliquots of the eluate were
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Figure 2(b)
Example of a typical Standard curve for Neutrophil Elastase
injected directly onto the column. The intra-assay coefficient of
variation was less than 3.5%. The results were expressed as umol/1.
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CHAPTER 3
COMPARISON OF TWO METHODS FOR ISOLATING HUMAN NEUTROPHILS
3.1 INTRODUCTION
Neutrophil labelling with gamma-emitting radionuclides for kinetic
studies as well as for imaging inflammatory foci is a useful, yet
relatively new technique (Thakur et al, 1977).
Because most radioactive agents for cell labelling are non-selective,
it is generally necessary to isolate the type of leucocyte of interest.
In this chapter, a comparison is made between two methods for
isolating neutrophils from whole blood. The first is a modification of a
single step method (Ferrante et al, 1980), and uses "Mono-Poly Resolving
Medium", (M-PRM) a solution commercially available from Flow
Laboratories Ltd.
The second method involves the use of a red cell sedimenting agent,
hydroxyethyl starch (Plasmasteril, Fresenius), followed by further
separation on a discontinuous density gradient composed of a
plasma/Percoll mixture (Pharmacia, Uppsala).
A comparative study of the neutrophil recovery, viability of the
isolated cells, degree of contamination by other cellular elements and
the time and technical expertise required to execute each of the methods
was made.
A total of 15 comparisons were carried out on blood samples from
normal laboratory staff. In a sub-group of 10, a differential leucocyte
count was made on the cell isolates to assess the purity of the cell
population recovered from each method.
65
3.2 MATERIALS AND METHODS
3.2.1 Blood Collection
Materials
Anticoagulant 0.3ml (300 units) Preservative free sodium heparin
(1000 units/ml) Leo Laboratories Ltd.
'19G' Butterfly infusion set
60 ml sterile syringe
Method
All procedures were performed using aseptic technique.
From each normal subject venous blood (60 ml) was collected from the
antecubital fossa via a 19G Butterfly infusion set into a sterile
syringe containing 300 units preservative-free sodium heparin.
A full blood count was performed on each sample and the remainder split
equally between the two techniques to be assessed.
3.2.2 Cell Counts
Materials
New Improved Neubauer Chamber (0.100mm)
Cover glass (22x25mm) BS748, Weber Scientific International Ltd.
2% acetic acid coloured pale violet with gentian violet crystals (1:20)
Method
Manual cell counts were performed on whole blood and the cell isolate as
follows:
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A 1:20 dilution of either whole blood or the leucocyte suspension was
made in 2% acetic acid coloured with gentian violet crystals and allowed
to mix thoroughly for 10 minutes. Each side of the counting chamber was
filled with the cell solution and left undisturbed in a damp atmosphere
for 15 mins to allow complete lysis of contaminant erythrocytes. The
leucocytes, with their nuclei stained deep violet/black, were counted
3
over an area representing (0.4 mm ). This was done on each counting grid
of the chamber to improve accuracy.
9
Cell numbers were expressed as N x 10 /litre.
3.2.3 Cell Staining Techniques
Materials
Water tight staining baths (2)




Clean glass slides were smeared with either whole blood or a few drops
of cell isolate and allowed to air dry. These were flooded with 1ml of
Wright's stain for 15 seconds and a further 2-3 minutes after the
addition of 1ml deionised water. After thorough rinsing the slides were
coverslipped in preparation for examination.
Initially the slides were scanned quickly at xlO to provide a general
overview. Then using a x50 oil immersion objective differential
leucocyte counts were performed by counting at least 300 cells to reduce
the inherent error associated with the random distribution of cells.
6 7
Differentials were recorded on whole blood and leucocyte suspensions.
3.2.4 Trypan Blue Exclusion Test
Materials
0.4% trypan blue stain (in 0.9% NaCl)
Phosphate buffered saline (PBS) pH 7.4
Haemocytometer and coverslip
Method
This method is based on the principle that viable cells exclude stain
from the cell interior and therefore allows enumeration of viable and
non-viable cells in a cell sample.
5
A suspension of the isolated cells (2-5x10 cells/ml) was prepared in
PBS (pH 7.4). Trypan blue was transferred to a test-tube containing
0.3ml of buffer (PBS) and 0.2ml of the cell suspension and mixed
thoroughly. This was allowed to stand for 5-15 minutes. With the
coverslip in place, a small amount of the trypan blue-cell suspension
was transferred to both chambers of the haemocytometer. All cells,
stained or non-stained, in a 1mm centre square and the four corner
squares were counted. The percentage of viable cells in the cell
preparation was calculated as:
% CELL VIABILITY = Total viable cells (unstained) x 100
Total cells (stained and unstained)
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3.3 Separation of Neutrophils from Whole Blood:
Comparison of two methods
3.3.1 Method One : A 'Single Step' Process
This technique involved the use of a single phase medium, Mono-Poly
Resolving Medium (M-PRM), produced commercially by Flow Laboratories
Ltd. M-PRM is a solution composed of a polysaccharide (Ficoll-400) and a
radiopaque contrast medium (Hypaque 85) in a specific ratio to yield a
density of 1.114+0.002 at 20°C. This mixture allows the resolution of
both mononuclear and polymorphonuclear (PMN) leucocytes into two
distinct bands in a single step. See Figure 3(a).
Materials
Mono-Poly Resolving Media (M-PRM), Flow Laboratories Ltd.
Sterile phosphate buffered saline, pH 7.4 (PBS)
Method
Venous blood (25ml) was layered over 12ml of M-PRM in a sterile 50ml
Falcon tube and centrifuged at 400g for 45 minutes at room temperature
(RT). Differential migration of the cells during centrifugation results
in two distinct cell bands and a red cell pellet. The top layer of
plasma was recovered by gentle aspiration with a pasteur pipette. The
remaining plasma and uppermost cellular band comprising mononuclear
leucocytes and platelets was discarded.
The cells in the lower of the two layers were predominantly
granulocytes. These were transferred into a 50ml polypropylene
centrifugation tube and washed twice in 40ml volumes of PBS. The
supernatant was discarded and the remaining cell pellet gently
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resuspended in a 10ml volume of phosphate buffered saline (PBS) for
evaluation of differential and absolute leucocytes counts and also for
estimation of viability.
3.3.2 Method Two : Density Gradient Separation after Red Cell
Sedimentation
This method of cell isolation requires an initial step to sediment out
the red cell population and is followed by separation of the remaining
cells on a discontinuous density gradient. The erythrocyte sedimentation
agent used was Plasmasteril and the discontinuous gradient comprised a
42% and 60% mixture of iso-osmotic Percoll and platelet poor plasma
(PPP). During centrifugation the mononuclear and polymorphonuclear
leucocytes accumulated at the plasma:42% and the 42%:60% interfaces
respectively. See figure 3(b).
Materials
Plasmasteril (Fresenius AG, Bad Homburg)
Percoll (Pharmacia, Uppsala, Sweden)
9% NaCl
Phosphate buffered saline, pH 7.4 (PBS)
Method
Plasmasteril (2.5ml) was added to 25ml of whole blood and gently
inverted to facilitate thorough mixing. Any bubbles present were burst
using a sterile needle. The red cells were allowed to sediment under the
action of gravity for 45 minutes at room temperature. The resultant
leucocyte platelet rich plasma (LRPRP) was aspirated and transferred to
a fresh tube and spun at 200g for 10 minutes to form a leucocyte pellet
7O
in platelet rich plasma. Platelet poor plasma (PPP) was obtained by high
speed centrifugation (lOOOg) of the platelet rich plasma from the
previous step.
Iso-osmotic Percoll was prepared by mixing nine parts Percoll (specific
gravity 1.13g/ml) with one part 1.5M sodium chloride (9% NaCl).
Iso-osmotic Percoll was diluted with PPP to obtain 42% and 60% solutions
of Percoll in plasma and 2ml volumes of each were overlayered to
construct a two-step discontinuous gradient. The mixed leucocyte pellet
was resuspended in PPP (4ml) and carefully layered on top of the
gradient and centrifuged at 200g for 5 minutes. The cells from the
42/60% interface were sampled, washed twice in PBS and resuspended in
10ml PBS for differential and absolute leucocyte counts and estimation
of cell viability.
3.4 STATISTICS
Results are expressed as mean+standard deviation. The data for the
separation processes using Methods 1 and 2 were analysed using




3.5.1 Total Cell Recovery
The total neutrophil count and neutrophil count in the cell isolate
were assessed manually using a New Improved Neubauer chamber. The cell
number recovered from the starting blood volume was expressed as a
percentage for each method.
The mean and standard deviation for 15 separations are shown in Table
3(i). The number of neutrophils recovered from 25ml of blood was
7
significantly greater using the M-PRM method (7.6+3.5x10 ,p<0.001) when
7
compared to the Percoll method (5.3+3.6x10 ). Correspondingly, the
percentage neutrophil recovery was also significantly higher using the
M-PRM method (63.3+14.0% vs 45.9+17.4%,p<0.01).
3.5.2 Differential Leucocyte Count
The purity of the isolated cell suspension was assessed in 10 of the
isolation procedures by performing a differential leucocyte on stained
films. A minimum of 300 cells were counted and the numbers of each cell
line were recorded and expressed as a percentage of the total number of
leucocytes counted. In addition, the number of erythrocytes per 100
leucocytes was also noted. Table 3(ii) shows the mean and standard
deviation and the range of the differential counts for 10 simultaneous
separations for Method 1 (M-PRM)and Method 2 (Percoll).
The neutrophil percentage present in the cell isolate for Method 1
(95.2+2.5%) was significantly higher than for Method 2 (87.2+ 4.8%,
p<0.001). In contrast, the lymphocyte presence in the cell suspensions
was significantly lower for Method 1 (2.2+1.2%) when compared to that of
Method 2 (10.2+4.6%; p<0.001). The mean percentages of monocytes,
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eosinophils and basophils for each method were low and did not differ
significantly. The degree of erythrocyte contamination using each method
was low at 9.8+5.8 red cells per 100 leucocytes for Method 1 and 8.5+5.3
red cells per 100 leucocytes for Method 2. There was no statistical
difference between the two methods.
3.5.3 Cell Viability
The neutrophils recovered by each of the methods showed no
significant difference in terms of viability as assessed by the trypan
blue exclusion test (Method 1: 98.7+ 1.2% vs 98.1+1.6% Method 2)
3.5.4 Time
The separation using the single step was completed approximately 60
minutes less than the discontinuous density gradient method.
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Table 3(i)






















































































M-PRM mono-poly resolving medium
PMNs polymorphonuclear leucocytes














PPP piateiet poor plasma
LRP leucocyte rich plasma
PMNs polymorphonuclear leucocytes
RBC red blood cells
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3.6 DISCUSSION
Isolation of neutrophils from whole blood is mandatory for
radiolabelling since current techniques allow neither labelling of
specific cell types in vivo nor in whole blood in vitro.
Many researchers have long sought a simple means of isolating
neutrophils from whole blood while maintaining their viability. All
separation techniques are bound to cause some change in the nature of
the cell, but until reliable specific in vivo labelling of neutrophils
is accomplished, these methods will continue to be used.
A method which would be considered 'acceptable' must therefore fulfil
certain criteria. First the method must yield an essentially 'pure'
preparation of neutrophils. Most radioisotopes, including
111
Indium-oxine will label all cell types in a blood sample. Ideally,
the red cells and other cell lines should constitute only a very low
percentage of the cell population to minimise competition for the
radionuclide. In particular, lymphocyte numbers should be as low as
possible, since several studies have shown that labelling this cell type
with "^"'"Indium oxine can result in spontaneous release of the label, 25%
at 24 hours, and a dose dependent reduction in the cells proliferative
capacity in response to several stimuli (ten Berge et al, 1983; Balaban
et al, 1987). Probably the most significant finding is that human
lymphocytes after exposure to ^"'"Indium oxine, but not its decayed form,
exhibit several chromosomal aberrations including gaps, breaks and
exchanges. It is well known that ionising radiation has mutagenic and
carcinogenic properties (Ischimari et al, 1971). Therefore, where
111
possible, it is advisable to avoid administering In-labelled
lymphocytes as contaminants of granulocyte suspensions. By preparing an
essentially pure isolate of neutrophils these two main problems should
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be circumvented.
Secondly, the requirement that the isolated cells are still
biologically competent is of paramount importance. Therefore to minimise
alteration in the functional and morphological integrity of the isolated
cell the separation method ideally should be a short, simple procedure
that requires a minimum of "cell manipulation".
Here, two methods were compared in these terms. The single step
procedure was shown to result in superior neutrophil isolation,
highlighted by a higher total recovery of neutrophils. The cell isolate
from this technique produced a "purer" preparation, with a significantly
greater proportion of neutrophils and a lower content of lymphocytes.
Red cell contamination was low for each method with approximately 8
erythrocytes per 100 leucocytes, which should not present significant
problems when using radionuclides such as indium because of the high
relative affinity of both of these chelating agents for granulocytes
compared with red cells (Weiblen et al, 1979).
The trypan blue exclusion test, a crude measure of neutrophil
viability showed no difference between methods. The time to complete
each method was taken into account and Method 1 was consistently
completed 60 minutes in advance of Method 2. The difference was mainly
attributable to the red cell sedimentation step required in the latter
case and also to the time taken to construct the discontinuous density
gradient.
In conclusion, Method 1, the single step procedure using Mono-Poly
Resolving Medium, satisfied the main requirements for a cell isolation
technique. Its use resulted in good neutrophil recovery, with little red
cell and virtually no lymphocyte contamination. The method was rapid and
involved less 'handling' of cells, thus reducing the risk of mechanical
79
damage and requiring less technical expertise
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CHAPTER 4
THE EFFECTS OF SEDIMENTATION AGENTS AND DENSITY GRADIENT MEDIA ON THE
NEUTROPHIL
4.1 INTRODUCTION
Chapter 3 detailed a comparison of two methods for isolating
neutrophils from whole blood. It concluded that the single step
procedure using Mono-Poly Resolving Medium (M-PRM), proved technically
easier, could be completed rapidly and resulted in isolation of a
'purer' neutrophil preparation than the method requiring initial red
cell sedimentation followed by separation through a discontinous density
gradient. However, while the M-PRM method has been proven to be superior
in this work, it is relatively new and techniques requiring red cell
sedimentation are still used routinely in many laboratories for
neutrophil isolation, with slight variations in the sedimentation agents
used and composition of the density steps in the discontinuous
gradients.
It is thought that the methods and materials used to isolate
neutrophils may alter the function of the cells (Saverymuttu et al,
1983). As a result there has been considerable interest in the methods
for isolating neutrophils (Haslett et al, 1985; Saverymuttu et al,
1983), and how these procedures may alter the function of the resultant
cells.
Ideally procedures for cell isolation should produce little or no
cell activation. In 1985, Haslett suggested that trace amounts of
bacterial lipopolysaccharide (LPS), found in preparations of
Ficoll-Hypaque but not Percoll, reduced the isolated neutrophil's
chemotactic responsiveness and increased lysosomal enzyme release upon
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stimulation with formyl-methionyl-leucyl-phenylalanine (FMLP).
Lane and co-workers demonstrated that isolated rabbit neutrophils,
when radiolabelled and subsequently reinjected, showed reduced
recirculation in vivo as a result of in vitro manipulation. In contrast,
these cells were shown to exhibit normal behaviour in in vitro tests for
chemotaxis or enzyme secretion (Lane et al, 1982) and therefore
questions the validity of in vitro methods of assessing cell function.
Neutrophils that are 'activated' cells become more 'adhesive' in
nature and this may explain delayed transit through the lung capillary
bed in vivo (Saverymuttu et al, 1983). Cells activated during isolation
from whole blood therefore, should not be reintroduced into the
circulation either as a qualitative test of cell function or as a
diagnostic tool for location of sites of inflammation.
As discussed in Chapter 1 there are many ways to assess cell function.
However, the majority of these techniques require cell isolation, the
process under scrutiny, therefore making such an assessment difficult.
Immunological detection of the release of neutrophil elastase from
neutrophils has been identified as a method of assessing neutrophil
activation (Plow et al, 1982), and can be measured in blood as well as
physiological media. Release of neutrophil elastase is by active
secretion, during phagocytosis or upon cell death, and is therefore a
sensitive index of its activated state.
In view of the concern and conflicting ideas surrounding the effects
of density gradient media and erythrocyte sedimentating agents on
neutrophil function, isolation procedures and their effect on neutrophil
activation was assessed.
The concentration of neutrophil elastase produced during incubation
of whole blood with three erythrocyte sedimentation agents;
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methylcellulose, hydroxyethyl starch and dextran and two density
gradient media; Mono-Poly Resolving Medium (M-PRM; a Ficoll-Hypaque
mixture) and Percoll was measured. Experiments were designed to simulate
conditions under which the agents would normally be used.
Neutrophil elastase, as a marker of neutrophil activation, was
measured using the specific radioimmunoassay as described in Chapter 2.
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4.2 EFFECT OF SEDIMENTATION AGENTS
4.2.1 MATERIALS AND METHODS
Materials
6% dextran 70 in 0.9% NaCl (Pharmacia)
6% hydroxyethyl starch in 0.9% NaCl (Plasmasteril, Pharmacia)
2% methylcellulose in 0.9% NaCl (Methocell E50 Premium, Dow)
Method
From 10 normal subjects, a 40ml sample of whole blood was withdrawn into
a sterile syringe containing 200 units preservative-free sodium heparin.
A 10ml sample was retained as a control sample and the remaining 30ml
was divided equally between three tubes containing a sterile solution of
either 6% dextran 70 in 0.9% NaCl (4.0ml), 6% hydroxyethyl starch in
0.9% NaCl (1.0ml) or 2% methylcellulose in 0.9% NaCl (0.4ml). The volume
of each of the agents was chosen to give the concentration used
routinely for erythrocyte sedimentation. The samples wore gently
inverted to ensure thorough mixing and then divided in two. One half of
the sample was kept at room temperature (21°C) while the remainder was
incubated at 37°C. Red cell sedimentation was allowed to proceed for 45
minutes at unit gravity. At the end of this period the supernatants were
carefully aspirated with a pasteur pipette and spun at 1500g for 10
minutes at 4°C to render the sample cell-free. The concentrations of
neutrophil elastase in the resulting supernatants were assayed using a
standard radioimmunoassay (described in Chapter 2). The results were
corrected for any dilution caused by the sedimentation agents.
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4.3 EFFECT OF DENSITY GRADIENT MEDIA
4.3.1 MATERIALS AND METHODS
Materials
Mono-Poly Resolving Medium (M-PRM),(Flow Laboratories Ltd).
Percoll (Pharmacia, Uppsala).
Phosphate buffered saline, pH 7.4 (PBS).
Method
Whole blood (10ml) was taken from eight healthy volunteers and
anticoagulated with sodium heparin (preservative free). This was split
into two 5m1 aliquots and added to either a 2.4ml volume of Mono-Poly
Resolving Medium (M-PRM) or a solution of iso-osmotic Percoll made 51%
in phosphate buffered saline (PBS). The ratio of blood to medium was
chosen to represent those used for these separation techniques. The
samples were placed on a rotary mixer at room temperature (21°C) for 15
minutes to ensure continuous con Lact between the separation media and
whole blood.
The samples were then centrifuged at 1500g for 10 minutes at 4°C. The
supernatants were aspirated and re-centrifuged to render them cell free.
Neutrophil elastase was measured in an aliquot of the resulting
supernatant, as described in Chapter 2. In addition, total lactate
dehydrogenase (LDH), as an indicator of cell viability, was measured in
the clinical chemistry department by the method of Bryden et al, (1973),




Results are expressed as mean + SEM. The data for the neutrophil
elastase levels in the supernatants of the samples after treatment with
either sedimentation agents or density gradient media are expressed as
ng/ml. Statistical analyses were performed using the Wilcoxon's test for
signed ranks. Values of p<0.05 were taken as significant.
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4.5 RESULTS
4.5.1 Effect of Sedimenting Agents:
Table 4(i) and Figure 4(a) show the mean results for neutrophil elastase
in ng/ml for the controls and for those samples treated with each
sedimentation agent at room temperature (21°C) and at 37°C.
4.5.2 At Room Temperature
The neutrophil elastase levels in the samples treated with 6%
hydroxyethyl starch (51.8+7.8 ng/ml; p<0.01) and 2% methylcellulose
(46.9+6.8 rig/ml; p=0.01) were significantly greater than the levels
measured in the control samples (32.4+5.0 ng/ml). In contrast, there was
no significant difference between neutrophil elastase levels for the
controls and samples incubated with 6% Dextran 70, (32.4+5.0 ng/ml).
When the effects of the sedimentation agents on neutrophil elastase
release within the group were examined, no statistical difference
between the effects of treatment of whole blood with either hydroxyethyl
starch and methylcellulose was evident. Both agents, however caused
significantly more neutrophil activation than Dextran 70 (p<0.01 and
p=0.01 respectively).
4.5.3 At 37°C
Neutrophil activation induced by the sedimenting agents at 37°C
exhibited a pattern similar to those seen at room temperature, but of
greater magnitude.
Incubation of the samples treated with sedimenting agents at 37°C
induced significant neutrophil activation in the supernatants when
compared to controls. This was most pronounced in those samples treated
with methlycellulose (206.6+43.2 ng/ml; p<0.01), with a slightly lower
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values for hydroxyethyl starch (186.3+28.6 ng/ml; p<0.01) and the least
amount of neutrophil activation induced by Dextran 70 (104.7 + 15.7
ng/ml; p<0.01). There was no significant difference between hydroxyethyl
starch and methylcellulose.
4.5.4 Effect of Density Gradient Media
The mean results (+SEM) for neutrophil elastase in the sample
supernatants after treatment with Mono-Poly Resolving Medium (M-PRM;
19.8+2.0 ng/ml) was significantly lower than for Percoll (25.1+2.7
ng/ml; p<0.01), however these results lay within the normal laboratory
range for plasma levels (20.8+11.0 ng/ml).
No statistical difference was found between total LDH levels for samples
treated with M-PRM (319.5+24.0 U/l) or Percoll (318+50.2 U/l).
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TABLE 4(i)
The mean+SEM for 10 samples incubated for 45 minutes at room temperature
(21°C) or at 37°C.
Neutrophil Elastase (ng/ml)
RT(21°C) 37°C
6% Dextran 70 32.4+5.0 104.7+15.7
(in 0.9% NaCl)
6% Hydroxyethyl Starch 51.8+7.8 186.3+28.6
(in 0.9% NaCl)
2% Methylcellulose 46.9+6.8 206.6+43.2
(in 0.9% NaCl)
TABLE 4(ii)
The mean. results+SEM for 8 samples incubated with either M-PRM or
Percoll
M-PRM Percoll
Total LDH 319.5+8.5 318+17.7
(U/l)




Release of neutrophil elastase in 10 subjects, (a) RT = room temperature




That cells may be altered from their 'resting state' by isolation
procedures, was demonstrated at the receptor level, in two studies in
which the expression of complement receptors on the neutrophil plasma
membrane was examined. Fearon et al, (1983) using indirect
immunofluorescence staining and flow cytometry demonstrated that
neutrophils expressed low levels of C3b (CR3) on their cell membrane and
that this was unaffected by increasing temperature between 20°C and
37°C. However an 8-fold increase in expression was invoked by increasing
the temperature of the isolated cell population. This increased
expression, considered in this study to represent maximal expression,
was only elicited in cells isolated from whole blood and was thought to
relate to the isolation procedure itself. This was confirmed by Berger
et al, (1984) who, using monoclonal antibodies and flow cytometry,
detected both C3b (CR3) and C3bi (CR1) on the neutrophils in whole blood
and cell isolates. Cells isolated from whole blood were shown to
"spontaneously" increase expression of these complement receptors at
raised temperatures, but could be further augmented by chemotactic
stimuli suggesting incomplete expression. Since the "spontaneous"
expression of the receptors occurred within minutes and in the presence
of protein synthesis inhibitors, it was suggested that the receptors
were translocated from an intracellular pool, the most likely site being
the primary granules. Additionally the specific effect of both Percoll
and Ficoll-Hypaque type density gradients on the receptor expression was
examined and no difference was found to exist between these.
In contrast, in a study of cell function after cell isolation
procedures, these two widely used density gradient media were claimed to
have differing effects on the functional state neutrophils. This was
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attributed to the presence of the bacterial lipopolysaccharide (LPS) in
Ficoll-Hypaque, but not Percoll, (density gradient media on which the
cells were isolated) which according to Haslett et al,(1985) "primes"
neutrophils, rendering them more susceptible to "activation".
As a result a great deal of controversy exists on the relative merits
and disadvantages of the use of density gradient media that are
available for cell isolation.
Percoll, a colloidal silica coated with polyvinylpyrrolidone and
Ficoll-Hypaque mixtures (of which M-PRM is an example) are among the
most commonly used agents.
These density gradient media and three red cell sedimentation agents
were assessed for their effect on neutrophil activation. The results
show that neither Percoll nor M-PRM caused significant neutrophil
activation during co-incubation with whole blood. In each case,
neutrophil elastase levels measured were within the normal laboratory
range (see Chapter 7), although treatment of whole blood with Percoll
resulted in elastase levels greater than for M-PRM.
In contrast, two of the three sedimentation agents; methylcellulose
and hydroxyethyl starch, when tested at room temperature caused
significant neutrophil activation, as did all three at 37°C.
Therefore if erythrocyte sedimentation is unavoidable, dextran is the
agent of choice and should be carried out at room temperature.
In conclusion, of the methods available for cell isolation, a single
step procedure, which does not require red cell sedimentation, is most
satisfactory since this minimises possible sources of cell activation.
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CHAPTER 5
IN—VIVO BEHAVIOUR OF ^^INDIUM LABELLED NEUTROPHILS SEPARATED ON
MONO-POLY RESOLVING MEDIUM (M-PRM)
5.1 INTRODUCTION
The processes of isolation from whole blood and subsequent
radiolabelling of neutrophils may alter their function. Ideally, cell
viability should be checked on all labelled cell preparations before
administration to the patient.
As yet, the best assessment of in vivo granulocyte viability appears
to be the pattern of cell transit through the circulatory system
immediately after administration (Saverymuttu et al, 1983).
Activation of the neutrophil population during in vitro processing
will be manifested in vivo by a departure from what is considered to be
the normal distribution of the cells in the circulation. Much of the
32 51
early work on granulocytes kinetics was performed with DFP or Cr
labelling (Dresch et al, 1975, McMillan et al, 1968) in human studies
and provided valuable information on the total body granulocyte pool,
the rate of production, intravascular life-span and also distribution
between the marginal and circulating pools. Normal granulocytes should,
after injection, pass rapidly through the lungs and equilibrate between
the marginating pools of the liver (usually within 5-15 minutes) and the
spleen (in about 40 minutes) (Peters et al, 1988).
Several studies have shown that poorly functioning or damaged cells
demonstrate lung retention and liver sequestration (Thakur et al, 1977;
McAfee et al, 1980; Saverymuttu et al, 1983). This is thought to be a
consequence of neutrophil activation since these cells show increased
endothelial adherence, and as the lungs present the first microvascular
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bed after reinjection, a significant proportion are "held up" here.
These cells on release from the pulmonary endothelial surface undergo
early non-specific removal into the reticuloendothelial system and is
manifested by high activity in the liver. An increase in pulmonary
margination under pathophysiological influence eg. that seen in adult
respiratory distress syndrome (ARDS), can be differentiated from that
due to in vitro damage to the cell population, by the persistence of
activity in the lungs compared to that for the circulating pool.
Optimal cell viability therefore is associated with rapid lung
transit, rapid spleen uptake, low liver uptake and rapid accumulation
within inflammatory loci.
It is therefore essential, as a qualitative measure, that cells
prepared by any 'new' isolation or labelling techniques be assessed for
lung retention and liver uptake. One method of achieving this is to
compare the passage through the lungs of simultaneously injected
99m 111
Tc-labelled red blood cells and Indium labelled neutrophils with
simultaneous acquisition in the two corresponding energy windows (Muir
99m
et al, 1984). Using this method the Tc time-activity curve represents
the passage of red cells through the lungs. Any retention of "^^In
labelled neutrophils within the lung vasculature will be demonstrated by
a difference in the lung time-activity curves for the two radionuclides.
Although dual isotope studies are an elegant solution, they are
technically demanding and the gamma camera system available at the time
of these studies did not have dual acquisition capabilities.
A simpler single isotope technique was used to image the passage of
the labelled neutrophils through the heart and lungs. Time-activity
curves for the heart and lung were made following a bolus injection of
^"'"labelled autologous neutrophils. Differences between the curves
94




The kinetics of Indium labelled neutrophils were studied in a group
of six subjects using this imaging technique. The six individuals all
gave informed consent and had no evidence of active lung infection or
disease.
5.3 METHODS
5.3.1 Neutrophil Isolation and Radiolabelling
The separation and labelling procedures described in Chapter 1 were used
to prepare the cells for reinjection.
5.3.2 Imaging
The following imaging technique was used to assess the in vivo kinetics
of the "'""^Indium labelled neutrophils.
Imaging was performed using a large field of view gamma camera (GEC-400T
Maxicamera) interfaced to a PDP11-34 computer (Digital Equipment
Corporation).
The subject to be studied was positioned below the camera, in the
anterior position, to visualise lungs, liver, spleen and heart in the
same field of view. It was ensured that the subject remained still
throughout the whole procedure.
The autologous 111Indium neutrophil suspension was administered
intravenously via a 16G cannula inserted in the right arm. The bolus was
flushed through with a 100ml of 5% dextrose. A sequence of images were
accumulated over the first 25 minutes of scanning time from the start of
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administering the labelled cell suspension. The time frames were of
varying length starting with 5 second frames and increased stepwise to
60 second acquisition frames for the latter images. The counts were
normalised for frame length.
5.3.3 Analysis of Images
Using each still frame acquired by the Gamma camera/PDPll-34 facility a
set of "movie" images were compiled. This allowed the transit of the
cells through the heart, lungs and subsequent accumulation in the spleen
and liver to be viewed on screen. This sequence was "stopped" at a frame
that conveniently allowed clear definition of the organs of interest and
using a light pen these were outlined and saved on disc. The counts in
each of these areas or regions of interest (ROI), then represented the
activity of the neutrophils as they passed through the organs at any
given time. The whole field of view showing the maximum count rate was
assumed to represent the total activity injected. The count rates from
the other regions of interest were expressed as a percentage of the
maximum whole field count rate. In this way time-activity curves were
created for each organ. Using this method of data analysis, direct




5.4.1 Cellular Recovery and Labelling
Neutrophils were isolated from whole blood in six subjects. The mean
neutrophil recovery was 60+15% which resulted in isolation of
7 111
19.4+9.1x10 cells. The neutrophils were labelled with Indium-oxine
with a mean labelling efficiency 73.3+8.7%. The mean cell-associated
dose administered was 20.8+8.2 MBq. Results are shown in Table 5(i).
5.4.2 Imaging
For each subject the absolute counts for each organ are shown in Tables
5(ii) and 5(iii). Table 5(iv) shows the mean indium-Ill neutrophil
kinetic data obtained from studies in six subjects. The data were
expressed as percentages of the maximum count rate achieved in the whole
field of view and the time-activity curves for each organ are shown in
Figure 5(a).
The mean heart and lung count rates were maximal at 12 seconds at 6.7%
and 35.2% of the total activity injected respectively. The count rate
over the heart fell to below 3% within the first 90 seconds of imaging
and after 5 minutes remained constant at approximately 1.9% for the
remainder of the study. The count rate corresponding to the area of lung
chosen, fell in a similar fashion to 17% within the first 90 seconds and
thereafter at a slower rate, to 7.8% by 20 minutes, indicating a small
degree of retention within the vasculature of the lung. The liver count
rate rose to 17.4% by 15 minutes and remained constant whereas the count
rate for spleen continued to rise throughout the study.
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TABLE 5(i)
CELLULAR RECOVERY FOR SIX SUBJECTS STUDIED
Initial Neutrophil Total Neutrophil
9 7














































































































TABLE 5(iii) PERCENTAGE OF MAXIMAL COUNT RATE FOR SIX SUBJECTS
LIVER COUNT % (1) (2) (3) (4) (5) (6)
12(secs) 1.6 2.1 1.8 3.4 2.2 0.8
27 5.5 2.6 2.9 5.7 7.6 2.4
55 6.8 5.9 4.8 11.2 10.9 4.0
95 11.1 7.6 6.7 14.9 12.4 5.8
150 13.0 9.1 8.8 17.9 15.2 6.9
230 14.4 10.3 11.7 21.4 17.2 8.2
315 16.2 11.0 13.1 23.8 18.2 8.6
435 17.0 11.9 14.4 25.5 19.4 9.5
585 17.6 12.2 15.1 26.8 20.1 10.1
930 20.0 12.4 16.0 27.3 19.5 9.4
1230 22.0 12.2 15.8 26.9 18.6 8.6
1529 23.4 12.1 15.2 26.8 18.2 8.1
SPLEEN COUNT % (1) (2) (3) (4) (5) (6)
12(sees) 0.6 0.4 0.3 0.8 2.2 0.6
27 1.1 1.1 0.1 1.8 3.5 1.5
55 1.5 0.9 0.8 1.7 3.3 1.8
95 2.2 1.4 1.1 2.0 3.4 2.5
150 2.4 1.5 1.2 2.4 4.0 3.1
230 2.8 1.8 1.1 2.7 4.6 3.9
315 3.1 2.1 1.3 3.0 5.5 4.6
435 3.5 2.6 1.5 3.3 5.8 5.4
585 3.6 3.0 1.8 3.8 6.4 5.9
930 4.5 3.9 1.9 4.5 7.2 6.9
1230 4.8 4.6 2.1 4.8 8.0 7.5
1529 5.3 5.1 2.3 5.1 8.6 7.8
IOO
TABLE 5(iv)












































































Mean indium—111 neutrophil time-activity curves
Time after injection (min)
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5.5 DISCUSSION
Mature neutrophils, with a 12-15um diameter, are a highly
specialised, non-dividing and short-lived cell population. Canine and
human neutrophils remain in the blood stream for only a short period,
leaving randomly with a half-life of six or seven hours. They
differentiate from a pluripotent stem cell, through stages from
myeloblast to promyelocyte, myelocyte, metamyelocyte, band form and
finally to the mature polymorphonuclear neutrophil leucocyte (Murphy et
al, 1976). Only the latter two forms are found in peripheral blood and
are distributed between the circulating granulocyte pool (CGL) and the
marginal granulocyte pool (MGP). These together constitute the total
blood granulocyte pool (TBGP). There is a dynamic equilibrium between
these two pools, with the CGP constituting approximately 44% of the
TBGP. This proportion, however, may increase at the expense of the MGP,
in response to several stimuli including physical exercise and
epinephrine administration (Athens et al, 1961; Muir et al, 1984).
Margination is a phenomenon which is thought to be exhibited
throughout the capillary beds of the body. This was first demonstrated
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by Athens et al, (1961), who showed that the DF P labelled granulocytes
found in the circulation 20 minutes after injection, accounted for only
approximately half of the injected dose. He also showed that a further
20 to 30% of the activity could reappear in the circulation after a
brisk 440 yard walk or an infusion of epinephrine. The distribution of
the marginating pool in man was estimated by Peters et al, (1985), using
a combination of dynamic gamma camera imaging and absolute
111
quantification of Indium tropolone labelled neutrophils in liver,
spleen and blood. The marginating pool was thus calculated to represent
approximately 60% of the TGBP and was distributed between spleen, liver,
I© 3
lung and the remainder of the body as 35%, 25%, 10% and 30%
respectively. The spleen therefore appears to be an important site of
granulocyte margination. This pooling of granulocytes in the spleen
normally will reach a plateau between 20 and 40 minutes and appears
similar to that seen for physiologic pooling of platelets (Peters et al,
1985). The reversibility and the physiological nature of this splenic
pooling was shown in observations that the fall in splenic activity
between 40 minutes and 24 hours and 3 and 24 hours was greater in
patients with inflammatory disease than in those without (Peters et al,
1988). Furthermore, a significant correlation was shown between this
fall and the uptake of activity into inflammatory foci, indicating not
only that the splenic activity was available for localisation, but that
it was present in viable and functionally intact granulocytes.
Interpretation of liver activity is more difficult. It could
represent any one or a composite of 3 processes: irreversible uptake
(presumably damaged cells), temporary, or physiological pooling. The
transit time of radiolabelled erythrocytes and neutrophils through the
liver has been evaluated and found to be comparable suggesting that
granulocyte activity in the liver is likely to represent a physiological
phenomenon (Peters et al, 1985).
Physiological margination in the lung accounts for only 10% of the
total marginating pool (Peters et al, 1985). Neutrophils activated
during isolation or labelling procedures exhibit increased adhesiveness
when in contact with vascular endothelium. Evidence that prolonged
retention of granulocytes in the lung is due to cellular damage was
provided by Thakur et al, (1977), who showed that heat damaged cells
behaved in this way. Several patterns of cellular kinetics were
described by Saverymuttu et al, (1983), with varying degrees of lung
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hold up, dependent on the method of isolation and labelling. Good
kinetics are therein described as exhibiting "rapid transit through the
pulmonary vasculature". Therefore following injection, functionally
viable and intact granulocytes should pass quickly through the lungs and
equilibrate between the circulating granulocyte pool and the marginating
pools of the liver and spleen. The assessment of in vivo behaviour of
isolated cells is therefore considered to be the best indicator of cell
functionality. Cells that are viable should exhibit kinetic patterns
similar to that described above, while damaged cells will be "held up"
in the lungs.
The behaviour of neutrophils isolated using the single step procedure
(described in Chapters 2 and 3) and labelled with the gamma-emitting
radioisotope, '^"'"Indium-oxine, was evaluated. The clearance of
neutrophils from the lungs was rapid, with slightly greater than 80% of
the total activity passing from the lungs within 90 seconds. At 20
minutes, only 7.8% of the total activity administered remained within
the area of lung, indicating only a small degree of lung 'hold up'.
These results correspond well with kinetic data reported in previous
studies (Weiblen et al, 1979; Saverymuttu et al, 1983), showing little
lung hold up and rapid pooling of neutrophils within the spleen. From
these data, it can be concluded that neutrophils isolated from whole
111
blood in Mono-Poly Resolving Medium and labelled with Indium oxine
have good in vivo kinetics and appear functionally normal.
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CHAPTER 6
CLINICAL EXPERIENCE OF NEUTROPHIL ISOLATION, LABELLING AND IMAGING
6.1 INTRODUCTION
This chapter is divided into two sections. The first deals with the
results of neutrophil isolation and labelling procedures performed in
100 patient studies. The second details the outcome of clinical
investigation of inflammation/infection using these methods.
6.2 NEUTROPHIL ISOLATION AND LABELLING
6.2.1 Patients Studied
A total of 100 cell isolations were carried out on blood from patients
with a variety of clinical conditions. They were classified here into
three main groups which included those who had recently suffered acute
myocardial infarction (AMI, n=58; 11F:47M; mean age 59+10 years), a
group with suspected infection and/or disease of the lung (n=10; 3F:7M;
mean age 66+14 years) and a group with occult infection (n=32; 12F:20M;
mean age 52+18 years). Neutrophils from successful isolation procedures
were radiolabelled with "'""'"^Indium oxine.
Patient details and other information considered relevant were
documented and included age, sex, social habits, previous medical
history and a record of drug regime at the time of study.




Neutrophil isolation was performed on blood for 100 consecutive patients
using Mono-Poly Resolving Medium (M-PRM) as described in Chapter 2.
Ill
6.3.2 Labelling with Indium oxine
Neutrophils isolated successfully from the above patient group were
111
radiolabelled with Indium oxine by the method is described in Chapter
2.
Ill
6.4 CLINICAL IMAGING WITH -^^INDIUM LABELLED NEUTROPHILS
111Indium labelled leucocytes were first used for the detection and
location of suspected abscesses in man in 1977 (Thakur et al, 1977).
Since then this method has been adopted and used successfully for
detection of occult infection and a variety of inflammatory conditions
including inflammatory bowel disease (Saverymuttu et al, 1982; Coleman
et al, 1980; Gilbert et al, 1985). This technique has proved very
satisfactory with specificities and sensitivities of approximately 90%
reported (Peters et al, 1982; McDougall et al, 1979).
Using the method for separating neutrophils from whole blood by
Mono-Poly Resolving Medium (M-PRM) and labelling discussed in this
chapter, its validity in locating sites of infection and inflammation
was examined.
This section of this chapter documents the clinical results for a group
of patients with suspected inflammation or infection.
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6.4.1 IMAGING
Planar imaging was performed, usually around 24 hours following
reinjection, using a large field of view gamma camera (GEC-400T
Maxicamera). The patients were positioned supine below the head of the
camera. Images were acquired in the anterior, posterior and left and
right oblique positions over the area or areas of interest for a fixed
number of counts (usually 50,000 counts; duration of aquisition was
dependent on several variables including injected dose and patient
mass). An image was considered positive when indium activity was





A total of 100 neutrophil isolations were performed using Mono-Poly
Resolving Medium. Of these, 86 were completed successfully to give an
essentially 'pure' neutrophil preparation and 14 'failed'. Reasons for
this were not clear initially and are discussed later.
The mean (+SD) results for initial leucocyte and neutrophils recovery
are shown in Table 6(i).
In the 86 separations successfully completed an average of 49.1+17.8%
9
of the mean initial neutrophil count of 9.3 x 10 /I were recovered,
7
resulting in isolation of a mean of 22.5+13.4 x 10 neutrophils per
procedure.
A separation was considered a failure when the erythrocyte population
did not settle below the layer of polymorphonuclear cells, thus making
isolation impossible. Factors that may have affected this technique were
examined where available and are shown in Table 6(iii).
Disturbance of red cell properties from the norm was the feature most
prevalent in this relatively small group. In all cases where the
erythrocyte sedimentation rate (ESR) was measured (8 of the 14), results
were raised markedly above the normal range of 0-15 mm/hr (Westergren
Method) with a mean+SD of 50+20mm/hr. Similarly the mean cell volume
(MCV) of the red cells in seven of this group were abnormally high and
ranged from 96 to 105 fl indicating the macrocytic nature of the
erythrocytes in these samples. Also, low haemoglobin values, indicating
anaemia, was a common feature.
The failure rate was considered within the specified patient groups,
details of which are shown in Table 6(iv). The highest percentage of
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failures occurred in the chest/lung group with 40%, which fell to 20% in
patients with occult infection and lowest (7%) for the patients with
acute myocardial infarction. It was notable that ten of the fourteen
patients were hypoxic at the time of study. This may explain the
prevalence of failed separations in the patient group with suspected
chest infection/inflammation (40% failure rate).
Ill
6.5.2 Indium Oxine Labelling of Neutrophils
From 86 successful separations, the neutrophils from 79 of these were
111
labelled with Indium oxine solution. Where possible the resultant
radiolabelled cells were used clinically for detection of sites of
inflammation or infection.
The mean (+SD) results and range for the neutrophil separations and
labelling (n=79) are shown in Table 6(ii).
The mean labelling efficiency in this group was 72.4+12.4% and resulted
in a mean injected dose of 27.1+12.0 MBq. The label was stable and no
loss of radioactivity occurred on washing.
6.5.3 CLINICAL IMAGING
The imaging results were considered according to two clinical
groupings; those with suspected infection or inflammation associated
with the lung and those with occult infection. The results of imaging
according to this classification are detailed in Table 6(v).
6.5.4 Infection/Inflammation of the Lung
Neutrophils were isolated successfully from six of this small group
of ten patients. The isolated cells were radiolabelled and the patients
were subsequently imaged. Reasons for study included empyema, pneumonia
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and general chest discomfort. All patients were receiving medication at
the time of study.
Uptake of "'""'"^Indium was detected in one subject. A dense area of
activity was seen in the left lung in Figure 6(a) . X-ray findings
showed extensive consolidation in the lower lobe of the patient's left
lung. The remaining five scans were negative; four of which were later
confirmed as cases of pneumonia.
6.5.5 Occult Infection
The neutrophil isolation procedure failed in six of this group of 32
patients with suspected foci of inflammation. The cells isolated from
the remaining 26 patients were labelled and scans were performed 24
hours after reinjection.
Seventeen patients had negative scans, while the remainder had
positive images. The diagnoses for the positive images are shown in
Table 6(v). Further investigation of those with negative scans failed to
confirm the existence of undetected foci of inflammation, except in one
patient where a subdiagphragmatic abscess was confirmed at post mortem.
An enlarged and 'grainy' appearance of spleen in this patient was noted
on inspection of planar images. However as physiological uptake in
spleen is normal this prompted no additional interest in this area and
consequently was reported as a "negative"' scan.
In four of the patients with uptake of the radiolabelled cells,
activity was focussed in the area of abdomen suggesting the existence of
inflamed or infected bowel and indeed one of the scans aided diagnosis
of ischaemic colitis (Bell et al, 1986). The planar image in the
anterior postion is shown in Figure 6(b).
Evidence of the inflammatory response to infection was demonstrated
in two subjects with unexplained rigors, the cause of which were later
identified as an infection at the site of an access site and Y-graft
repair.
Several 'pockets' of radioactivity were shown in a patient with
septicaemia, particularly in the kidneys and the pericardial sac.
Finally, the combined use of single photon computed emission tomography
(SPET) and 99mTc-HSA as a blood pool marker for enhance anatomical
localisation identified the uptake of "'"''"''"Indium labelled neutrophils in
one patient in the left paravertebral area of lower thorax as a mycotic
aneurysm (Bell et al, 1987), shown in Figure 6(c) and in a second with a
cerebral abscess (Figure 6(d) and 6(e)).
112
Table 6(i)
Mean+SD for neutrophil isolations in 86 patients.
9
Initial leucocyte count (xlO /l) 11.6+4.8
g
Initial neutrophil count (xlO /l) 9.3+4.5
7
Neutrophil recovery (xlO cells) 22.6+13.3
Neutrophil recovery (%) 49.1+17.8
Table 6(ii)
Mean+SD of neutrophil labelling procedures (n=79) using "'""'""'"Indium-oxine
7
Number of neutrophils (xlO ) 23.6+13.3
Total dose Indium oxine (MBq) 37.3+15.1
Cell associated dose (MBq) 27.1+12.0
Labelling efficiency (%) 72.4+12.4
I 13
Table 6(iii)
Factors thought to influence separation procedure using M-PRM.
Myocardial Infarction
Patient ESR MCV Hb Hypoxic COAD
1 N/A 105* 9.6** N/A +
2 N/A 103* 14.5 + +
3 N/A 87 15.1 + +
4 53* 99* 14.4 + +
Lung Infection/Inflammation
* *
1 14 96 14.8 + +
* * *
2 30 90 12.4 + +
3 N/A 105* 13.1** + +
* **
4 73 92 12.3 + +
Occult Infection
1 64* 76 10.1** - +
* #*
2 59 89 11.1 - +
3 N/A N/A 8.0 N/A N/A
* * **
4 63 97 12.4 +
**
5 N/A 89 13.2 + +
6 45* 102* 15.3 + +
* denotes above normal range
** denotes below normal range
N/A information not available
+ or - Yes or No
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Table 6(iv)
Results of neutrophil isolations in patient groups studied.
Number of separations (n)
Number of successes (n)











































Anterior chest image (24h) showing marked uptake of Indium in the
left upper lobe of a patient with obstructive pneumonia.
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Figure 6(b)
Gamma camera image (24h) showing the anterior abdominal view from a
patient with ischaemic colitis. Predominant uptake of "'"'^Indium can be













Simultaneously acquired computer reconstruction images in the same
sagittal plane.
Upper: Technetium-99m ( Tc) labelled human serum albumin showing blood
pool in the left ventricle, aorta and the region of the aneurysm.
Ill
Lower: Indium-Ill( In) labelled neutrophils showing abnormal uptake at
the site of the aneurysm, with normal uptake in the spine.
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Figure 6(d)




Reconstruction ^"11Indium transverse and coronal head images at 24h
obtained using single photon emission computerised tomography (SPET) in
a patient with a right frontal cerebral abscess.
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6.6 DISCUSSION
Leucocytes labelled with a variety of radionuclides have been used to
locate infection or inflammation since the early 1970s (Coleman et al,
111
1980; McDougall et al, 1979). In recent years, Indium chelates have
been used to label leucocytes for routine diagnostic purposes. Due to
the non-specific nature of this isotope, the cell of interest must be
isolated from the other blood cell types. Here, experience of neutrophil
isolation, labelling and subsequent patient imaging is described.
In this group of 100 consecutive patient studies only 14 of the
leucocyte isolation procedures were technical failures. Reasons for this
were examined retrospectively and appear to relate to departure from
normal erythrocyte properties. An increased ESR, MCV and reduced
haemoglobin content of the red cells from these blood samples was
common. Reinhart et al, (1989), suggested that the shape of the red cell
is important in determining its sedimentation properties. He
demonstrated that blood comprised of erythrocytes with irregular plasma
membranes caused a reduction of the ESR.
The use of M-PRM for isolation of neutrophils in patients with
anaemia, particularly in those with a microcytic, hypochromic anaemia,
is discouraged by the manufacturer. Also several drugs have been
demonstated to interfere with leucocyte separations. Drug regime at the
time of study was also taken into account, however there was no
prevalence of a particular drug or drug type in these cases. It was
notable that ten of the group were hypoxic at the time of study which
may lead to alteration of erythrocyte properties.
Each of these examples may alter cell shape and mass and therefore
may interfere with cell migration and thus the outcome of the isolation
procedure.
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In the remaining 86 cases, good cell recovery was achieved quickly
and easily using this method. The high purity and viability of the
resultant isolate with little or no erythrocyte contamination was
assessed and confirmed in Chapter 2.
In a proportion of the patients, the cell isolate was radiolabelled
111
with Indium oxine and suspected sites of inflammation or infection
investigated using gamma camera imaging techniques. Labelling efficiency
111
was excellent and compared well with other data published for Indium
oxine (Mountford et al, 1985; Thakur et al, 1977). Further confirmation
that the labelled cells were functional was provided by the positive
scans obtained in a number of the studies.
As infection is only a clinical suspicion, many of the patients
referred for imaging may not have had an infective process and therefore
may lead to low sensitivity and specificity of the technique. Clinical
follow up in this study showed only one marked failure of the technique
(ie. the patient with the subdiaphragmatic abscess). However as the
labelled neutrophils normally sequestre in the spleen and liver,
diagnostic accuracy in this area is limited. Positive uptake was
demonstrated in only one of the cases of pneumonia, and was the only
case in which cell labelling occurred early in the disease process; the
importance of which will be developed in the following chapter.
The detection of activity in the bowel in four of the patient studies
highlights the suitability of this method for detecting inflammation in
07
this area. The clinical use of Gallium citrate for this purpose has
been superceded by labelled leucocytes for a number of reasons. One of
07
the main problems is that under normal conditions Ga citrate is
excreted into the bowel and hence can give rise to false positive
/
122
results (Caffee et al, 1977). Also, although both are established as
effective methods for abscess detection, Indium labelled leucocytes
allows distinction to be made between this and inflammation of the
bowel.
No false positives or negatives were acquired in the course of these
imaging studies other than the single false negative result already
mentioned.
In two of the patients, this technique allowed diagnoses of
intrathoracic mycotic aneurysm and ischaemic colitis with perforated
bowel where routine diagnostic radiology had failed. Cases such as these
demonstrate the benefits of combining radioisotopic and routine
radiological imaging to aid diagnosis in difficult clinical situations.
The search for easier and more effective non-invasive methods for the
detection of infection and inflammation will undoubtedly continue,
however, this study confirms that this method of isolating and labelling




IMAGING THE ACUTE INFLAMMATORY RESPONSE TO MYOCARDIAL INFARCTION
7.1 INTRODUCTION
The migration of neutrophils into recently infarcted myocardium
represents the initial phase of a process that leads to the removal and
subsequent reorganisation of damaged tissue (Mallory et al, 1939,
Lautsch et al, 1979). Neutrophil infiltration into an area of the
irreversibly damaged myocardium, facilitates the breakdown of the
necrotic tissue by phagocytosis. After removal of the tissue debris,
capillaries and fibroblasts invade the area of infarcted myocardium,
leading to the formation of collagen-rich scar tissue which eventually
replaces the necrotic area (Lautsch et al, 1979).
These events have been well characterised histopathologically in
animal studies, particularly in experimental myocardial infarction in
dogs. Karsner demonstrated that the infiltration of polymorphonuclear
leucocytes began as early as 12 hours after coronary occlusion,
increased substantially within 24 hours and constituted a marginating
zone defining the periphery of an infarct within 5 days. The
polymorphonuclear and lymphocytic infiltration persisted as long as 18
days, but was invariably absent after 61 days (Karsner et al, 1916).
In the classic pathological study of infarction in man, the
polymorphonuclear leucocyte infiltrate was initially demonstrable within
24 hours of the infarct, with the degree of penetration progressing
gradually, reaching its peak at around four days. Necrotic changes in
the neutrophils themselves were evident by the fifth and sixth days and
by day fourteen had practically disappeared (Mallory et al, 1939).
During the initial phase of the inflammatory response, neutrophils
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undergo a complex series of biochemical changes facilitating the release
of oxygen-derived free radicals and proteolytic enzymes which promote
tissue lysis (Sbarra et al, 1959). Although these processes are
important for the control of bacterial infection, it is also possible
that they may lead to the destruction of the surrounding potentially
viable tissue.
The large accumulation of neutrophils and their subsequent release of
oxygen derived free radicals and proteolytic enzymes might lead to the
extension of myocardial damage after myocardial infarction. Several
studies in animals have demonstrated that neutrophil inhibition results
in the reduction in size of the experimentally induced infarct (Romson
et al, 1982; Thakur et al, 1979).
Very few studies of this nature have been undertaken in man, however
a study by Davies and colleagues attempted to image the acute
inflammatory response to myocardial infarction in a group of 36 patients
with ^"^Indium labelled neutrophils. "'""'"^Indium activity in the
myocardium, representing neutrophil uptake, was demonstrated in 21 of
the subjects. The outcome of imaging was found to be influenced by the
time to reinjection of labelled cells after chest pain and patient age,
but not by the site of infarct, peak serum creatine kinase, peripheral
leucocyte count, cell labelling efficiency or leucocyte function (Davis
et al, 1981)
Using the methods developed for isolating a 'pure' neutrophil
111
preparation and labelling with Indium oxine, we attempted to image
the acute inflammatory response to myocardial infarction in a group of




Thirty patients who had recently experienced acute myocardial infarction
detailed in Chapter 6 were studied. The patients were selected on the
basis of the diagnosis of acute myocardial infarction (AMI) based on a
history of prolonged ischaemic pain lasting longer than thirty minutes,
ECG changes associated with AMI and a rise in creatine kinase to at
least twice the upper limit of normal.
Details of patient age, sex, site of infarction, peak creatine kinase
and time from initial onset of chest pain to reinjection of autologous
^"'"Indium labelled neutrophils are shown in Table 7(i).
All patients gave informed consent and the study had the approval of the
Institute's Ethical Committee.
7.3 MATERIALS AND METHODS
7.3.1 Neutrophil Isolation, Labelling and Reinjection
Venous blood (60ml), was taken from each patient within hours of
experiencing AMI. The time of sampling from the 'major onset' of chest
pain was noted along with a note of any medication the patient was
receiving at that time.
Neutrophils were isolated from this volume of blood and labelled with
^"'"Indium oxine using the methods described in Chapter 2.
Ill
The autologous Indium labelled neutrophils were reinjected into a
fresh site in the patients' arm.
Cell isolation and radiolabelling were completed within two hours of
venesection in all thirty patients.
The protocol is shown in diagramatic form in Figure 7(a).
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7.3.2 Human Serum Albumin with Technetium
A Blood Pool Marker
In 12 of the 24 patients who had single photon emission computed
99m
tomography (SPET) performed, blood pool was imaged using Technetium
99m
labelled human serum albumin ( Tc-HSA), to further improve anatomical
localisation.
QQrn
Tc-HSA was prepared from a freeze-dried kit (TCK-2, CIS(UK) Ltd.) and
injected 10 minutes prior to imaging with SPET.
7.3.3 PLANAR IMAGING
Imaging was performed 24 hours post re-injection on all 30 patients.
This time was chosen as it was shown to be the optimal time for scanning
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patients who have received Indium labelled neutrophils (Thakur et al,
1979). Moreover, by 24 hours, sufficient time has elapsed for
equilibration of the granulocyte pool to have occurred, thus minimising
false positive results. Consequently, all patients were scanned as close
to 24 hours post-injection as hospital routine would allow.
Patients were imaged supine under a large field of view gamma camera
(GEC-400T Maxicamera) interfaced to a PDP11-34 Computer (Digital
Equipment Corporation). Planar images were acquired in the anterior,
left anterior oblique and the left lateral positions. The acquisition
period was set to accumulate 100 000 counts in the field of view.
7.3.4 SPET (Single Photon Emission Computed Tomography)
In 24 of the 30 patients, SPET was also performed in an effort to
improve anatomical definition. SPET was not felt appropriate in all
cases as it increased the imaging time. Patients considered to be
'unwell' were not subjected to this test.
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To further improve organ localisation Tc labelled human serum albumin
q9m
( Tc-HSA) was injected ten minutes prior to imaging, to allow
visualisation of blood pool relative to the heart.
'Windows' were set at 171-281 KeV and 128-281 KeV thus allowing
simultaneous acquisition of indium and technetium activity. A sequence
of 64 of these images were acquired by rotating the camera head through
180 degrees at a fixed distance from the patient, starting at the right
anterior oblique position (RAO). The patient remained perfectly still
throughout the whole of the procedure, which took approximately 32
minutes. On completion, the images were reconstructed using software
written locally for the PDP11/23+.
7.3.5 STATISTICAL ANALYSIS
Data from the groups were compared using unpaired t-test, exact
probability or unpaired Wilcoxon rank sum as appropriate. Values of
p<0.05 were considered not significant.
7.3.6 IMAGE ANALYSIS AND INTERPRETATION
An independant observer, who was unaware of the patient identity or
clinical history was asked to grade the planar and SPET images as
111
positive, (where Indium activity was clearly defined in the region of
the heart) and negative (where there was no detectable uptake ^"^Indium
activity in the myocardium).
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7.4 RESULTS
7.4.1 PLANAR AND SPET IMAGING
The results of planar and SPET imaging are shown in Table 7(ii).
The planar images were judged positive or negative as described above.
Planar imaging was performed on all 30 patients. Twentyfour of the 30
patients also underwent SPET to allow improved anatomical localisation.
Where SPET was available, the outcome of imaging agreed with that of the
planar images. In deciding the outcome of imaging of those patients with
negative planar scans, SPET was also taken into account. As a result,
six patients showing no indium activity in the planar images, had
positive uptake in the area of the heart on the SPET reconstructed
images.
In 23 of 30 patients studied, uptake of indium labelled neutrophils
in the area of infarcted myocardium was detected by either planar images
alone or by a combination of planar imaging and SPET.
Three patterns of uptake were seen and were classified as focal
myocardial uptake (11 patients), diffuse myocardial uptake (2 patients)
and a 'doughnut' shaped uptake (3 patients), see Figure 7(c). One
patient showed both diffuse and focal uptake in the myocardium and is
shown in Figure 7(b). Of the six patients in whom the planar images were
considered negative, SPET reconstruction showed localised uptake within
the myocardium, Figure 7(d). For the remaining seven patients no uptake
of indium activity was detectable either on planar or SPET images.
In addition, in 12 of the patients who had SPET performed, imaging of
blood pool was permitted by imaging "mTechnetium activity. The mean+SD
99m
injected dose was 44.7+5.7 MBq. Where necessary the Tc images were
scrutinised together with that for indium uptake to allow differential
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localisation of tissue and blood pool-associated activity.
7.4.2 INFLUENCING FACTORS
The patients were grouped according to the outcome of imaging (ie.
positive n=23; or negative n=7) and factors which may have influenced
the results were documented. (See Table 7(iii))
Patient age, sex, site of (inferior; INF or anterior; ANT) and size of
infarct, peripheral leucocyte count, injected neutrophil number and
radioactivity dose, as well as the time from onset of chest pain to
reinjection, were compared between the two groups.
There was no statistical difference in age (62.0+10.8 years vs
59.8+9.4 years) or sex distribution (6F:17M vs 2F:5M) in patients in
whom images were positive or negative.
The site of infarct (10 INF:13 ANT vs 3 INF:4 ANT), as well as the
size of infarct, as indicated by peak creatine kinase (2023.5+916.0 U/l
vs 1825.0+1214.0 U/l) also did not appear to influence the uptake.
9
The patient peripheral leucocyte count (12.9+3.2x10 /I vs
9 8 8
12.5+3.4x10 /l), neutrophil number (2.7x10 cells vs 2.6x10 cells) and
activity of the radiolabelled neutrophils injected (32.8+8.4MBq vs
29.4+8.3 MBq) did not differ significantly for positive and negative
studies respectively.
The interval between onset of chest pain and reinjection of
autologous labelled neutrophils however, was significantly shorter for
the group with positive images (20.3+6.4 hours) when compared to those
whose images were negative (27.6+5.8 hours: p<0.02).
The patient group was then subdivided according to three time
intervals; those injected within 18 hours of chest pain; between 18 and
24 hours and between 24 and 36 hours. Details of the imaging results
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within these time periods are shown in Table 7(iv) and Figure 7(f).
Nine subjects of the 30 patients were reinjected within 18 hours of
the onset of chest pain and all had positive images. As the interval
between onset of chest pain and the time of reinjection increased, the
frequency of positive images reduced with 10 of the 12 patients (83%)
reinjected between 18 and 24 hours with positive images and only four of





Number of subjects studied
Sex (F:M)
Location of acute myocardial infarct
Peak creatine kinase (U/l)
Interval from onset of chest pain
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to reinjection of In neutrophils (h)
9
Total leucocyte count (10 /l)
7
Number of neutrophils injected (10 )
Activity of 11:^In administered (MBq)
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Results of planar and SPET imaging for 30 patients grouped according to
time between onset of chest pain and reinjection.
TIME PATIENTS POSITIVE (+)
IMAGE
Planar (+) Planar (-)













Mean(SD) for patients with positive and negative images,




Peak creatine kinase (U/l)
WBC (xl09/l)
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Neutrophils injected (xlO )
"L1"''Indium dose (MBq)
Time between onset















20.3(6.4) (3) p 0.05 27.6(5.8)
Statistical Analysis used in each case
(1) Unpaired t-test
(2) Exact probability















Upper: Planar image in the left anterior oblique view showing normal
uptake of "^^Indium-labelled neutrophils in the liver and spleen, with
diffuse uptake in the region of the heart and an area of focal uptake in
the inferior wall of the left ventricle.
Lower: The line drawing shows the areas of uptake.
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Figure 7(c)
Planar image in the left anterior oblique view showing normal uptake in





Upper: Anterior planar image with normal uptake in liver and spleen and
no definite myocardial uptake.
Lower: Single photon computed emission tomographic (SPET) image in the





Simultaneous SPET images in the transverse plane. The Tc image shows
the blood pool in the left (LV) and right ventricle (RV).
Ill
The corresponding Indium image shows extensive uptake within the
myocardium of both ventricles.
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Figure 7(f)
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7.5 DISCUSSION
This study shows that the acute inflammatory response to myocardial
111
infarction in man can be imaged using autologous Indium labelled
neutrophils.
When the patients were divided according to the time from onset of
chest pain to the injection of labelled cells, it was found that the
highest frequency of positive images were obtained for those patients
reinjected within 18 hours of the major onset of chest pain (77% of
patients). This high incidence of positive results fell as the interval
from the estimated time of infarction increased and was lowest in the
patient group in which the time interval was furthest from the event
(24-36 hours), with only 44% of the patients with positive scans.
The high incidence of positive images (77%) obtained here compares
favourably with that of Davies (58%), (Davies et al, 1981). This may in
part be due to the earlier reinjection of the labelled cells after onset
of chest pain; 8-36 hours in our study compared with 18-112 hours in the
study of Davies and colleagues (Davies et al, 1981).
None of the other factors investigated influenced the outcome of
imaging, and again contrasted with the findings from the study by Davies
et al, (1981), who found that the age of the subject was also a
determinant of the outcome of imaging.
The use of planar imaging makes it difficult to determine the site of
the activity. Here the additional use of single photon emmission
computed tomography (SPET) increased the number of positive images by
allowing spatial separation of positive myocardial uptake of indium from
99m
adjacent bone, liver and spleen. Also dual isotope SPET with Tc-HSA
allowed unequivocal differentiation between blood pool and 1"'~1Indium
activity localised within the myocardium.
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The temporal relationship found here, suggests that the stimulus for
activation and migration of the neutrophil population into the site of
the myocardial infarct appears to be early and somewhat transient.
Whilst histologic studies demonstrate the number of leucocytes that
have accumulated in the tissue since the onset of infarction they do not
reflect the temporal sequence or the rate of this process. In contrast
cardiac imaging 24 hours after the injection of cells reflects only
111
Indium neutrophil infiltration that occurred during that time.
Although imaging indium-labelled autologous neutrophils in patients
with acute myocardial infarction allowed the acute inflammatory response
to myocardial damage to be imaged, this technique should not be
considered as a method of diagnosis or localisation of acute myocardial
infarction as existing technology is more appropriate. It may however
provide a useful means of monitoring the effects of therapy aimed at
improving the prognosis of these patients.
Several methods aimed at reducing infarct size thus improving patient
prognosis have received interest. Attention has focussed on the use of
thrombolytic therapy to achieve these objectives (Mathey et al, 1981;
Been et al, 1985). Administration of thrombolytic agents such as
streptokinase and tissue plasminogen activator, can produce coronary
reperfusion and therefore may improve myocardial salvage. However it is
thought that the sudden reintroduction of oxygen and neutrophils into
ischaemic tissue on reperfusion may also produce a chain of events
leading to further tissue necrosis, a situation aptly described by
Braunwald as "the sword of Damocles" (Braunwald et al, 1985).
Therefore if these and other therapies do exert their action by
inhibiting neutrophil migration into myocardium, then this method should





WHITE CELL COUNT, NEUTROPHIL ACTIVATION AND FREE RADICAL ACTIVITY IN
PATIENTS WITH STABLE ISCHAEMIC HEART DISEASE AND ACUTE MYOCARDIAL
INFARCTION
8.1 INTRODUCTION
Following acute myocardial infarction, myocyte damage occurs,
initiating an acute inflammatory response. This inflammatory response
was generally viewed as a secondary process serving the purpose of
demolition and restoration of dead and dying tissue, however recent work
raises the possibility that the influx of neutrophils during this
response may contribute to the extension of myocardial cell death.
The inflammatory response is characterised by migration of
neutrophils into the infarcted myocardium, which in animal (Sommers et
al, 1964) and human studies (Mallory et al, 1939) has been shown to
occur within 24 hours with a maximal response by 96 hours.
Neutrophils, once activated, are capabable of liberating proteolytic
enzymes and several reactive oxygen-derived free radicals, which are
potentially harmful to the surrounding tissue if poorly regulated.
Neutrophil elastase, a serine protease contained in the azurophilic
granules of the neutrophil is among the substances released and is an
established marker of neutrophil activation (Plow, 1982).
Reactive oxygen free radical species released during activation of
neutrophils can also cause cellular damage, lysis and disruption of
endothelium (Harlan, 1985). In vivo assessment of free radical activity
is difficult, due to their highly reactive and short-lived nature.
However these species once produced, interact with adjacent molecules,
particularly polyunsaturated fatty acids (Halliwell et al, 1984). The
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diene conjugated non-peroxide isomer of linoleic acid (PL-9,11-LA') has
been used as a marker of free radical activity (Iverson et al, 1985).
Here these markers of neutrophil activation and free radical activity
were measured in a group of patients with acute myocardial infarction,




Three groups were studied. A group of 20 patients (15M:5F; mean age 62
years) with a diagnosis of acute myocardial infarction based on a
history of prolonged ischaemic chest pain (duration longer than 30
minutes), electrocardiographic changes associated with myocardial
infarction and a rise in creatine kinase at least twice the upper limit
of normal. Thirty patients (24M:6F; mean age 62 years) with stable
angina and documented ischaemic heart disease (previous myocardial
infarction or coronary angiography) attending the out-patient clinic.
The normal control group comprised of 35 healthy volunteers from
hospital staff (31M:4F; mean age 31 years). All gave informed consent
and the study had the approval of the Institute's Ethical Committee.
Subject details are given in Table 8(i).
8.2.2 Blood Sampling
In patients with myocardial infarction, venous blood was taken for
estimation of full blood count, creatine kinase, plasma neutrophil
elastase (PNE) and the diene conjugated non-peroxide isomer of linoleic
acid (PL-9,11-LA1). Samples were taken as close to the time of admission
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as possible and thereafter every 6-8 hours over the remainder of the 48
hour period. Normal volunteers and out-patients with ischaemic heart
disease had blood taken for full blood count, neutrophil elastase and
PL-9,11-LA'. Samples for neutrophil elastase and PL-9,11-LA' estimation
were separated and stored at -20°C until assayed, as described in
Chapter 2, within a week of sampling. Full blood counts were performed
on a sequestrene sample, using a Sysmex E5000 Toa Electronics Ltd, Kobe,
Japan. Creatine kinase in heparinised plasma was measured by the
hospital clinical chemistry department.
8.2.3 STATISTICS
The Kolmogarov-Smirnov test showed that the data was not normally
distributed. Results are therefore expressed as the median and range.
The data was analysed non-parametrically using the Mann-Whitney test for
two independent samples. Values of p<0.05 were taken as significant.
8.3 RESULTS
8.3.1 White Cell Count (WBC)
The white cell count was significantly higher in patients with ischaemic
9
heart disease (6.7x10 /l, 5.2-12.6, p<0.01) than in the normal group
(5.8x10 /l, 3.4-9.3).
The peak white cell counts for the period of study in patients with
9
acute myocardial infarction (13.2x10 /l, 8.8-19.4) were significantly
greater than isolated measurements for both the normal controls
(p<0.001) and those patients with stable ischaemic heart disease
(p<0.001). See Figure 8(a). The peak value occurred early after
infarction (15+10h) and fell over the remaining period of the study.
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8.3.2 Plasma Neutrophil Elastase (PNE)
The concentration of plasma neutrophil elastase was significantly lower
in controls (18.6ng/ml, 9.2-51.0) than in patients with chronic
ischaemic heart disease (25.8ng/ml, 12.2-49.5; p<0.05). Peak plasma
neutrophil elastase for the patients with myocardial infarction
(61.0ng/ml, 16.2.0-128.0) was significantly greater than both the
ischaemic group (p<0.001) and the normal control group (p<0.001). See
Figure 8(b).
8.3.3 PL-9,11-LA'
There was no significant difference in PL-9,11-LA' between normal
volunteers (19.3umol/l, 7.5-32.9) and patients with ischaemic heart
disease (19.8umol/l, 7.9-43.2).
Peak levels of PL-9,11-LA' in patients with acute myocardial infarction
were 30.6umol/l, (11.5-57.3) and were raised significantly over that for
the normal group (p<0.001) and the ischaemic patient group (p<0.001).
See Figure 8(c).
8.3.4 Temporal Relationship
In the group of patients with myocardial infarction the time at which
the plasma levels of neutrophil elastase and PL-9,11-LA' peaked,
differed. The peak level of PNE occurred at around 25 hours (4-49 hours)
while the PL-9,11-LA' level occurred earlier at 12 hours (1.5-29 hours).
8.3.5 Influencing Factors
Neither plasma neutrophil elastase nor PL-9.11-LA' correlated with
subject age or peripheral leucocyte count in the normal controls and
patients with acute myocardial infarction. There was however a weak
U7
correlation of PL-9,11-LA' with WBC (r=0.47; p<0.01), but not PNE, in
the patients with stable ischaemic heart disease.
In the group with acute myocardial infarction there was a weak
correlation of peak creatine kinase with PL-9,11-LA' (r=0.47; p<0.05),
but there was no correlation with PNE.
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Table 8(i)
Details of patients with acute myocardial infarction (AMI, n=20), stable
ischaemic heart disease (IHD, n=30) and a group of normal controls (N,
n=35). Median and ranges are shown where appropriate.
Age Sex Infarct Site Creatine Kinase





























































































The results of this study confirm that patients with chronic
ischaemic heart disease have an elevated leucocyte count. This agrees
with work by Kostis, who reported that raised white cell counts
correlated with the severity of coronary artery disease (based on
coronary angiography) in a series of 573 patients (Kostis et al, 1984).
An elevation of peripheral leucocyte count has also been shown to
correlate with the risk of stroke, myocardial infarction and subsequent
reinfarction (Friedman et al, 1974; Ernst et al, 1987; Lowe et al,
1985). The risk of myocardial infarction in particular is thought to
increase by a factor of four in subjects with white cell counts greater
than 9x10^/1 (Ernst et al, 1987).
Whilst smoking also increases the risk of myocardial infarction, only
50% to 65% of the increased risk in those with a high leucocyte count
can be accounted for by smoking. In the patients with chronic stable
heart disease only two admitted to smoking, although 10 had a previous
history of tobacco use. Moreover as neither carboxyhaemaglobin nor
cotinine were measured at the time of study it was difficult to gauge
the contribution current smoking may have made to the leucocyte counts.
The elevation of the leucocyte count in patients with acute
myocardial infarction occurred early after the event and fell over the
ensuing period of the study. This was due to the more general response
to stress with the mobilisation of the marginated leucocyte pool
(Bierman et al, 1952).
Neutrophil elastase is released from the azurophilic granules of
neutrophils following cell activation. The polyclonal antiserum against
purified human neutrophil elastase did not bind to any other neutrophil
protein and did not detect the antigenically distinct elastases of
platelets and pancreas. It did however measure neutrophil elastase
equally well in the free form and when complexed to its inhibitors
alpha-l-proteinase inhibitor and alpha-2-macroglobulin, the forms in
which it circulates in plasma.
Elastase measured in whole blood correlates with the total neutrophil
count and is primarily a measure of the intracellular stores of this
protease. Since neutrophil elastase in plasma does not correlate with
either leucocyte count or neutrophil count, then elevated levels of
plasma neutrophil elastase reflect an increase in neutrophil activation
in the form of degranulation (Greer et al, 1989).
The concentration of neutrophil elastase in normal plasma is usually
low (Plow, 1982) as shown here, but is elevated in the plasma of both
the patients with chronic stable ischaemic heart disease and acute
myocardial infarction.
The higher than baseline levels for ischaemic heart disease may
reflect a prevalent state of neutrophil activation. Neutrophil elastase,
used here as a marker of activation, can cause substantial tissue damage
as its substrates include not only elastin but also collagen,
proteoglycans and other basement membrane components (Janoff, 1985). As
discussed earlier in Chapter 1, when neutrophils adhere to the vascular
endothelium they can create a "protected microenvironment" at the
interface between the neutrophil and the endothelial cell so that the
neutrophil proteases may attack and degrade the vascular tissue while
remaining inaccessible to its plasma protease inhibitors.
Several studies correlating vascular disease with elevated
circulating plasma levels of neutrophil elastase have been reported.
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These include pregnancy-induced hypertension, (Greer et al 1989),
peripheral vascular disease (Weissman et al, 1980) and diabetes mellitus
(Collier et al, 1989).
Therefore this association of the neutrophil count and atheromatous
vascular disease, in this case ischaemic heart disease is consistent
with neutrophil activation contributing to the pathogenesis of vascular
disease.
Evidence that the neutrophil plays a major role in the extension of
myocardial damage has been provided by several animal studies but has
proved more difficilt in man.
Romson demonstrated that dogs rendered neutropenic by administration
of antisera to canine neutrophils, evolved infarcts that were 43%
smaller than those dogs treated with non-immune sera. Since there were
no haemodynamic differences caused by either treatment for the two
canine groups, the reduction could be attributed to the induced
neutropenia (Romson et al, 1983). The neutrophil's role as a mediator of
tissue injury extension was further consolidated by Mullane et al,
(1984), who showed a decrease in infarct size in dogs by reducing the
circulating neutrophil count by 60%. More recent work investigating the
neutrophil's involvement in myocyte injury by Simpson et al, (1988)
demonstrated that blocking leucocyte cell adhesion-promoting
glycoproteins (Mol;CDllb/CD18) on the neutrophil membrane with
appropriate monoclonal antibodies (antiMol; antiCDllb), reduced the
experimental infarct size without altering blood pressure, heart rate or
coronary blood flow.
These observations provide additional evidence to support the
important role of inflammatory cells in extending myocardial injury
beyond that caused by ischaemia itself.
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The response to tissue injury includes the activation of complement,
the formation of chemoattractants and activators of neutrophils and
local release of mediators capable of causing tissue injury. One of the
complement components formed is C5a which has been reported as a
potential mediator of the inflammatory response to myocardial ischaemia.
(Williams et al, 1981). Included in its actions on neutrophils are
aggregation, chemokineses, chemotaxis, release of oxygen free radicals
and degranulation with release of enzymes (Crawford et al, 1988).
This study demonstrates that the release of neutrophil elastase is
significantly raised in patients with acute myocardial infarction. The
peak levels of this protease were detected in plasma at 24 hours
post-infarction, at a time consistent with the presence of an
inflammatory infiltrate in the myocardium.
All mammalian cells are subject to free radical reactions which occur
continuously in vivo. Oxidative stress in cells and tissue occurs when
there is increased oxygen tension, and as a result of activation of
enzyme systems may lead to the formation of 0^ (Bellavite et al, 1988).
As discussed in Chapter 1, activated neutrophils are capable of
generating reactive oxygen species through reduction of molecular oxygen
by NADPH oxidase at the plasma membrane.
However neutrophils do not represent the only possible source of
these highly reactive moieties. Recent studies (Chambers et al, 1985)
suggest that xanthine oxidase may be an important source of free
radicals within ischaemic tissue. During ischaemia, cytosolic xanthine
dehydrogenase is converted to xanthine oxidase by limited proteolysis.
This, rather than producing NADH as its reaction product, generates the
superoxide radical via univalent reduction of oxygen. However, although
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this system is known to exist in the vascular endothelium, its role in
myocyte damage is still questioned as its presence has yet to be
confirmed in myocardial specimens (Werns et al, 1987; Watts et al,
1965).
Therefore in man the most likely sources of free radical production
in the myocardium are the electron transport chains in the myocyte
mitochondria or from activated neutrophils via membrane linked NADPH
oxidase (McCord, 1987).
PL-9,11-LA1, the non-peroxide isomer of linoleic acid was used here
as an in vivo marker of free radical activity (Iversen et al, 1985). The
plasma levels of PL-9,11-LA' in patients with myocardial infarction were
high initially and fell over the remaining 48 hours, suggesting early
free radical activity.
Sources of PL-9,11-LA' are present in the diet and also have been
shown to be manufactured by bacterial flora in the gut. Although
feasible, it is unlikely that the diet or bacterial flora would
contribute to the change in the PL-9,11-LA' observed in this relatively
short 48 hour period following infarction.
This study demonstrates that increased lipid oxidation occurs in the
early phase of myocardial infarction and is consistent with free radical
activity in man. Neutrophil activation also occurs and may be implicated
in potentiating myocardial injury after myocardial infarction.
The results of this study confirm that neutrophil activation and
increased free radical activity occurs in man in the 48 hour interval
after acute myocardial infarction.
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CHAPTER 9
EFFECTS OF THROMBOLYSIS ON PNE, PL-9,11-LA' AND -—INDIUM IMAGING
IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
9.1 INTRODUCTION
As early as 1912, in describing the syndrome of acute myocardial
infarction, Herrick suggested that "hope for the damaged myocardium lies
in the direction of securing a supply of blood so as to restore as far
as possible its functional integrity" (Herrick et al, 1912). In the
1930s several groups (Tennant et al, 1935; Blumgart et al, 1940) studied
coronary occlusion and the effect of its duration in canine studies.
Results highlighted the benefits of early restoration of blood flow to
the ischaemic tissue in resolving abnormalities in myocardial
contraction and in some cases infarction was avoided. Further studies in
the 1970's by several groups (Smith et al, 1974; Theroux et al, 1976)
showed, in animal models of infarction, that early reperfusion limited
the damage to the heart and also greatly improved left ventricular
function.
These observations led to the evaluation of strategies in man to
re-establish blood flow early in the evolvement of infarction.
Originally these were aimed at reducing myocardial oxygen demand
(Constantini et al, 1975) but these treatments did not demonstrate
benefit and as a result failed to gain support. Similarly, failure to
show convincing benefit with heparin and inconclusive results with
streptokinase led to the examination of percutaneous transluminal
angioplasty, surgical revascularisation and thrombolysis as vehicles for
reperfusion. Both angioplasty and revascularisation are technically
difficult and neither has been shown to be of major value.
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In contrast numerous clinical trials have shown the benefit of the
use of thrombolysis. Ischaemic. myocardium, which may otherwise become
irreversibly damaged, may be, at least partly salvaged by timely
reintroduction of the hearts blood supply by dissolution of thrombus as
a result of intracoronary or intravenous administration of a variety of
thrombolytic agents.
The use of thrombolytic agents for this purpose is now common
practice (GISSI, 1986; TIMI, 1985) and although experimentally it is
difficult to show what is happening to myocardium, results from clinical
trials show that patients treated with thrombolytic therapy have lower
immediate and longer term mortality rates.
Despite this, there is considerable interest in the concept of
reperfusion injury (Werns et al, 1986). Early fears surrounding this
treatment were based on studies in animals. Following administration of
the thrombolytic agent, reperfusion was found to be associated with
development of ventricular arrhymias, myocardial 'stunning',
microvascular damage, cell necrosis and haemorrhage (Anon. 1989).
Postulated mechanisms of reperfusion injury include; the no-reflow
phenomena, increased free radical production and neutrophil activation
with concomitant release of lysosomal enzymes (Braunwald et al, 1985).
The value of thrombolysis to the clinical course of the patient with
myocardial infarction heavily outweighs these potentially harmful
side-effects. Subtle changes in the reperfused myocardium are difficult
to characterise in vivo, however if they exist, reduction of any
deleterious effects would be desirable.
Successful imaging of the migration of neutrophils into infarcted
myocardium was described in Chapter 7 and evidence of increased
neutrophil activation and free radical activity accompanying the acute
159
inflammatory response to myocardial infarction in 20 patients treated
conventionally was described and characterised in Chapter 8.
The aim of this part of the study was to assess the effect of
intravenous administration of thrombolytic agents on the inflammatory
response by measuring plasma neutrophil elastase, the non-peroxide
isomer of linoleic acid (PL-9,11-LA') and imaging the cellular response
in a group of patients with myocardial infarction who received
thrombolysis and comparing them to a further group who were treated
conventionally. In addition these patients were compared the previously
defined (Chapter 8) normal controls and patients with stable ischaemic
heart disease.
I 6 O
9.2 MATERIALS AND METHODS
9.2.1 SUBJECTS STUDIED
CONTROL GROUPS
The control group of healthy subjects (N; n=35) and the group of
patients with a documented history of stable ischaemic heart disease
(IHD; n=30), were described in Chapter 8.
ACUTE MYOCARDIAL INFARCTION
Clinical trials have conclusively shown benefit of thrombolytic
therapy to patient health. It was therefore considered unethical to deny
patients this treatment where indicated and consequently randomisation
of patient therapy was not considered appropriate in this study.
A group of 32 patients with acute myocardial infarction were studied.
Diagnosis was made on evidence of prolonged chest pain (duration longer
than 30 minutes), characteristic ECG changes and an increase in creatine
kinase to at least twice the normal value.
This patient group was further divided according to medical treatment
received while in coronary care unit (CCU). A sub-group of patients
received thrombolytic therapy (n=17), either by administration of 1 200
000 units of streptokinase (Kabivitrum, Middlesex) or 30 units
anisoylated plasminogen streptokinase complex (APSAC, Beechams
Pharmaceuticals, Epsom, UK). The remaining 15 patients were judged
unsuitable to receive thrombolysis and so were treated conventionally.
Reasons for excluding thrombolytic therapy included late admission
(after 4 hour of chest pain), patient history of peptic ulcer, bleeding
episodes or recent cerebrovascular event.
Patients in this group had venous blood taken for estimation of
plasma neutrophil elastase (PNE), the non-peroxide isomer of linoleic
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acid in the phospholipid fraction of plasma (PL-9,11-LA'), peripheral
white cell count (WBC) and creatine kinase (CK). The initial samples
were taken within 6-8 hours of admission and every 6-8 hours thereafter
in the first 48 hours after the major onset of chest pain. The time of
sampling was relative to the best estimate of the time of the major
onset of chest pain. The protocol of the blood sampling regime is shown
in Figure 9(a).
In addition to measuring these markers of neutrophil activation and
free radical activity, the acute inflammatory response to myocardial
infarction was imaged in 21 of the 32 patients. Venous blood (60ml) was
taken from 11 of the patients receiving thrombolytic therapy and 10 of
those being treated conventionally. The methods used for isolation of
neutrophils from whole blood and labelling with "'"Indium oxine are
described in Chapter 2.
9.2.2 Plasma Neutrophil Elastase (PNE)
Plasma neutrophil elastase was measured in citrated plasma using a
standard specific radioimmunoassay which employed rabbit polyclonal
antiserum, (Greer et al, 1989) and is described in Chapter 2. The
results are expressed as ng/ml and the intra-assay coefficient was less
than 5%.
9.2.3 PL-9,11-LA' and PL-9,12-LA
The molar concentrations of PL-9,11-LA1 and PL-9,12-LA (linoleic
acid) in heparinised plasma were measured by high performance liquid
chromatography (HPLC) in plasma after enzymatic hydrolysis with
phospholipase A^ and solid phase sample preparation by the method of
Iverson et al, (1985), described in Chapter 2. The intra-assay
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coefficient was less than 3.5%. Results are expressed as umol/1.
9.2.4 White Cell Count (WBC) and Creatine Kinase (CK)
Peripheral white cell counts were performed on a sequestrene sample
using a Sysmex E5000 (Toa Electronics Ltd., Kobe, Japan). Creatine




Due to the limited availablity of the radioisotope and the clinical
problems associated with imaging patients in the acute phase of
infarction, 21 of the 32 patients were included in this part of the
study. Eleven patients who had received thrombolytic therapy and 10
treated conventionally had blood taken for neutrophil isolation and
labelling. (Methods described in Chapter 2).
It was shown in Chapter 7 that using "^''"Indium labelled autologous
neutrophils, the inflammatory response that accompanies acute myocardial
infarction could be reliably imaged provided the labelled cells were
injected within 18 hours of the onset of chest pain.
All 21 patients were reinjected with 11"'"Indium labelled neutrophils
(Median Dose 25MBq; Range (18-51 MBq)) within 18 hours (9 hours (5-17
hours))of initial chest pain.
Single photon emission tomography (SPET) was performed on each
patient 24 hours after injection of the labelled neutrophils, using a
IGE 400AT Maxicamera linked to a Seimens Microdelta Computer. (See
Figure 9(b). A series of 64 images were acquired during 360° rotation
around the patient. These were constructed by back projection using a
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Butterworth filter to create saggital, transverse and coronal views. A
111
study was considered positive when Indium uptake in the area of the
heart was seen in all three views.
9.2.7 Infarct Sizing
The following day SPET imaging was used to image the size of the
infarct in the same patients. Each received an intravenous dose of
99m
500MBq of technetium-99m pyrophosphate ( Tc-PYP) and imaged 2 hours
later using the same procedure as described for neutrophil uptake
(described above).
9.2.8 Estimation of the Volume of Uptake of Neutrophil Infiltrate
compared to Infarct Volume
99m 111
For each patient the uptake of Tc-PYP and Indium labelled
neutrophils in all the transverse slices with myocardial uptake were
analysed using a semi-automated program which counted the number of
volume cell elements (VOXELS) with values 65% of the peak myocardial
uptake (Jansen et al, 1985). Using this method the volume of the heart
showing neutrophil uptake and the volume of infarcted myocardium, as
judged by the pyrophosphate images, may be compared.
9.2.9 Radionuclide Ventriculography
Each of the infarct patients had radionuclide ventriculography
performed to assess left ventricular function. Ejection fraction was
assessed at equilibrium using multiple gated acquisition method (MUGA).
0
Technetium-human serum albumin (740MBq) was prepared from a
freeze-dried kit (TCK-2, CIS (UK) Ltd) and injected intravenously into
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the antecubital fossa. At equilibrium the gamma camera head was
positioned in the left anterior oblique (LAO) position to isolate the
left ventricle. A series of 24 images were acquired (approximately 5x10*
counts), triggered by the R wave of the ECG. A region of interest was
drawn around the left ventricle and the ejection fraction (EF)
calculated from:
EF= diastolic counts-systolic counts/diastolic counts x 100%
9.2.10 Statistical Analysis
The data were found not to be normally distributed, as tested by the
Kolmogorov-Smirnov test. Results are expressed as the median and range.
The data were compared using non-parametric analysis using the Wilcoxon
Rank Sum Test for two independent samples (Mann-Whitney). Values of
p 0.05 were taken as significant. The statistics were performed by




9.3.1 WHITE CELL COUNT
The white blood cell count was significantly lower in the normal
9
controls (5.8x10 /l, 3.4-9.3) than in the patients with stable ischaemic
g
heart disease (6.7x10 /l, 5.2-12.6, pC0.004) and this was also true for
the initial white cell count for the patients with myocardial infarction
(16.4x109/1, 7.9-33.0, p<0.0001).
The white blood cell count was significantly lower in the group with
stable ischaemic heart disease compared to the patients with acute
myocardial infarction (p<0.0001).
9.3.2 PLASMA NEUTROPHIL ELASTASE
The concentration of neutrophil elastase in plasma for normals
(18.6ng/ml, 9.2-51.0) was significantly lower than that for the patients
with stable ischaemic heart disease (25.8ng/ml, 12.2-49.5, p<.0.002).
In the patients with acute myocardial infarction,plasma neutrophil
elastase was significantly higher than both the ischaemics and the
normal controls (see Figure 9(c)) throughout the 48 hour period after
infarction.
9.3.3 PL-9,11-LA' and PL-9,11-LA1/PL-9,12-LA
There was no significant difference in PL-9,11-LA' or the molar ratio
PL-9,11-LA'/PL-9,12-LA between the normal controls (19.3umol/l,
7.5-32.9; 4.7, 1.9-9.1) and the patients with ischaemic heart disease
(19.8umol/l, 7.9-43.2; 5.4, 1.7-12.1).
The values of PL-9,11-LA' for the patients with myocardial infarction at
all times over the 48 hour period were significantly higher than both
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the controls and the ischaemic group. This was also true for the molar
ratio of PL-9,11-LA'/PL-9,12-LA compared to the control group, however
the ratio was significantly higher than the ischaemics only during the
first 24 hours following infarction (Figures 9(d) and 9(e)).
9.3.4 Comparison Within the Patient Group with Myocardial Infarction
Thrombolysis and Conventional Treatment
9.3.5 White Cell Count (WBC)
There was no difference in white cell count between the non-thrombolytic
9
group (13.2x10 /l, 9.5-23.0) and the patients who received thrombolytic
therapy (16.8xl09/l, 7.9-33.7).
9.3.6 Plasma Neutrophil Elastase (PNE)
The pattern of change in levels of elastase in plasma was different in
the two treatment groups (Figure 9(f)). Plasma neutrophil elastase for
the patients who received thrombolytic therapy peaked at 8 hour
(48.2ng/ml, 25-250) and was significantly higher than the non
thrombolytics (32.6ng/ml, 15.6-101, p<0.025) at this time. Over the
remaining period the elastase values fell slowly.
Those patients treated conventionally tended to have low early values
and the peak (49.8ng/ml, 21.4-196) occurred later, at around 40 hours
post infarct and was significantly higher than those treated with
thrombolysis (34.2ng/ml, 15.8-83, p<0.037).
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9.3.7 PL-9,11-LA' and PL-9,11-LA'/PL-9,12-LA
There was no significant difference in PL-9,11-LA' or the molar ratio
PL-9,11-LA'/PL-9,12-LA in those treated conventionally after myocardial
infarction and those given thrombolysis. For both groups the values were
maximal at 16 hours and gradually fell to normal levels. (See Fig 9(e)
and 9(h))
9.3.8 Plasma Creatine Kinase (CK)
There was no significant difference in peak creatine kinase between
patient treated conventionally (1635U/1, 522-6255) and those who were
treated with thrombolysis (2059U/1, 533-6955). The plasma activity of
creatine kinase reached a peak earlier in those treated with
thrombolysis (16 hours) than in those treated conventionally (24 hours).
9.3.9 Left Ventricular Ejection Fraction (LVEF)
There was no significant difference in the LVEF measured by radionuclide
ventriculography 10 days after infarction, though those patients who
were treated with thrombolytic, agents (40%, 24-68) had slightly higher
values than those who were treated conventionally (32%, 15-71).
9.3.10 Imaging
There was no significant difference in the peak creatine kinase, LVEF
and time to reinjection of autologous radiolabelled neutrophils for
patients treated conventionally and those treated with thrombolytic
therapy (see Table 9(ii)).
Uptake of Tc pyrophosphate was similar for the two treatment groups
suggesting little difference in the size of infarcts experienced by
these patients. This is further supported by the similarity of the peak
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creatine kinase for both. The uptake of Indium labelled neutrophils
was less in the patients treated with thrombolysis.
Ill 99m
The ratio of In/ Tc serves as an estimate of the inflammatory
response for a given infarct, and this was significantly less in
patients treated with thrombolysis (0.41, 0-0.96) than in those treated
conventionally (0.79, 0.06-2.14, p<0.05).
Figure 9(i) shows an example of the reduced uptake of "'""'"^Indium labelled
neutrophils in a patient treated with streptokinase compared with that
seen in a patient who received no thrombolysis.
9.4 Influencing Factors
There was no correlation between the leucocyte count and the plasma
concentration of neutrophil elastase in any of the groups studied. There
was a weak correlation between the leucocyte count and PL-9,11-LA' in
the non-thrombolytic group (r=0.63;p<0.02) and in the patients with
ischaemic heart disease (r=0.45; p<0.02) but this did not hold for the
corrected molar ratio and no correlations were found in the normal
volunteers and patients treated with thrombolysis.
9.4.1 Acute Myocardial Infarction
There was no correlation of creatine kinase with PL-9,11-LA' or the
molar ratio of PL-9,11-LA1/PL-9,12-LA measured in the same sample.
Creatine kinase did not correlate with the increase in plasma neutrophil
elastase seen in either group of patients whether treated with
thrombolytic therapy or not.




Details of healthy volunteers (controls), patients with chronic
ischaemic heart disease (IHD), and patients with myocardial infarction
(AMI).
Myocardial Infarction
Controls IHD No Thrombolysis Thrombolysis
(n=35) (n=30) (n=15) (n=17)
M/F 30:5 24:6 10:5 13:4
Age 34 59 58 56
(22-63) (37-76) (38-74) (30-69)
WBC(x109/1) 5.8 6.7 13.2 16.8
(3.4-9.3) (5.2-12.6) (9.6-23.0) (7.9-33.7)
LVEF (%) 41 32 40
(18-63) (15-71) (24-68)
Peak CK(U/l) 1635 2059
(522-6255) (533-6955)










Details of patients treated with and without thrombolysis who were
111
imaged with Indium-labelled neutrophils and
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IGE 400AT Maxicamera linked to a Seimans Microdelta Computer showing a
volunteer in position for SPET imaging.
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Figure 9(c.)
Plasma neutrophil elastase for normals (N), patients with ischaemic heart
disease (IHD) and acute myocardial infarction (AMI)
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Figure 9(d)
PL-9f11-LA* for normals (N), patients with ischaemic heart disease (IHD)
and acute myocardial infarction (AMI)
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Figure 9(e)
PL-9f11-LA7PI-9,12-LA for normals (N), patients with ischaemic heart
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Time after infarction (h)
Plasma neutrophil elastase for patients with myocardial infarction treated
conventionally (o) or with thrombolytic therapy {•).
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Figure 9(g)
{•) THROMBOLYSIS vs (o) NO THROMBOLYSIS
60 -i
Time after infarction (h)
PL-S.II-LA' for patients with myocardial infarction treated







(•)THROMBOLYSIS vs (o) NO THROMBOLYSIS
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Time after infarction (h)
48
PL-9f11-LA'\PL-9f12-LA for patients with myocardial infarction
treated conventionally (o) or with thrombolytic therapy (•).
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Figure 9(i)
SPET images comparing the uptake of labelled neutrophils
99m
with the size of infarction as assessed by Tc-PYP. The upper
111 99m
pair of images show easily detected uptake of In and Tc-PYP
in a patient with anterior AMI who was not given thrombolytic
treatment. The lower pair of images show markedly reduced uptake
111 99m
of In labelled neutrophils compared with Tc-PYP in a patien
with anterior AMI treated with anistreplase.
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9.5 DISCUSSION
This study confirms the findings of Chapter 8 that statistically
significantly raised levels of neutrophil elastase and PL-9,11-LA1
indicating increased neutrophil activation and free radical production
respectively, exist in the plasma of patients following acute myocardial
infarction when compared to normal subjects and a further control group
of patients with stable ischaemic heart disease. Moreover, the pattern
of production of these species differs in patients with acute myocardial
infarction according to whether or not thrombolytic therapy has been
administered. More importantly, reperfusion did not appear to be
associated with an exacerbated production of these potentially harmful
species.
The clinical benefits of thrombolysis after myocardial infarction are
now well documented (GISSI-2, 1990). The dramatic decrease in patient
mortality, coupled with improvement in left ventricular function has
more than proved the case for its use where clinically indicated.
Naturally, as with all novel therapies, and particularly one which has
received such close scrutiny by the medical profession, there has been
considerable debate on the balance between the beneficial and possibly
detrimental effects of such treatment. Complications of reperfusion were
first indicated in studies on animals and was found to be associated
with development of ventricular arrhymias, haemorrhage and less obvious
abnormalities such as myocardial stunning, microvascular damage and cell
necrosis. The problems of arrhymia and bleeding have been monitored in a
number of studies (ISIS-2, 1988; AIMS, 1990), however hastening of
myocyte necrosis with extension of myocardial injury and several other
phenomena are much more difficult to quantify in man. 'Reperfusion
Injury' due to early reintroduction of oxygen into the ischaemic tissues
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has been supposed to occur through several possible mechanisms.
Braunwald in addressing this problem postulated the involvement of
several factors which include the 'no-reflow' phenomenon, the calcium
and oxygen paradox and the involvement of leucocytes (Braunwald et al,
1985).
Markers of free radical production and neutrophil activation were
measured in two groups of patients with myocardial infarction and the
effects of thrombolysis on these parameters was also studied.
Plasma neutrophil elastase was maximal in the period between 32 and
40 hours after myocardial infarction in patients treated conventionally.
This coincides with the presence of the inflammatory infiltrate which is
known to be present histologically (Sommers et al, 1954) at this time.
In contrast, in patients treated with thrombolytic agents (either
streptokinase or Anistreptlase) there was an early and significant
increase in plasma neutrophil elastase within the first few hours of
treatment. This agrees with previous reports (Gutteridge et al, 1988) of
early neutrophil activation. This early peak of plasma neutrophil
elastase may reflect clot lysis at the time of thrombolysis or
intracoronary activation of neutrophils, as few will be present in the
myocardial tissue at this early stage (Mallory et al, 1939). It is of
note that the elevation of neutrophil elastase seen in the plasma of the
conventionally treated patients in the period which appears to concur
with the presence of the inflammatory infiltrate, is absent in this same
period after myocardial infarction in patient group who received
thrombolysis.
Differences in drug regime, other than that due to the
administration of thrombolytic agents may be considered as a possible
source for the disparity in results. The administration of lignocaine,
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an anti-arrhythmic, may be considered as an influencing factor in view
of the known in vitro (Goldstein et al, 1977) and potential in vivo
effects (de Lorgeril et al, 1988). However, similar numbers of patients
in each group received lignocaine. Also in the thrombolytic group,
patients who received hydrocortisone prior to receiving streptokinase,
111
did not have reduced uptake of Indium or lower elastase
concentrations than the patients treated with Anistreplase, who did not
receive hydrocortisone. This suggests that the results seen in the
thrombolysis group were not influenced by the potentially suppressive
effect of hydrocortisone on the inflammatory response and neutrophil
function (Hart et al, 1984).
Therefore the absence of the later peak of neutrophil elastase might
suggest that administration of thrombolysis may in fact suppress the
cellular inflammatory response.
This hypothesis is supported by the results of imaging. Of the 21
111
patients who were imaged with autologous Indium labelled neutrophils
only 2 of these showed no uptake of activity in the area of the heart.
Although this may be due to a failure of cell labelling or imaging
procedures, this is unlikely, since all subjects received the labelled
cell preparation within the prescribed time following onset of chest
pain thus ensuring a positive result ie. within 18 hours of chest pain.
The two patients who had negative scans received thrombolysis and since
all of this group had significantly reduced uptake of neutrophils in
99m
relation to infarct size, (assessed by Tc-PYP) it is more likely that
the response was reduced to such an extent that indium activity was
indetectable.
Increased free radical activity, measured indirectly as the
isomerised diene conjugate of a membrane lipid in the phospholipid
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fraction of plasma of both infarct groups, was confirmed. The values of
PL-9,11-LA' and the molar ratio of its substrate linoleic acid, were
initially high and then fell over the 48 hours following myocardial
infarction suggesting early maximal free radical activity. The
conventionally treated and the thrombolytic groups followed a similar
trend and no statistical differences in the levels could be detected
over the period of the study. This similar pattern of free radical
generation for the two groups, with the thrombolytic group showing
slightly lower values, suggests that in this study, reperfusion, induced
by thrombolysis was not associated with a delayed or further increase in
free radical production. Neither the concentration of PL-9,11-LA' nor
the molar ratio correlated with creatine kinase measured in the same
sample and it therefore seems unlikely that the raised values were
merely a marker of cell damage (Halliwell et al, 1984).
The results from this study support the concept of a reduction in the
acute inflammatory response to acute myocardial infarction by treatment
with thrombolytic therapy.
The conventionally treated patient group showed an early and
continued elevation in free radical activity. This was coupled with a
sharp increase in neutrophil activation, and was coincident with the
presence of the infiltrate associated with the inflammatory response to
ischaemic tissue as evidenced by the radiostopic studies. A rise in free
radical activity similar temporally but slightly reduced was seen in the
thrombolytic group. If the early peak of neutrophil elastase detected in
this group represents clot lysis or intracoronary activation at a time
when the neutrophil numbers present in the tissue will be neglible, then
the absence of the later peak seen in the previous group would suggest a
reduction in the infiltrate, a point also demonstrated in this work by
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the attenuation of 11 Indium-labelled neutrophils into the area of
infarct.
If late myocyte injury does occur after myocardial infarction it may
be mediated by the release of proteolytic enzymes from the large number
of neutrophils present at the height of the inflammatory response rather
than free radicals. The presence of these species was confirmed by the
continued increase in lipid oxidation. The ability of free radical
products to inactivate one of the main regulatory inhibitors of
neutrophil elastase ie. alpha-l-antiproteinase by oxidation of its
reactive centre is well documented, (Weiss, 1989) and may further
potentiate tissue injury by the neutrophil.
In animals, administration of free radical scavengers such as
superoxide dismutase (SOD) has been successful in reducing the extent of
myocardial damage (Schlafer et al, 1982) and there is evidence that this
agent may work in part by reducing neutrophil migration (McCord et al,
1982). It may be possible, therefore that part of the beneficial effect
of the administration of thrombolytic therapy post-infarction may lie in
the partial inhibition of the inflammatory response to myocardial
injury, perhaps by reduction in the extent or duration of the production
of neutrophil chemoattractants, such as C5a or LTB^ (Hartmann et al,
1977).
This study has shown that after myocardial infarction neutrophil
activation and free radical production occurs. Reperfusion, following
successful thrombolysis did not appear to associated with an
amplification of the inflammatory response of prolonged free radical
production. Rather, these were somewhat diminished and it may be that
some of the benefits of thrombolysis may be due to down regulation of




Acute myocardial infarction in man is one of the commonest causes of
mortality in the western world.
Evidence from experimental models of infarction suggest that the
neutrophil may exert additional harmful effects on the surrounding
myocardial tissue (Romson et al, 1983; Jolly et al, 1986).
The aim of this thesis was to determine if the neutrophil played a
significant role in acute myocardial infarction in man. To study
neutrophil activity, a method to isolate and radiolabel autologous
neutrophils was developed. This, in conjunction with established markers
of neutrophil activation and free radical activity, was used to
determine neutrophil involvement in acute myocardial infarction.
Particular focus was then made on patients who received coronary
thrombolysis as "Reperfusion Injury" has been frequently been
demonstrated in animal studies (Engler et al, 1983).
This final chapter will discuss to what extent these aims have been
fulfilled and how research in this field has developed during the last
few years.
Studies in animal studies, have shown that the inflammatory response
may be monitored in vivo by administration of autologous radiolabelled
leucocytes with subsequent imaging (Thakur et al, 1979; Weiss et al,
1977). To assess whether the neutrophil played a significant role in
myocardial infarction in man, methods for neutrophil isolation and
labelling were developed.
Although methods for neutrophil isolation and labelling existed at
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the time of study, most were time consuming, requiring initial red cell
sedimentation and preparation of a discontinous density gradient.
I developed a method where neutrophils were isolated from whole blood
using a single-step procedure using Mono-Poly Resolving Medium (a
Ficoll-Hypaque mixture). This circumvented the need to perform an
initial red cell sedimentation step using dextran, hydroxyethyl starch
or methylcellulose (Segal et al, 1978; Danpure et al, 1982; Pfieffer et
al, 1982) as was current practice.
A "pure" cell population was isolated with a minimum of 'handling'
and could be completed within one hour of venesection. The efficiency of
cell separation was high, as was the purity of the sample, determined
from differential leucocyte counts.
Advantages of neutrophil isolation using this method included
preservation of cell viability by minimising manipulation of the cells.
Also, when used in conjunction with non-discriminant radionuclides,
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Indium oxine in this case, reduction in non-specific labelling of
other blood cells, in particular avoidance of labelling radiosensitive
lymphocytes was possible. Labelling efficiency of 70-80% of the pure
cell isolate agreed well with other published data (Thakur et al, 1977;
Mountford et al, 1985).
Since my work was completed, alternative means of neutrophil
labelling have been demonstrated. Two of the major developments is that
99m
of Technetium, which is used to label mixed leucocyte populations and
constitutes a cheap and readily available source of radioactivity.
Secondly, specific labelling of neutrophils in vitro or in vivo with
monoclonal antibodies to neutrophil surface glycoproteins.
Technetium labelling has been tried before but the instability of
99m
Tc in combination with ligands thwarted these attempts. However the
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re-discovery of an agent, already used as a brain scanning agent,
99m
hexamethylpropylene amine oxime (HMPAO), made Tc labelling feasible
(Ell et al, 1985).
Several studies report the successful use of mixed leucocyte
populations labelled with 99mTc-HMPA0 in the study of inflammatory
lesions, with detection as early as 4 to 6 hours after injection (Peters
et al, 1986; Roddie et al, 1988). However the relatively short half life
9 9m
of Tc (6.02 hours), may be a problem as maximum white cell
localisation may not take place for up to 24 hours.
While initial reports are promising, there may be other associated
limitations of its use. For example, reduced efficacy was demonstrated
99m
by studies in dogs where significantly lower accumulation of Tc-HMPAO
activity located in abscesses compared with simultaneously injected
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Indium-labelled leucocytes (McAfee et al, 1987) was found. Also
higher radiation doses are routinely administered due to the
99m
considerably shorter half-life of Technetium. A radiation dose of
around 740 rads (0.5mCi or 18.5Bq) is generally associated with
99m
indium-labelled leucocytes whereas for Tc a dose of 3120 rads is
common. Whilst it was previously thought that administration of 10 000
rads and below had no effect on cell function, more recent studies
suggest that this may be a considerable over-estimate. This was
illustrated when cells, exposed to a 60-Cobalt gamma cell, showed marked
impairment of localisation at sites of inflammation (Bassano et al,
1979). Also such high doses may potentiate the risks associated with
radiolabelling lymphocytes, since this radionuclide is recommended for
use with mixed leucocyte populations.
The second approach, designed to circumvent the complexities of
labelling leucocytes in vitro, is the development of methods for
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labelling neutrophils in vivo using monoclonal antibodies. These
monoclonals, raised against cell membrane glycoproteins, may be labelled
with ^mTc or "'"^^"In, which permits imaging as a detection system.
This relatively new approach has several disadvantages including
uncertainty on the exact mode of action (Gardner et al, 1989), the
possibility of reactions to the murine antibodies (Seybold et al, 1988)
and of more consequence to this type of study, that
granulocyte-associated radioactivity accounts for less than 30% of the
injected dose (Joseph et al, 1988).
While possible refinements of these methods may eventually lead to
the successful use of these agents in vivo, cells isolated on M-PRM and
subsequently labelled with Indium-oxine provided the optimal means of
studying the specific nature of neutrophil involvement in acute
myocardial infarction.
The effects of isolation procedures; the isolation media used,
centrifugation steps, temperature and completion time, on neutrophil
function remains a contentious issue.
While assessment of viability was carried out on the cell isolates
using the trypan blue exclusion test, this was a crude measure of the
cell's state. Results from studies on the effects of Ficoll-Hypaque and
Percoll, on neutrophil activation, as assessed by release neutrophil
elastase, a recognised marker of cell activation (Greer et al, 1989)
showed neither agent caused significant cell activation. More notably,
agents used to effect red cell sedimentation were shown to represent a
more important source of neutrophil activation with the compounding
effect of increased temperature also clearly illustrated. Therefore
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where 'pure' neutrophil isolates are required, a one step isolation
procedure, avoiding the requirement for use of sedimentation agents,
provides the best option.
A common technique of assessing cell viability of neutrophils after
labelling is their passage, after intravenous injection, through the
lungs and subsequent collection in the liver and spleen. Ideally,
leucocyte transit should be compared to that of the red cell population,
Q 0 j1^
generally labelled with Tc (Muir et al, 1984). This method requires
simultaneous acquisition of both isotopes but because of data processing
limitations was beyond the scope of our equipment. In this study a
single-isotope method was used to compare the transit of neutrophils
through the lungs with the heart.
Several studies have shown that poorly functioning or damaged
"^"'"Indium labelled neutrophils demonstrate lung retention or liver
sequestration (Weiblen et al, 1979; Saverymuttu et al, 1983). Indeed
there has been considerable debate about the chemical form of indium
with at least one group favouring troplone over indium. Isolated
granulocytes, labelled with "^"'"Indium tropolone in plasma were shown to
exhibit "rapid transit through the pulmonary vasculature" whereas cells
labelled in saline exhibited behaviour that represented "stimulation
and/or damage" (Saverymuttu et al, 1983). Because ^"'"Indium oxine will
preferentially label the proteins in plasma (McAfee, 1984) , neutrophils
must be labelled in saline, as was the case in this study.
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The cells isolated on M-PRM and labelled with indium oxine
followed "typical" in vivo behaviour, in that lung retention of the
cells was minimal, with subsequent accumulation in liver and spleen, in
19 O
a manner similar to previous observations (Muir et al, 1984).
Thus pure neutrophils separated and labelled as described have good
in vivo kinetics and appear functionally normal.
"The ultimate test of granulocyte function from a clinical point of
view" according to Joseph et al, (1988), is that "they accumulate in
abscesses and other inflammatory lesions".
Such a quality was demonstrated for the cells used in this study. In
those patients, considered here in isolation from those with acute
myocardial infarction, indium activity, representing neutrophil uptake
was shown in patients in whom active infection of inflammation was later
confirmed.
The frequency of the positive images here was relatively low but
probably reflects the large number of requests for this test as a means
of diagnosis in cases where other diagnostic tests had proved
inconclusive.
Failure to detect an infection site occurred in only one subject.
This case of a subdiaphragmatic abscess was later found at post mortem
and presumbly was undetected due to the proximity of liver and spleen,
both normally sequestering labelled neutrophils.
Leucocyte scanning proved especially useful in diagnosing infection
of inflammatory foci in the bowel. This method has advantages in that,
67 99m
unlike Gallium and Tc-HMPAO, background and non-specific uptake
radioactivity in the gut does not interfere with image interpretation
(Costa et al, 1988).
Detection of neutrophil uptake was shown in a case of pneumonia and
contrasts to results of a study by Lavender et al, (1988). While
diagnosis is normally made using routine radiological techniques, the
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inability to do so with labelled leucocytes has puzzled many groups
working in this field. This was originally attributed to reduced lung
perfusion during the disease process, but has since been disproved
(Lavender et al, 1988). Successful imaging found here was thought to
relate to the timing of the study. Autologous labelled neutrophils were
administered very early in the progress of the pneumonia and preceded
commencement of antibiotic therapy. This would suggest that the stimulus
for neutrophil recruitment to the site of inflammation may be early and
somewhat transient. This postulate was developed further in the study of
factors which determined neutrophil uptake in the heart after myocardial
infarction.
This study confirmed that using labelled autologous neutrophils, the
inflammatory response to acute myocardial infarction could be imaged in
man.
In 23 of the 30 patients studied, uptake of indium activity in the
region of the heart, was demonstrated by planar or SPET imaging or a
combination of both. Factors that were considered might influence the
outcome of imaging were assessed. The only determinant that could
reliably be used to predict the outcome of imaging was the time span
between the onset of the major chest pain and injection of the labelled
cells. The earlier after the event the cells were injected, the greater
the probability of obtaining a positive image, a fact clearly
demonstrated by the 100% success rate in patients reinjected within 18
of infarction which fell dramatically to 44% if delayed to between 24
and 36 hours.
The temporal relationship found here suggests that the stimulus for
neutrophil recruitment into the injured myocardium is an early and
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somewhat transient phenomenon. As explained above, the concept of a
"time-window" for cell migration may also explain why some workers were
unable to demonstrate neutrophil uptake in pneumonia. If labelled cells
are administered late in the disease process, the signal or stimulus for
neutrophil migration may be "switched off" (Lavender et al, 1988).
The timing of the sequence of events, particularly that relating to
early maximal cellular involvement, may appear to conflict with evidence
from pathologic studies where maximal neutrophil presence is seen 2 to 4
days after infarction (Mallory et al, 1939). However it must be noted
that pathological observations only show the total accumulation of
neutrophils and do not address the dynamics of the process.
Information from planar images is often limited. Interference from
physiological activity located in spleen and liver makes it difficult to
unequivocally demonstrate uptake in specific locations. Improved
anatomical localisation was achieved with the use of single photon
emission computed tomography (SPET). Further improvement of activity
localisation was obtained by administration of 99mTc-HSA, a blood pool
marker which allowed differentiation between tissue or blood pool
associated activity.
The use of SPET resulted in significant improvement in anatomical
localisation of indium uptake in the earlier studies of
inflammation/infection. This was important in the 2 patients who
sustained a perforated bowel and mycotic aneurysm repectively. In the
latter case, further definition was achieved employing SPET in
99m
conjunction with a blood pool marker ( Tc-human serum albumin). More
importantly, the use of SPET in the study of myocardial infarction also
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increased the number of positive images found by making separation of
the inferior surface of the heart from liver and spleen possible .
The results from the imaging studies show neutrophil infiltration to
be a relatively early phenomenon in acute myocardial infarction.
The second phase of the work set out to examine evidence of
neutrophil activation.
It has been known for some time that the leucocyte count is increased
in ischaemic heart disease (Ernst et al, 1987; Kostis et al, 1984). An
association between leucocyte count and myocardial infarction,
particularly prediction of first and subsequent re-infarction, has also
been established (Friedman et al, 1974; Lowe et al, 1985). Certainly my
own observations again demonstrate this increase in leucocyte count in
patients with ischaemic heart disease.
The leucocyte count was also elevated in the patients with acute
myocardial infarction (Nash et al, 1989), but reflects the more general
response to stress (Muir et al, 1984).
In view of the contribution the neutrophil makes to the rheology of
the blood, and its interaction with the vascular endothelium, it is
believed the presence of high numbers of neutrophils or perhaps
activated neutrophils, may contribute to the risk of ischaemic events by
promoting vascular occlusion, post occlusive inflammatory injury and
endothelial injury (Dinerman et al, 1990).
To establish whether the increased leucocyte numbers in these groups
represented an activated cell population, markers of in vivo neutrophil
activation were also measured.
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Such measurement, in plasma, of substances released from neutrophil
granules provides a means of assessing cell activation in vivo (Ernst et
al, 1987), Neutrophil elastase, a neutral protease contained in the
azurophilic granules, was measured in plasma using a standard
radioimmunoassay technique. The polyclonal antisera raised in-house,
against human neutrophil elastase, was specific, in that it did not bind
to the antigenically distinct elastases of platelets and pancreas. It
detected neutrophil elastase in its free and also in complex with its
natural inhibitors, the state in which it circulates in plasma.
When measured in whole blood, elastase correlated with the total
neutrophil count and is primarily a measure of the intracellular stores
of this protease. Neutrophil elastase in plasma does not correlate with
leucocyte count or neutrophil count and therefore the elevated levels
reflect an increase in neutrophil activation in the form of
degranulation (Greer et al, 1989).
Plasma neutrophil elastase (PNE) was elevated significantly in
patients with stable ischaemic heart disease, and although neutrophil
count was raised in this group, no correlation with plasma neutrophil
elastase was found and therefore was consistent with a prevailing state
of neutrophil activation.
In the patients with acute myocardial infarction, neutrophil elastase
was raised over the 48 hour period following infarction and was further
raised at around 24 hours. This peak of activity coincided with a time
when the inflammatory infiltrate is known to be present histologically
in the myocardium, as shown by the imaging studies.
In a similar study of patients with unstable angina and acute
myocardial infarction, evidence of neutrophil activation was found
(Mehta et al, 1988). In contrast however, no evidence of in vivo
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neutrophil activation was found in patients with stable ischaemic heart
disease, although a state of "hyperactivity" was indicated by increased
neutrophil function. Therefore evidence is emerging to indicate the
existence of neutrophil activation in ischaemic heart disease. This
enhanced activity, as seen in these patients, therefore may provide a
pathophysiologic environment for progression from stable to unstable
coronary heart disease.
An association between in vivo neutrophil activation and vascular
disease have been reported. Several of these studies, carried out in
Edinburgh on diabetes mellitus (Collier et al, 1989), pregnancy-induced
hypertension (Greer et al, 1989) and groups particularly at risk from
vascular disease (Jackson et al, 1991) have shown evidence of
neutrophils contributing to the progession of the disease. Although
attempts to correlate severity of disease with elastase levels have
proved inconclusive, where end-organ damage was present, circulating
plasma levels of elastase were further increased.
The non-peroxide isomer of linoleic acid, PL-9.11-LA', was used as a
indicator of free radical activity. The method used was a modification
of that of Iversen et al, (1985) using high performance liquid
chromatography.
PL-9,11-LA', indicating free radical activity, was raised in the
patients with acute myocardial infarction, but not in patients with
ischaemic heart disease and was consistent with the production of free
radical activity after myocardial infarction.
In the early part of this study only the PL-9,11-LA' isomer was
measured. In view of concern on the origins of linoleic acid in vivo,
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especially through dietary intake, in subsequent studies, the substrate,
linoleic acid (PL-9,12-LA ) was also measured. In this way the molar
ratio of the isomer to its substrate could be expressed, thus providing
a more sensitive index of change.
However in the patients with acute myocardial infarction PL-9,11-LA'
levels were measured sequentially over a period of 48 hours and
therefore changes associated with dietary intake over this period of
hospitalisation would seem unlikely.
As yet electron spin resonance spectroscopy (ESR), represents the
best method for detecting free radical activity in vivo. However as
discussed in Chapter 1, this system, while readily applicable to the
chemistry of non-biological systems, its use in living systems presents
significantly greater problems, although it has been used with some
success in animal models. Once this method has been modified for more
general in vivo use, valuable information, most specifically on the site
of production may be provided.
Until this is possible, indirect methods of assessment must suffice.
It may be prudent then, where feasible, to use a range of indicators of
free radical activity to generate a more comprehensive picture of these
processes. This should include measurement, not only of body
constituents altered as a result of free radical interaction but also
scavengers and anti-oxidants. Several recent studies have measured at
least four indirect indicators of free radical activity eg. superoxide
dismutase, plasma thiol, erythrocyte lysate thiol and caeruloplasmin
(Collier et al, 1990). Also detection of anti-oxidants, such as vitamins
E,C, A and also carotene (Reimersma et al, 1991) may provide further
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information.
As discussed in Chapter 1, evidence of infarct size attenuation by
neutrophil depletion in animals, suggests that neutrophils may cause
secondary heterolytic damage of myocytes after myocardial infarction
(Romson et al, 1982; Jolly et al, 1986). This additional damage was
attributed to the release of lysosomal enzymes (Engler et al, 1987) or
to free radical production (McCord, 1985). Such damage is thought to be
further augmented by institution of reperfusion by intravenous
thrombolysis (Braunwald et al, 1985). This additional damage, termed
"reperfusion injury" is thought to off-set the known benefits of
reperfusion (ISIS-2, 1988; GISSI-2, 1990) by mechanisms of injury
including capillary plugging (Kloner et al, 1974), generation of
oxygen-derived free radicals (Werns et al, 1986) and neutrophil
activation with concomitant release of lysosomal enzymes (McCord, 1987).
As a result of these studies in animals, possible therapeutic
intervention to reduce or abrogate neutrophil recruitment and activation
during myocardial ischaemia has been suggested (Crawford et al, 1988).
Since the completion of this study, several investigators have used
indirect methods of assessing free radical production in man, after
periods of induced clinical ischaemia. Coronary angioplasty (Roberts et
al, 1990), pacing (Oldroyd et al, 1990) and coronary bypass surgery
(Davies et al, 1990) provided models of ischaemia and reperfusion. Each
of these studies detected free radical activity by measurement of lipid
peroxidation products and sampled almost upon the point of reperfusion.
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While there are variations in the results, the general finding was that
there is a small, but significant increase in free radical production
within minutes of reperfusion. A study of free radical production in man
after thrombolysis by Davies et al, (1990), showed that successful
thrombolysis was associated with increased lipid peroxidation two hours
after administration.
The data from Chapter 7 had shown that the acute inflammatory
response to myocardial infarction could be imaged in man and the studies
in Chapter 9 confirmed this. Moreover the observation from Chapter 8
that there is evidence of neutrophil activation and free radical
activity was also confirmed in Chapter 9. Reperfusion injury has been
demonstrated in animals but when we examined patients treated with
intravenous thrombolysis, there was no evidence of enhanced neutrophil
activation and free radical activity.
Animal models suggest that neutrophil activation and free radical
activity can extend myocardial injury. Our own observations confirm that
neutrophil activation and free radical activity occurs in man following
infarction, but we can make no observations on how this affects infarct
size. At present therefore there seems little justification for the use
of anti-inflammatory drugs in man, particularly since, while known to
reduce ischaemic myocardial injury in animals, these may adversely
affect the reparative process, resulting in subsequent scar thinning
(Cannon et al, 1985; Jugdutt et al, 1985).
Clearly much remains to be done. Improvements in radiolabelling
techniques continue, making more detailed examination of the in vivo
behaviour of the neutrophil possible. Other markers of neutrophil
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activation exist and elastase is certainly not the only proteolytic
enzyme released by the neutrophil. A more detailed examination of the
mechanisms of secondary destruction of the myocyte is essential.
Improved methods of studying the role of reactive oxygen are required
and perhaps ESR will one day allow in vivo imaging of tissue release.
Given the practical and ethical difficulties of studies in man, it
may continue to be difficult to assess the role of the neutrophil in
myocardial damage in man. However the increasing importance of early
intervention with revasularisation after acute myocardial infarction
makes it all the more needy for means of documenting heterolytic damage
to the myocardium.
Clearly our observations do not give cause for concern, as patients
receiving thrombolysis seemed to sustain no additional damage. However
the possibilities of further limiting infarct size and perhaps
favourably affecting tissue repair make further observations of
neutrophil behaviour in this common condition mandatory.
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Activated neutrophils releasing proteo¬
lytic enzymes and oxygen free radicals
have been implicated in extending myo¬
cardial injury after myocardial infarc¬
tion. Neutrophil elastase was used as a
marker of neutrophil activation and the
non-peroxide diene conjugate of linoleic
acid was used as an indicator of free
radical activity in 32 patients after acute
myocardial infarction; 17 were treated by
intravenous thrombolysis. Patients with
acute myocardial infarction had higher
plasma concentrations of neutrophil
elastase and the non-peroxide diene
conjugated isomer of linoleic acid than
normal volunteers or patients with stable
ischaemic heart disease. Patients treated
by thrombolysis had an early peak of
neutrophil elastase at eight hours while
those who had not been treated by throm¬
bolysis showed a later peak 40 hours after
infarction. The plasma concentration of
non-peroxide conjugated diene of linoleic
acid was highest 16 hours after the
infarction irrespective of treatment by
thrombolysis. Quantitative imaging with
single photon emission tomography
showed decreased uptake of indium-Ill
labelled neutrophils in the infarcted
myocardium (as judged from tech-
netium-99m pyrophosphate) in those who
had received thrombolysis, suggesting a
decreased inflammatory response.
The results indicate increased neutro¬
phil activation and free radical produc¬
tion after myocardial infarction; they
also suggest that thrombolysis does not
amplify the inflammatory response and
may indeed suppress it.
Activation of neutrophils with release of
lysosomal enzymes and production of oxygen
free radicals is an important part of the host
defence mechanism against microbial infec¬
tion. Activated neutrophils, however, have
been implicated in the pathogenesis of several
disease processes including emphysema, adult
respiratory distress syndrome, and myocardial
infarction.1 It has been suggested that the
neutrophil may cause secondary heterolytic
damage of myocytes, because neutrophil
depletion limited infarct size in animal models
of infarction23; the damage was attributed to
the release of lysosomal enzymes4 or free radical
production.5 Further experimental evidence
suggests that reperfusion of ischaemic
myocardium, for example after thrombolytic
treatment, may be a double edged sword with
the benefits of reoxygenation being partly
offset by the potential harmful effects of
reperfusion injury.6 Postulated mechanisms of
reperfusion injury include plugging of small
capillaries,7 generation of oxygen free radicals,8
calcium influx" and neutrophil activation with
release of lysosomal enzymes.10 Thus
the neutrophil may have a role in reperfusion
injury but its importance in patients has
not been determined, though the clinical
benefits of thrombolytic treatment are now
established." 12
Degranulation of neutrophils releases
neutrophil elastase, a lysosomal enzyme; this
has been used as a specific marker ofneutrophil
activation.13 Activated neutrophils are one
potential source of oxygen free radical produc¬
tion.14 It is difficult to measure these unstable
oxygen species but once they are generated
they will react and oxidise adjacent molecules,
particularly polyunsaturated fatty acids.15 The
diene conjugated non-peroxide isomer of
linoleic acid (phospholipid 9, 11-linoleic acid;
PL-9, 11-LA') has been used as a marker of
human free radical activity.16 To determine if
and when neutrophil activation takes place
after myocardial infarction, we measured serial
changes in plasma neutrophil elastase and PL-
9, 11-LA'. We also investigated how these
indices were influenced by reperfusion by
studying patients treated with and without
thrombolytic agents. .Finally, because the acute
inflammatory infiltrate within myocardium
after myocardial infarction can be imaged,17 we
examined the effect of treatment with and
without thrombolysis on the myocardial uptake
of indium-111 labelled neutrophils.
Patients and methods
VALUES IN HEALTHY VOLUNTEERS AND PATIENTS
WITH CHRONIC ISCHAEMIC HEART DISEASE
To establish a normal range for plasma
concentrations of neutrophil elastase and the
conjugated diene of linoleic acid, blood samples
were taken from 35 healthy volunteers from
laboratory and hospital staff. As a further
control group we also studied 30 patients with a
documented history of ischaemic heart disease
based on coronary angiography (n = 12) or
distant myocardial infarction (n = 18)
(table 1).
PATIENTS WITH ACUTE MYOCARDIAL
INFARCTION
Observations were based on 32 patients who
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Table 1 Characteristics of healthy volunteers, patients with chronic ischaemic heart disease, and patients with
myocardial infarction
Myocardial infarction
Volunteers IHD No thrombolysis Thrombolysis
(n = 35) (n = 30) (n = 15) (n = 17)
Age (yr) 34 59 58 56
(22-63) (37-76) (38-74) (30-69)
M/F 30:5 24:6 10:5 13:4
WBC(x 10'/1) 5-8 6-7 13-2 16 8
(3-4-9-3) (5-2-12-6) (9-6-23-0) (7-9-33-7)
LVEF(°<„) — 41 32 40
(18-63) (15-71) (24-68)
Peak creatine kinase (U/l) — — 1635 2059
(522-6255) (533-6955)
Heparin (subcutaneously) — — 15 —
Heparin (intravenously) — — — 17
Streptokinase/anistreplase — — — 9/8
Lignocaine — — 3 5
Hydrocortisone — — — 9
ft Blockers — 24 2 5
Diuretics — 4 6 5
Deaths — — 2 1
WBC, white blood cells; LVEF, left ventricular ejection fraction.
had sustained a recent acute anterior
myocardial infarction. The diagnosis was based
on the history of prolonged ischaemic chest
pain, characteristic electrocardiographic
changes, and increase in the enzyme creatine
kinase. The patients were subdivided into the
17 who had been given intravenous thrombo¬
lysis with either 1 200 000 units streptokinase
(Kabivitrum, Middlesex, UK), or 30 units
of anistreplase (anisoylated plasminogen
streptokinase complex (Eminase, Beecham
Pharmaceuticals, Epsom, UK). The other 15
were deemed ineligible to receive thrombolytic
treatment because of late admission (> 4 hours
after the onset of symptoms), a history of active
peptic ulceration, other source of haemorrhage,
or recent cerebrovascular accident and were
treated in conventional fashion. Table 1 shows
the details of the two groups including drug
treatment. All study times were taken from the
onset of symptoms. All patients gave informed
consent and the study was approved by the
institute's ethics committee.
PROTOCOL
In patients with acute myocardial infarction
blood was taken for full blood count and
measurement of creatine kinase, neutrophil
elastase, and linoleic acid (PL-9,12-LA) and its
diene conjugated non-peroxide isomer (PL-9,
11-LA') esterified as phospholipids. Samples
were taken at 6-8 hours after the onset of
symptoms and every 8 hours thereafter until 48
hours. Samples were centrifuged and plasma
separated immediately and held at — 20°C until
analysis was performed.
PL-9, 11-LA' AND PL-9, 12-LA
The molar concentrations ofPL-9, 11-LA' and
PL-9,12-LA in plasma were measured by high
performance liquid chromatography in plasma
after enzymatic hydrolysis with phospholipase
A2 and solid phase sample preparation as
described by Iversen et a/.16 The intra-assay
coefficient of variation was <3-5%. The
results are expressed as /tmol/l.
PLASMA NEUTROPHIL ELASTASE
Human neutrophil elastase was measured by
specific radioimmunoassay with rabbit poly¬
clonal antiserum.13 The antigen was purified
from human neutrophils after leucopheresis.
The antibody was specific for neutrophil
elastase and measured free enzyme and enzyme
complexed to the natural inhibitors a,-protein¬
ase inhibitor and a2-macroglobulin equally
well. The results are expressed as ng/ml and the
intra-assay coefficient of variation was <5%.
IMAGING
Our previous work has shown that labelled
neutrophil uptake within the myocardium can
be imaged reliably providing the time from
onset of infarction to reinjection of labelled
cells is < 18 hours.17 Only 21 of the patients
could be studied by this technique within the
appropriate time limits because of limited
availability of the radionuclide indium-Ill.
The patients received 20-30 MBq of indium-
111 labelled autologous neutrophils within 18
hours of the onset of symptoms. Single photon
emission tomography was undertaken 24 hours
after the injection of the labelled cells with an
IGE 400 AT maxicamera linked to a Siemens
Microdelta computer. On the following day the
patients were injected with 500 MBq of
(technetium-99m labelled pyrophosphate
C9mTc-PYP) and two hours later further SPET
imaging was undertaken to estimate infarct
size. Apart from the different energy windows
and imaging time the protocol on each day was
identical. The single photon emission tomo¬
graphic imaging was performed over 360°, 64
images being acquired and reconstruction
being undertaken by back projection with a
Butterworth filter to create sagittal, coronal,
and transverse images. A study was regarded as
positive when uptake could be clearly seen in all
three views. In these studies all transverse
slices for both indium-111 and 99mTc-PYP with
uptake in the region of myocardium were then
analysed by a semiautomatic programme that
counted the number of volume cell elements
(voxels) with values greater than 65% of the
peak myocardial uptake.18 For each patient it
was possible to compare the volume of
myocardium showing neutrophil uptake with
the volume of infarcted myocardium as judged
from the pyrophosphate images.
Patients also had a predischarge radionuclide
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ventriculogram to assess residual left
ventricular function.
statistical analysis
The Kolmogorov-Smirnov test showed that
the data were not normally distributed. Results
are therefore expressed as median and range.
We used non-parametric analysis (Wilcoxon
rank sum test) for two independent samples
(Mann-Whitney). Values of p < 0-05 were
taken as significant and data were analysed by
computer with the statistical package for social
sciences (SPSS Inc, Chicago).
Results
white blood cell count
The white blood cell count was significantly
lower in the normal volunteers (5-8 x 109/l,
3-4—9-3/1) than in patients with ischaemic heart
disease without recent infarction (6-7 x 109/1,
5-2—12-6/1, p < 0-004) and in both groups
counts were lower than the initial white cell
count in patients with acute myocardial infarc¬
tion (16-4 x 1071, 7-9-33-7, p < 0-0001). This
was also true for the neutrophil count for the
three groups.
plasma neutrophil elastase
The plasma concentration of neutrophil elas-
tase was significantly lower in the normal
volunteers (18-6 ng/ml, 9-2-51-0) than in the
patients with stable ischaemic heart disease
(25-8 ng/ml, 12-2-49-5, p < 0-002). For the 48
hours after myocardial infarction, however,
plasma neutrophil elastase was higher than in
either normal volunteers or patients with
ischaemic heart disease (fig la). The time
course differed in patients who had received
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Figure 1 (a) Mean plasma neutrophil elastase (1 SD)
in healthy volunteers, patients with chronic ischaemic
heart disease (IHD), and those with acute myocardial
infarction. Changes in plasma concentration neutrophil
elastase (PNE) after myocardial infarction are shown
for those treated with and without thrombolysis. The
values of PNE are significantly greater at all sampling
times after myocardial infarction than in healthy
volunteers or patients with chronic ischaemic heart
disease. Patients treated by thrombolysis have
significantly higher values of PNE at 8 hours
(p < 0-025) and lower values at 40 hours (p < 0-037)
than those not treated by thrombolysis, (b) Mean PL-9,
11 -LA' (1 SD) in the same groups showing significantly
higher values after myocardial infarction than in
ischaemic heart disease or in healthy volunteers. There
was no difference between those treated by thrombolysis
and those not treated by thrombolysis at any time.
pl-9, 11-la' and the molar ratio pl-9,
ii-la'/pl-9, i2-la
There was no significant difference in PL-9,
11-LA' or the molar ratio PL-9, 11-LA'/
PL-9, 12-LA between normal volunteers (19-3
fimoljl, 7-5-32-9; 4-7, 1-9-9-1) and patients
with ischaemic heart disease (19-8 nmol/1, 7-9-
43-2; 5-4, 1-7-12-1). For the 48 hours after
myocardial infarction PL-9, 11-LA' was sig¬
nificantly greater than in the healthy volun¬
teers. The concentration reached a maximum
at 16 hours; by 48 hours the values were not
significantly greater than those of patients with
chronic ischaemic heart disease (fig lb). The
molar ratio ofPL-9, ll-LA'/PL-9, 12-LA was
significantly increased in the 48 hours after
myocardial infarction and followed a similar
time course.
comparison of patients with myocardial
infarction who were treated by
thrombolysis and those who were not
There was no significant difference in peak
creatine kinase activity between patients
treated conventionally and those who were
treated by thrombolysis. Plasma activity of
creatine kinase reached a peak earlier in those
treated by thrombolysis (16 hours) than in
those treated conventionally (24 hours).
Similarly, there was no significant difference in
the left ventricular ejection fraction measured
by radionuclide ventriculography, 10 days after
infarction, though those patients who were
treated by thrombolysis had slightly higher
values (table 1).
plasma concentrations of neutrophil
elastase
The pattern of change in plasma neutrophil
elastase differed in the two groups of patients
with acute myocardial infarction (fig la).
Patients given intravenous thrombolysis had
higher early maximal values at 8 hours (48-2 ng/
ml, 25-250) than those treated conventionally
(32-6 ng/ml, 15-6-101, p < 0-025). Those
treated conventionally tended to have lower
early values with a late peak at 40 hours (49-8
ng/ml, 21-4—196) than those treated with
thrombolysis (34-2 ng/ml, 15-8-83, p < 0-037).
pl-9,11-la' and the molar ratio pl-9, 11-
la'/pl-9, 12-la
There was no significant difference in PL-9,
11-LA' or the molar ratio PL-9, 1 l-LA'/PL-9,
12-LA in those treated conventionally after
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Table 2 Details of patients treated with and without thrombolysis who were imaged with 1
,,mTc pyrophosphate
'In labelled neutrophils and
CK max LVEF Time to injection '•'In Tc
(U/l) (°/o) (h) (voxels) (voxels ) "' Inl""'Tc
No thrombolysis 2508 36 8 114 201 0-79
(n = 10) (522-6255) (15-51) 6-5-10 (19-276) (77-405) (0-06-2-14)
Thromolysis 2500 40 11 81 217 0-41
(n = 11) (533-6955) (27-68) 5-18 (0-160) (111-323) (0-0-96)
P NS NS NS NS NS <0-05
(Each voxel or volume picture cell element represents approximately 250 mm'.)
CK, creatine kinase; LVEF, left ventricular ejection fraction.
myocardial infarction and those given
thrombolysis. For both groups the values were
greatest at 16 hours, gradually falling towards
normal values (fig lb).
There was no correlation between the white
blood cell count and plasma concentration of
neutrophil elastase in any of the groups. There
was a weak correlation between white cell count
and PL-9, 11-LA' in the non-thrombolytic
group (r = 0-63, p < 0 02), and in patients with
ischaemic heart disease (r = 0-45, p < 0 02),
but this did not hold for the corrected molar
ratio and no correlations were found in the
normal volunteers and patients treated with
thrombolysis.
IMAGING (TABLE 2)
In general, in the patients who were imaged
there was a significantly greater number of
voxels showing an uptake of "mTc pyro¬
phosphate than of nlln labelled neutrophils
(p < 0-0006). Uptake of 9,mTc pyrophosphate
was very similar in patients who were treated
by thrombolysis and those who were not,
suggesting little difference in infarct size in
these patients. This is supported by similar
values of residual left ventricular ejection frac¬
tion and peak creatinine kinase in both groups
(table 2). In contrast, the uptake of "'In
labelled neutrophils was less in the patients
who were treated by thrombolysis. Thus the
ratio of'"In/99mTc, which serves as an estimate
of the inflammatory response for a given infarct
size, was significantly less in patients treated by
thrombolysis (0-41, range 0-0-96) than in those
treated without (0-79, range 0-06-2-14, p <
0-05). In fig 2 an example of the greater uptake
of "'In labelled neutrophils in a patient treated
without thrombolysis is contrasted with that




neutrophils with the size of
infarction as assessed by
"™Tc-pyrophosphate
(PYP). The upper pair of
images show easily detected
uptake of "'In and ,,mTc-
PYP in a patient with
anterior myocardial
infarction who was not
given thrombolytic
treatment. The lower pair
of images show markedly
reduced uptake of "'In
labelled neutrophils
compared with Tc-PYP
in a patient with anterior
myocardial infarction
treated with anistreplase.
seen in a patient who had received streptokin¬
ase.
Discussion
We found both an increased neutrophil elastase
release and an increase in the plasma concentra¬
tions of the diene conjugated non-peroxide
isomer of linoleic acid (PL-9, 11-LA') after
myocardial infarction. The association of
leucocytosis and the severity of myocardial
infarction was first described by White in
1926." We noted increased neutrophil
leucocytosis after myocardial infarction but
there was no correlation between the peripheral
neutrophil count and the raised plasma
concentrations of neutrophil elastase. A
distinction must be made between whole blood
elastase and plasma elastase. Whole blood
elastase correlates with the total neutrophil
count but is not a marker of neutrophil activa¬
tion and reflects the much greater intracellular
stores of the enzyme. Increased plasma neutro¬
phil elastase relates to neutrophil degranulation
and presumably reflects release within the
area of myocardial injury. The peripheral
leucocytosis is part of the more general
response to stress.20 Like others we also noted
an increased leucocyte count in patients with
stable ischaemic heart disease and this has been
shown to be a predictor of future myocardial
events.2' The neutrophil has been recognised as
an early part of the inflammatory response to
myocardial infarction,2223 but it is only more
recently that experimental evidence has been
put forward to suggest that it may be involved
in secondary heterolytic myocyte damage after
myocardial infarction4 5 and that suppression of
the neutrophil infiltrate can reduce infarct
size.23 One mechanism by which activated
neutrophils can induce cell damage is through
the release of potent proteolytic enzymes.
Neutrophil elastase is a serine protease
released from the primary granules after major
cell stimulation such as phagocytosis or cell
death.24 It has a wide range of substances
including elastin, collagen, fibrinogen, and
other matrix macromolecules and is implicated
in the pathogenesis of several human diseases.'
Our study showed that plasma concentrations
of human neutrophil elastase were significantly
higher in patients after myocardial infarction
than in healthy volunteers and patients with
stable ischaemic heart disease. Further, the
pattern of elastase release was different in
patients treated conventionally and in those
treated with thrombolysis. In patients treated
with streptokinase or anistreplase there was a
significant early increase in plasma neutrophil
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elastase within the first few hours of treatment.
This confirms previous observations2' and it
seems likely that this represents clot lysis or
intracoronary activation of neutrophils because
few inflammatory cells will have migrated into
myocardial tissue by this stage.22 23
In contrast, in patients treated convention¬
ally concentrations of neutrophil elastase reach
a peak later, between 32 and 40 hours after the
onset of symptoms, when the inflammatory
infiltrate is present histologically and can be
imaged.17 Drug treatment, particularly
hydrocortisone or lignocaine, might be expec¬
ted to influence neutrophil behaviour. But a
similar number of patients in both groups
received lignocaine, which is known to depress
neutrophil function in vitro.26 Also patients
given hydrocortisone before streptokinase did
not have lower "'In uptake by neutrophils or
lower concentrations of elastase than patients
treated with anistreplase, who did not receive
hydrocortisone. This suggests that the results
in the thrombolytic group are not influenced by
the potential suppressive effect of hydro¬
cortisone on the inflammatory response and
neutrophil function.2'
Although the neutrophil is a source of
cytotoxic oxygen species, there are other
potential sources of oxygen free radical
production after myocardial infarction, includ¬
ing the conversion of xanthine dehydrogenase
to xanthine oxidase, mitochondrial production,
the auto-oxidation of catecholamines, and the
arachidonic acid cascade.8 Although xanthine
dehydrogenase is converted to xanthine
oxidase in the vascular endothelium, this
enzyme system is not present in human
myocytes and is therefore unlikely to be
directly involved in myocardial damage.28
Therefore, the most likely sources of free
radical production within the human myo¬
cardium are the electron transport chains of the
myocyte mitochondria or from activated
neutrophils via the membrane linked nico¬
tinamide adenine dinucleotide phosphate
(reduced form) (NADPH) oxidase.10 Our
studies of peripheral blood did not define the
increase as being of myocardial origin, but the
myocardium is the most likely site in patients
who are haemodynamically stable.
Products of lipid peroxidation have been
used as markers of free radical activity because
exposure of cell membranes to oxygen free
radicals stimulates "lipid peroxidation"2''—
perhaps better termed lipid oxidation. Lipid
peroxidation products have themselves been
implicated in damaging cell membranes after
myocardial infarction,30 though some have
suggested that increased evidence of lipid
peroxidation merely reflects cell damage.15 For
this reason we chose to measure the diene
conjugated non-peroxide isomer of linoleic
acid PL-9, 11-LA' in plasma because this is
thought to be a marker of human free radical
activity.1631 PL-9, 11-LA' is present in the diet
and can be manufactured by bacterial flora and
this may account for the conflicting reports of
the usefulness of this as a marker of cervical
cancer.3233 It is unlikely that changes in dietary
intake or bacterial flora would alter signifi¬
cantly in the 48 hours after myocardial infarc¬
tion to account for the changes seen in plasma
PL-9, 11-LA'. Also the concentrations were
not increased in the patients with stable, but
documented ischaemic heart disease and there
was no change in linoleic acid, which is also
affected by dietary intake.
Heparin was shown to increase 9,11-LA'34—
the assay method, which is designed to measure
the molar concentration of 9,11-LA'and 9,12-
LA esterified as phospholipids, also measures
9,11-LA' and 9,12-LA present as free fatty
acids. Free fatty acids are increased by the
lipolytic action of heparin though the magni¬
tude of the response is often overestimated
because the method does not take account of
the extensive ex-vivo lipolysis.35 In our study
heparin is unlikely to have had any significant
effect because the thrombolytic group received
only intravenous heparin as an adjuvant to
thrombolysis a mean of 18 hours 36 minutes
after the onset of symptoms. The patients
treated conventionally also received heparin
but as a low dose subcutaneously. We noted no
difference in the values of PL-9, 11-LA'
between the two groups despite the widely
different heparin regimens. The similarity of
responses of the two groups also argues for a
lack of effect of the thrombolytic drugs in
themselves on PL-9, 11-LA'.
The concentration of PL-9, 11-LA' or the
molar ratio did not correlate with creatine
kinase measured on the same sample and it
therefore seems unlikely that the raised
concentrations are merely a marker of cell
damage1' and the evidence is consistent with
the diene being a free radical marker in human
beings. In general, in patients with myocardial
infarction the values of PL-9, 11-LA' and the
molar ratio were high initially and then fell; this
suggests that maximum free radical generation
occurs early. We were unable to detect any
difference in the concentrations of PL-9, 11-
LA' or the molar ratio of PL-9, 1 l-LA'/PL-9,
12-LA between patients treated conventionally
and those who received thrombolysis. This lack
of difference in* the molar ratio (indeed it was
somewhat lower in the group treated by
thrombolysis) suggests that reperfusion was
not associated with a delayed or secondary
increase in free radical production with the
potential for further myocardial damage. Even
when samples were taken earlier (less than 6
hours after the onset of symptoms) we did not
detect any difference in those treated by
thrombolysis. We cannot exclude the
immediate increase in free radical production
after reperfusion shown in some animal
studies.36 However, in human beings free
radical injury after reperfusion may be reduced
by the presence of red blood cells, which
contain the antioxidant enzyme catalase3'
unlike the cell free perfusate often used in
animal experiments.
This study confirms that the human inflam¬
matory response to myocardial infarction can
be imaged. In only two of the 21 patients
studied no uptake of "'In-labelled neutrophils
could be detected. Both patients had been
treated by thrombolysis and although this
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result could represent failed imaging, this is
unlikely because all the thrombolytic group
had significantly reduced uptake of neutrophils
in relation to infarct size assessed by WmTc-
pyrophosphate. The concept of a reduced
inflammatory response is supported by the
different patterns of release of neutrophil
elastase. If the early neutrophil activation in
those given thrombolysis represents intra-
coronary activation and the late response
corresponds to acute inflammatory infiltrate
within damaged myocardium we would expect
greater neutrophil uptake in those who did not
receive thrombolytic agents. As an extension,
the lack of a late increase in lipid oxidation
suggests that the neutrophil is not the main
source of free radical production in myocardial
infarction. By inference this implies that if
there is later heterolytic myocardial injury and
if it is mediated by neutrophils, it may be
secondary to release of proteolytic enzymes
rather than oxygen free radicals. The results do
not necessarily contradict the experimental
evidence that suggests that free radical scaven¬
gers reduce myocardial damage,36 because
there is evidence that superoxide dismutase
may work in part by reducing neutrophil
migration.38 It is therefore possible that some of
the beneficial effects of thrombolysis are the
result of partial inhibition of the inflammatory
response to myocardial injury, perhaps by
reducing the degree or duration of production
of neutrophil chemoattractants, such as com¬
plement.3940
Our studies suggest that after acute myo¬
cardial infarction neutrophils are activated and
free radicals are produced. Although animal
studies suggest such activation can extend
myocardial injury we have no evidence of this
in human beings. However, thrombolysis and
presumed reperfusion are not associated with
amplification of the inflammatory response or
prolonged free radical production in patients.
Indeed these responses seem to be diminished
and some of the beneficial effects of thrombo¬
lysis may be the result of down regulation of the
acute inflammatory response.
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Intrathoracic mycotic aneurysm detected by indium-111 labelled autologous
neutrophils with single photon emission computed tomography
DEREK BELL. MELANIE H JACKSON. ALLAN J M STEVENSON.
JEREMY J NICOLL
From the Departments ofMedicine, Radiology, and Medical Physics, Royal Infirmary, Edinburgh
Scintigraphy using neutrophils labelled with indium-Ill
(" Mn) has been shown to be a reliable method of detecting
occult infection,' particularly within the abdominal cav¬
ity."1 J We report a case in which an intra-abdominal source
of infection was suspected bul a labelled neutrophil scan
showed the site to be an intrathoracic mycotic aneurysm,
which was subsequently confirmed at thoracotomy.
Case report
A 63 year old woman was admitted to hospital for the in¬
vestigation of a discharging sinus in the left iliac fossa. Eigh¬
teen months previously a Hartmann's procedure had been
performed for a peridiverticular abscess and one month be¬
fore this a right aorlo-femoral graft and femoro-femoral
crossover graft had been performed for severe peripheral
-v-t-.'-ew ,"VY-
' J'.".
Lie ! Posterior image: indium-1II labelled neutrophils
slum nip abnormal uptake !arrowed) in the left paravertebral
area ol the lower thorax.
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vascular disease. On admission the patient was febrile (38°C)
and abdominal examination showed previous operative
scars, with a discharging sinus in the left iliac fossa. The
remainder of the clinical findings were entirely normal.
Apart from a slightly raised leucocyte count (11-2 x lO'/l)
and a growth of Staphylococcus aureus from the sinus dis¬
charge fluid, routine investigations all gave normal results. A
sinogram failed to show any communication between the










Fig 2 Simultaneously acquired computer reconstruction
images in the same sagittal plane. Upper Tcchnetium-Wm
) labelled human serum albumin showing blood pool in
the left ventricle, aorta, and region of the aneurysm. Lower
Indium-JII f)n In J labelled neutrophils showing abnormal
uptake at the site ol the aneurysm, with normal uptake in the
spine.
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showed slight irregularity of the abdominal aorta, with a
patent aorto-femoral and fcnioro-femoral graft. Treatment
with fiucloxacillin was started on admission and one week
later the patient underwent excision of the sinus in the left
iliac fossa. The histological appearances were those of a sim¬
ple "stitch sinus." Despite these measures the pyrexia persis¬
ted and further investigations to identify the cause were
instituted. Repeated blood, urine, and sputum cultures
failed to grow any organism. Chest radiography and com¬
puted tomography of the abdomen showed no abnormalities
(photographs supplied not published). Abdominal ultra¬
sound examination showed no abnormality. Six weeks after
admission to hospital a neutrophil scan showed uptake in
the left paravertebral area of the lower thorax extending
from T7 to TII (fig 1). To improve anatomical localisation,
dual isotope single photon emission computed tomography
was performed with technetium-99m labelled human serum
albumin to allow simultaneous imaging of the blood pool.
This showed uptake of'1' In labelled neutrophils in the same
position as the descending thoracic aorta, suggesting the
diagnosis of a mycotic aneurysm (fig 2). An ascending
aortogram then confirmed the presence of a saccular
aneurysm in the descending thoracic aorta. The patient
underwent emergency surgery and a 5 cm aneurysm,
adherent to the left lower lobe, was resected and replaced
with a low porosity Dacron graft. The aneurysm contained
clot and liquified atheroma, from which Staphylococcus au¬
reus was subsequently grown. Unfortunately, the patient
died five weeks after operation.
Discussion
Autologous neutrophil scanning is not frequently required
or performed for the detection of occult infection in the
thorax, hut this case demonstrates the usefulness of whole-
body imaging even when an extra-abdominal source is not
suspected.4 The use of a medium energy isotope, indium,
allowed further interrogation of the area of abnormal up¬
take in the thorax when it was combined with the low energy
isotope technetium as a blood pool marker. By using single-
photon emission computed tomography we could infer that
the area of infection lay adjacent to or within the descending
thoracic aorta, a finding confirmed at aortography and
surgery. We believe that this is the first case report of
detection of a mycotic aneurysm of the aorta by a "'In
labelled autologous neutrophil scan; while other techniques,
such as ultrasound or computed tomography, could have
detected an aneurysm, they could not have confirmed that
this was the source of infection.
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The acute inflammatory response to myocardial
infarction: imaging with indium-111 labelled
autologous neutrophils
D BELL,* M JACKSON,* A M MILLAR,* J J NICOLL,t M CONNELL,t
A L MUIR*
From the *Departments of Medicine, fMedical Physics, and \Radiopharmacy, Royal Infirmary, Edinburgh
summary The uptake of indium-Ill labelled neutrophils was examined in 30 patients with
acute myocardial infarction by planar imaging and single photon emission computed tomo¬
graphy. The time from venepuncture to reinjection of the autologous labelled neutrophils was
<2-5 hours and imaging was carried out 24 hours later. Twenty three patients had a positive
uptake of neutrophils in the myocardium and imaging was improved by single photon emission
computed tomography. There was a significant difference between the intervals from the onset of
chest pain to injection of labelled neutrophils between patients with positive and negative images;
early reinjection was more likely to produce a positive image. Indeed, all nine patients reinjected
within 18 hours of the onset of symptoms had positive images.
The results suggest that the stimulus for activation and migration of neutrophils is transient;
this is an important factor if neutrophil release products play a role in cell damage after coronary
occlusion.
After myocardial infarction, myocardial cell death
and damage produce an acute inflammatory
response characterised by the migration of neutro¬
phils into the area of infarcted muscle. Histological
examination shows neutrophil infiltration into the
infarcted area within 24 hours and the response is
maximal at 4-5 days.1 2 As part of the inflammatory
response, neutrophils release oxygen derived free
radicals and proteolytic enzymes that in certain cir¬
cumstances may increase tissue injury. To date, the
neutrophil has been implicated in damage to pul¬
monary capillaries in adult respiratory distress syn¬
drome and may also contribute to the pathogenesis
of emphysema. No definite role has been established
for the neutrophil extending myocardial damage in
man, but in animal models of myocardial infarction,
infarct size can be limited by neutrophil
inhibition.2 *
Although experimental studies have shown
uptake of indium-11 If111 In) labelled neutrophils in
infarcted myocardium5 6 studies in man have pro¬
duced conflicting results. McDougall etal did not
Requests for reprints to Dr D Bell, Department ofMedicine, Royal
Infirmary, Edinburgh EH3 9YW.
detect uptake of labelled cells in three patients with
acute infarction.7 The time of injection of labelled
cells may be of importance, however, because
Davies and colleagues obtained positive images
when the time to reinjection was short.8 They also
found that positive images were more likely in
younger patients.
We have used 11'In labelled autologous
neutrophils in 24 patients with acute myocardial
infarction. Our results confirm the importance of
early injection of the neutrophils in obtaining a posi¬
tive image. We also found that reconstructional
imaging from single emission photon computed
tomography can be used to resolve difficulties in the
interpretation of planar imaging.
Patients and methods
PATIENTS
We studied 30 patients with a diagnosis of acute
myocardial infarction based on a history of pro¬
longed ischaemic chest pain (>30 minutes), electro¬
cardiographic changes associated with myocardial
infarction, and a rise in serum creatine kinase to at
least twice the upper limit of normal. All gave
informed consent, and the study had the approval ofAccepted for publication 30 September 1986
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our institute's ethical committee. Table 1 shows
patient details and a full record of the drugs admin¬
istered within the first 24 hours of myocardial
infarction.
PREPARATION OF '"iN LABELLED
NEUTROPHILS
Autologous neutrophils were separated from whole
venous blood and labelled with inIn-oxine.9 We
used an aseptic technique to withdraw whole blood
(60 ml) into a syringe containing 300 units of pre¬
servative free heparin. Duplicate samples (25 ml) of
blood were layered over 12 ml of mono-poly
resolving medium (Flow laboratories) in a sterile
tube and centrifuged at 400 £ for 60 minutes. This
produced a top plasma layer, two distinct cell bands,
and a red cell pellet. We collected 8 ml from the top
plasma layer and centrifuged it at 1000^ for 10
minutes to obtain platelet poor plasma. The remain¬
ing plasma and upper ceil band were discarded and
the neutrophils were recovered from the lower cell
band. The neutrophils were washed by diluting the
recovered cell suspension to 40 ml with phosphate
buffered saline pH 7-4, centrifuging at 400^ for 10
minutes, and discarding the supernatant. The cell
pellet was resuspended in 10 ml phosphate buffered
saline and 1 ml of 111 In-oxine solution (20-40 MBq)
was added drop by drop to the suspension of neu¬
trophils. After incubation at room temperature for
15 minutes, 3 ml platelet poor plasma was added and
the cell suspension was centrifuged at 250g for 10
minutes. The supernatant was discarded, the neu¬
trophil cell pellet was resuspended to a total volume
of 5 ml with equal parts of phosphate buffered saiine
and platelet poor plasma and the labelled cells were
then ready for reinjection.
Bell, Jackson, Millar, Nicoll, Connell, Muir
PATIENT IMAGING
All patients were injected at a fresh site with 11'In-
labelled autologous neutrophils within two and a
half hours of the initial venesection. Preliminary
studies had suggested that the optimal time for
imaging was 24 hours after the injection of labelled
neutrophils and we used this imaging time in all our
patients. Thus the earliest imaging time for any
patient was 36 hours after the onset of chest pain and
the latest was 57 hours. Each patient was imaged
while supine and planar images were acquired in the
anterior, left anterior oblique, and left lateral posi¬
tion for 100 000 counts with a gamma camera
(GE400 AT). In 24 patients single photon emission
computed tomography was performed with the same
gamma camera linked to a DEC PDP11/23+ com-'
puter that used locally written software. Ten
minutes before the single photon emission .-
computed tomography study, 40MBq of
technetium-99 m (99mTc) human serum albumin
was administered to allow blood pool imaging. A
sequence of 64 simultaneous images of 99mTc and
111 In was then acquired as the head of the gamma
camera rotated through 180°, starting in the right
anterior oblique position. The total imaging time
was 32 minutes. At the end of this period
computerised reconstruction of the images was
performed.
IMAGE INTERPRETATION
An observer who was unaware of electro¬
cardiographic findings or the maximum creatine
kinase rise graded planar and single photon emission
computed tomography images as positive (in which
indium activity was clearly seen in the region of the
heart) or negative (where there was no detectable




Table 1 Patient details and results of imaging with indium-Ill labelled autologous neutrophils
Positive image Negative image Statistical
In = 23) (n = 7) significance
Age (years) 62-0 (10-8) 59-8 (9-4) NS(1)
Sex (6F; I7M) (2F; 5M) NS (2)
Location of acute myocardial
infarct 10 inf: 13 ant 3 inf: 4 ant NS (2)
Interval from onset of chest pain to
injection of '"In neutrophils (h) 20-3 (6-4) 27-6 (5-8) p < 0-02 (3)
Peak creatine kinase (u/1) 2023-5 (916-0) 1825 (1214-0) NS (1)
Total leucocyte count (10"'/l) 12-9 (3-2) 12-5 (3-4) NS (1) -
Number of neutrophils injected ( x 108) 2-7 (0-9) 2-6 (0-7) NS (1)
Activity of "'In administered (MBq) 32-8 (8-4) 29-4 (8-2) NS (I)
Drugs administered:
**
All values are shown as mean (SD).
(1) Unpaired i test.
(2) Exact probability test.
(3) Unpaired Wilcoxon rank sum test.
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activity or where there was an area of activity on
planar imaging that was inseparable from the liver,
spleen, or ribs). Dual isotope single photon emission
computed tomography images were considered to be
positive when indium activity was seen in all three
reconstruction views and corresponded with the
99mTc blood pool image.
STATISTICAL ANALYSIS
Data from the groups were compared by means of an
unpaired t test, exact probability test, or unpaired
Wilcoxon rank sum test as appropriate. Values of
p > 0-05 were regarded as not significant.
Results
In 23 of the 30 patients with acute myocardial
infarction there was uptake of '"In labelled
neutrophils within the myocardium. Three patterns
of cardiac uptake were seen5: focal myocardial
uptake (12 patients), diffuse myocardial uptake (3
patients), and "doughnut pattern" (3 patients).
Figure 1 shows an example of myocardial uptake.
Planar images from all patients were graded as
unequivocally positive or negative. In six patients in
whom the planar images were considered to be nega¬
tive, single photon emission computed tomography
reconstruction showed localised uptake within the
myocardium (fig 2). In addition, dual isotope single
photon emission computed tomography recon¬
struction improved anatomical localisation of the
infarct by confirming uptake corresponding to the
cardiac blood pool (fig 3). There is a significant
difference between the intervals from onset of chest
pain to injection of labelled neutrophils in the
groups with positive and negative images (p < 0-02)
(table 1). Furthermore, all patients reinjected within
18 hours had positive images whereas positive
images were increasingly less common in those
injected at progressively later intervals. Other
features such as age, sex, peak creatine kinase,
peripheral white blood cell count, dose of '"In
administered, and drug treatment did not influence
the imaging results (table 1).
Discussion
This study confirms that '"In labelled autologous
neutrophils can be used to image the inflammatory
response to acute myocardial infarction in man. The
increased frequency of positive images in this study
(77% compared with the 58% as previously
described8) is in part related to earlier reinjection of
'"In labelled neutrophils after the onset of chest
pain. This suggests that the stimulus for activation
and migration of neutrophils to the area of myo¬
cardial damage is transient. This temporal relation
may be of particular relevance because of the current
interest in reducing the extent of myocardial damage
after myocardial ischaemia or infarction by the use
of intravenous thrombolytic treatment10" or the
potential for the administration of lipoxygenase or
cycloxygenase inhibitors.3
Thrombolytic treatment can produce coronary
reperfusion and hence it could improve myocardial
salvage, but it may result in other events which in
themselves are potentially harmful.12 In particular,
if the inflammatory response is exaggerated as a
Fig 1 Planar image in the left anterior oblique view
showing normal uptake of 111 In labelled neutrophils in the
liver and spleen and diffuse uptake in the region of the heart
with an area offocal uptake in the inferior wall of the left
ventricle. The line drawing shows the areas of uptake.
Diffuse •spine
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Fig 2 Anterior planar image with normal uptake in liver
and spleen and no definite myocardial uptake (top). Single
photon emission computed tomographic image (bottom) in the
transverse plane showing uptake within liver and spleen and
an area offocal myocardial uptake > arrowed).
result of neutrophils entering ischaemic tissue in
greater numbers after reperfusion, the activated
neutrophils could generate a number of cytotoxic
products including oxygen derived free radicals and
proteolytic enzymes, which can extend myocardial
damage.13 Both neutrophil depletion and the use of






Fig 3 Simultaneous single photon emission computed
tomographic images in the transverse plane. The 99mTc image
shows blood pool in the left and right ventricle. The
corresponding 111 In image shows extensive uptake within the
myocardium of both ventricles.
non-steroidal anti-inflammatory drugs have been
shown to reduce infarct size in experimental myo¬
cardial infarction,3 4 and these findings may indicate
further potential methods of improving myocardial
salvage in the post-infarct period.
Single photon emission computed tomography
increased the number of positive images by allowing
spatial separation of positive myocardial uptake of
indium from adjacent bone, liver, and spleen. It is
not possible to ascertain from the planar images
whether the'11'In activity detected in the region of
the heart is due to blood pool activity. Dual isotope
single photon emission computed tomography with
99mTc human serum albumin as a marker of blood
pool, however, unequivocally demonstrated that the
"'In activity was localised in the myocardium.
Single photon emission computed tomography, like
pyrophosphate scans,14 may also provide a method
of quantifying neutrophil uptake within the myo¬
cardium.
Imaging with 111 In labelled autologous neutro¬
phils in patients with acute myocardial infarction
allows us to image the acute inflammatory response
to myocardial damage, but should not be regarded as
a technique for the diagnosis or localisation of acute
myocardial infarction because other techniques are
currently more successful. If inhibition of neutro¬
phil migration limits the extent of myocardial
Positive images
Number of Planar positive Planar negative
Time (hi patients SPECT positive SPECT positive Positive images %
18 9 7 2 100
18-24 12 7 3 83
24-36 9 3 1 44
SPECT, single photon emission computed tomography
Imaging the acute inflammatory response to myocardic
infarction this method can be used to monitor the
temporal relation and extent of neutrophil uptake in
acute infarction.
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Letters to the Editor
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Indium-Ill Neutrophil Imaging in Ischemic Colitis
TO THE EDITOR: Indium-Ill ('"In) autologous neutro¬
phils arc used for imaging the colon in inflammatory bowel
disease (7) and Clostridium difTicilc colitis (2) allowing non¬
invasive assessment of colonic involvement in these condi¬
tions but not differentiating between the different forms of
colitis. We report a ease where "'In labeled neutrophil uptake
in the colon of a patient with unsuspected ischemic colitis
demonstrates the usefulness of the technique both in assessing
the extent of colonic involvement and as an aid to diagnosis,
but emphasise the importance of confirming the diagnosis of
colitis by other techniques.
A 61-yr-old white female was referred for assessment by
Iter family physician because of systemic hypertension resist¬
ant to therapy. Physical examination confirmed features of
hypertension with elevated blood pressure at 230/1 15 mmHg.
a grade 2/6 mid-systolic murmur at the left sternal edge and
grade 2 hypertensive retinopathy.
Combination therapy with beta-blockers, diuretics, and
vasodilators had failed to control the blood pressure ade¬
quately and therefore the patient was commenced on an
angiotensin converting enzyme (ACE) inhibitor (captopril)
and a diuretic (furoscmidc). This regimen caused an abrupt
deterioration in renal function, blood urea rising to 22.7
mmol/l (136.2 mg/IO() ml) and creatinine to 220 /iniol/l
(2.42 mg/100 ml). As ACE inhibition can cause reversible
deterioration of renal function (J) in hypertensive patients
with bilateral renal artery stenosis, noninvasive llow studies
and aortography combined with bilateral renal angiography
were undertaken and confirmed the presence of bilateral renal
artery stenosis with almost total occlusion of the right renal
artery. In addition, aortography demonstrated extensive ath¬
erosclerotic aneurysmal dilatation of the aorta. The patient
was then referred to the Vascular Surgery Department and
subsequently underwent a Dacron graft repair of the aortic
aneurysm with bilateral saphenous vein grafting to the renal
arteries.
Her postoperative course was complicated by the develop¬
ment of transient atrial fibrillation, hyponatremia, and right
basal pneumonia requiring antibiotic therapy with ampicillin.
On the tenth postoperative day. the patient developed profuse
diarrhea, which was positive for occufl blood, and the follow¬
ing day became scpticaemic. Stool cultures at this time, yielded
Clostridium difficile and oral vancomycin therapy was insti¬
tuted. Abdominal examination at this stage was unremarka¬
ble. but the severe diarrhea persisted and sigmoidoscopy re¬
vealed a nonspecific proctitis. To assess the degree of colonic
involvement a ['"Injncutrophil scan was requested and "'In
autologous neutrophils were prepared as described elsewhere
(4). Gamma camera images obtained 12 hr after reinjcction
of the cells demonstrated localized uptake in the distal and
sigmoid colon with a cutolf at the level of splenic llexure in
the distribution of the inferior mesenteric artery (Fig. I). The
patient's condition continued to deteriorate and she developed
VI.v'. •
FIGURE 1
lndium-111 neutrophil image (anterior) showing abnormal
uptake in sigmoid and descending colon with no uptake
beyond splenic flexure
clinical and radiological signs of bowel perforation which
required emergency laparotomy. At laparotomy the descend¬
ing and sigmoid colon were in farcied and a left hemicolectomy
and colostomy was performed. The histologic features of the
resected specimen were those of an ischemic colitis, with
extensive mucosal ulceration associated with a superficial
inflammatory exudate. In areas there was complete loss of
mucosa, submucosa and muscle with replacement by granu¬
lation tissue. There was no evidence of massive intramural
hemorrhage or pericolic abscess formation. Clostridium diffi¬
cile toxin assay was later reported as negative. The patient
made an uneventful recovery and has had a subsequent bowel
re-anastomosis. Blood pressure remains normal on no thcr-
apy.
This case illustrates the difficulty in establishing a precise
diagnosis in a patient with severe diarrhea and septicaemia
after major abdominal surgery. The patient might have had
Clostridium difficile induced colitis in view of her antibiotic
exposure, elevated blood urea and recent laparotomy. This
diagnosis was initially supported by the finding of Clostridium
difficile in the stool but the Clostridium difficile toxin assay
was subsequently negative. Toxin assay results are not im¬
mediately available and a positive stool culture in isolation
may lie misleading. The ['"ln]rieulrophil scan was useful in
showing the extent of the colonic disease and more impor¬
tantly. in view of the anatomical distribution, suggesting a
vascular etiology. The possibility of an ischemic colitis was
thus raised which prompted an immediate review of the ease
by the surgeons prior to the progression of her abdominal
symptoms. The histology of the resected specimen demon-
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-slralcd neutrophils in the inflammatory exudate and deeper
granulation tissue. In the absence of pericolic abscess forma¬
tion or extensive intramural hemorrhage, the localization of
'"In in the descending colon demonstrates uptake of neutro¬
phils throughout the ischemic segment of bowel. This is com¬
patible with an inflammatory response to ischemia.
This ease confirms that ['"ln]leucocyte imaging is useful:
in demonstrating noninvasively the anatomical extent of co¬
lonic disease, which may also suggest alternative diagnoses
such as ischemic colitis. In cases of ischemic colitis, it may
provide information as to the site and extent of the disease
preoperatively. This technique does not give a pathological
diagnosis and it is, therefore, important to pursue this with
further appropriate investigations such as colonoscopy, bar¬
ium enema, or even exploratory laparotomy.
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Chylothorax on Tcchnctium-99m Antimony Sulfide
Colloid Scan
TO TIIE EDITOR: Interstitial injection of a radiolabeled
colloid will allow visualization of regional lymph nodes. We
have performed lymphoscintigraphy in two patients with chy¬
lous pleural clTusions. The studies were performed with tech-
nclium-99m (WmTc) antimony sulfide colloid and satisfactor¬
ily demonstrated the abnormal thoracic localization.
The first patient, a male infant, was born prematurely at
26 wk gestation. He required surgery for necrotizing entero¬
colitis. and received hyperalimentation for five months. This
process was complicated by bilateral subclavian vein throm¬
bosis related to subclavian venous line placement. At the age
of 9 mo he was readmitted to hospital with increasing respi¬
ratory distress. He was found to have a right-sided pleural
elTusion that was tapped repeatedly but which continued to
reaccumulate. It was noted to be chylous in appearance, and
in an attempt to better characterize the mechanism of abnor¬
mal fluid accumulation, a radionuclide scintigram was per¬
formed.
After obtaining informed consent 100 nC\ of pTcJanti-
mony trisulfide was injected subcutancously into the web
space between the first and second toes of each foot. Using a
low-energy, all-purpose collimator, 10-min images were ob¬
tained at 2, 4, 6, and 24 hr after injection. Overlapping images
allowed visualization of activity in the lower limbs, abdomen,
and thorax. Lateral and oblique views helped to localize
abnormal foci of activity. By 2 hr activity was noted within
the right hemithorax. This was more evident by 4 hr, at which
time it was mainly at the right base in the supine position
(Fig. I). The patient subsequently died from respiratory failure
complicated by bilateral pneumothoraces. There were fibrous
adhesions involving the distal one-fourth of the thoracic duct
and the great veins at autopsy.
The second case, a 7-yr-old girl, was initially seen with
staphylococcal pericarditis. Treatment at that time included
stripping of the pericardium on two occasions. During surgery,
the thoracic duct was damaged, and was tied off in the upper
mediastinum. She then presented because of persistent cough¬
ing. Chest x-ray showed bilateral pleural effusions and prom¬
inent vascular markings. Pulmonary function tests indicated
a severe restrictive defect.
Symptomatically the patient deteriorated, with persistent
pleural effusion and marked engorgement of pulmonary lym¬
phatics. She slowly became hypoxemic and was prone to
FIGURE 1
Posterior image obtained at 4 hr in 9-mo-old boy shows
abnormal accumulation of activity in right lung, mainly at
base (arrowheads). Activity is also noted in abdominal
lymphatics and in liver and spleen
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Summary
Leucocytes labelled with lnIn or "Tcm are used as diagnostic agents for detecting sites of
infection by scintigraphy. Before radiolabelling is performed, leucocytes are isolated from
whole blood. The effect of isolation procedures on neutrophil activation has been studied by
measuring the neutrophil elastase produced during incubation of whole blood with three
erythrocyte sedimentation agents (dextran 70, hydroxyethyl starch and methylcellulose) and
two density gradient media (Percoll and Mono-Poly Resolving Medium). Neutrophil elastase
was measured using a standard radioimmunoassay. At 21° C, dextran caused no elastase
release while hydroxyethyl starch and methylcellulose induced significant release (p = 0.01 and
p <0.01 resp.). All three agents caused significant elastase release at 37° C. When whole blood
was incubated with Percoll and Mono-Poly Resolving Medium, no release of neutrophil
elastase was observed. These results show that neither density gradient medium induces
neutrophil activation but that certain erythrocyte sedimentation agents do. Of the three
sedimentation agents investigated, dextran is the agent of choice if neutrophil activation is to be
minimized.
Introduction
Leucocytes labelled with 11 Tn or "Tcm are used routinely in nuclear medicine as
diagnostic agents for detecting sites of infection by scintigraphy. All the presently ,
available labelling techniques require separation of the leucocytes from whole blood
before labelling can be performed. The preparations of labelled cells used most
commonly contain mixed leucocytes which have been obtained following treatment of r"
whole blood with a red cell sedimentation agent [1-5]. For studies where a "
preparation of pure neutrophils is desired, these cells are isolated from leucocyte-rich
* To whom all correspondence should be addressed.
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plasma [6, 7] or whole blood [8] using a density gradient medium. There has been
considerable interest in the methods for separating neutrophils from whole blood
prior to radiolabelling because of potentially harmful effects of the separation
techniques on the cells [3, 9]. Preliminary work from our laboratory suggests that it is
not only the density gradient media and labelling procedures that may influence
neutrophil function but also the red cell sedimentation step which is commonly
employed.
Neutrophil elastase is released from 'activated' neutrophils and has been used as a
marker of activation [10]. In this work we have studied the effect of cell separation
procedures on neutrophil activation by measuring the concentrations of neutrophil
elastase produced during incubation of whole blood with three erythrocyte sedimen¬
tation agents and two density gradient media.
Materials and methods
Effect of sedimentation agents
From each of 10 subjects, 40 ml venous blood were withdrawn into a syringe containing 200
units of preservative-free sodium heparin. Heparin was chosen since it is the anticoagulant
used in our routine technique for the isolation of neutrophils [8]. A 10 ml aliquot was retained
as a control sample and the remaining 30 ml was divided equally between three tubes
containing a sterile solution of either 6% dextran 70 in 0.9% NaCl (4.0 ml), 6% hydroxyethyl
starch in 0.9% NaCl (1.0 ml) or 2% methylcellulose in 0.9% NaCl (0.4 ml). The volume of each
agent was chosen to give the concentration used routinely for erythrocyte sedimentation. The
samples were gently inverted to ensure thorough mixing and then divided in two. One sample
was incubated at room temperature (21° C) and the other at 37° C for 45 min. At the end of
this period the supernatants were aspirated and rendered cell free by high spin centrifugation
(1500 g) at 4° C. The concentrations of neutrophil elastase in the supernatants were assayed
using a standard radioimmunoassay technique [10] and corrected to account for dilution by the
sedimentation agents. Statistical analyses were performed using the Wilcoxon's test for signed
ranks.
Effect of density gradient media
Whole blood (10 ml) was taken from 8 healthy volunteers and 5 ml were added to 2.4 ml
aliquots of Percoll (Pharmacia) made 51% with phosphate buffered saline and Mono-Poly
Resolving Medium (M-PRM, Flow Laboratories). The ratio of blood to medium was chosen to
represent those used in the various methods which have been described for the isolation of
neutrophils. The samples were incubated at room temperature (21° C) on a rotary mixer for 15
min to ensure continuous contact between media and blood. The samples were then
centrifuged at 1500 g for 10 min at 4° C. The supernatants were aspirated and recentrifuged to
render them cell free. Neutrophil elastase was measured as before and lactate dehydrogenase
(LDH) was measured by a standard colorimetric technique to assess cell viability. The results
were corrected to account for dilution by the density gradient media.
Results
The effects of the sedimentation agents are shown in Fig. 1 and demonstrate that at
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room temperature, no significant difference was found between the control samples
and those treated with dextran (p >0.05). Methylcellulose and hydroxyethyl starch
induced significant release of neutrophil elastase, compared to both the control
samples (p = 0.01 and p <0.01 resp.) and dextran (p = 0.01 and p <0.01 resp.). At
37° C all agents were found to cause significant release of elastase.
Fig. 1. Release of neutrophil elastase in 10 subjects, (a) RT = room temperature of 21° C;
(b) 37° C. (C = controls; D = dextran; H = hydroxyethyl starch; M = methylcellulose).
In the experiment to investigate the effects of density gradient media, the
mean results (± S.D.) for neutrophil elastase resulting from treatment with M-PRM
(19.7 ± 5.7 ng ml-1) and Percoll (25.1 ± 7.6 ng ml-1) are within our normal range for
plasma (20.8 ± 11.0 ng ml-1). Similarly there was no difference in LDH between the
samples (Percoll 315.6 ± 47.5 U/l, M-PRM 322.4 ± 24.2 U/l). Unlike previous studies
[9, 11], these results suggest that neither M-PRM nor Percoll cause neutrophil
activation.
Discussion
During the isolation of leucocytes to be radiolabelled, procedures which induce
activation of the neutrophils are to be avoided. If neutrophil activation occurs, the
radiolabelled cells exhibit increased adhesiveness when reinjected into the patient.
The most obvious consequence of this effect is retention of labelled cells in the
vasculature of the lungs, this being the first capillary bed that they encounter
following intravenous injection.
Percoll and M-PRM are two density gradient media commonly used for the
isolation of neutrophils to be radiolabelled. Percoll is based on colloidal silica coated
with polyvinylpyrrolidone while M-PRM is a Ficoll-Hypaque mixture. It has been
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suggested that, in comparison to Percoll, Ficoll-Hypaque mixtures have a detrimental
effect on neutrophil function [9, 11], In contrast to these findings, the results of our
study show that neither M-PRM nor Percoll causes neutrophil activation.
This study also shows, however, that the density gradient medium is not the only
step in cell separation which needs to be considered in relation to neutrophil
activation and subsequent cell behaviour. Our results indicate that the red cell
sedimentation agent is a more important source of neutrophil activation and that
dextran is the sedimentation agent of choice if activation is to be minimized.
Furthermore, the presence of neutrophil elastase, and presumably other neutrophil
release products in the residual plasma following red cell sedimentation, may make
this an unsuitable source of platelet-poor plasma. Moreover, as neutrophil activation
is influenced by temperature, we suggest that separation techniques should be
performed under controlled temperature conditions. As single step procedures for
isolating neutrophils from whole blood [8, 11] do not require an initial red cell
sedimentation step, we would therefore support the use of these methods to •
minimize possible sources of neutrophil activation.
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Summary
Using a single step separation procedure, we have developed a method for labelling human
neutrophils with '1 'In-oxine. This method allows a rapid separation of neutrophils from whole
blood, with negligible mononuclear or red cell contamination. Preliminary studies using
111 In-labelled neutrophils show minimal lung retention and early accumulation in the spleen
consistentwith viable cells. In addition, focal accumulation of "1 In has been imaged in patients
with localized inflammation or sepsis.
Introduction
Indium-Ill ('"In) labelled leucocyte imaging has become a common investigation
for the localization of inflammatory lesions [1-5]. The neutrophils are the pre¬
dominant cell involved in the inflammatory response and it has therefore been
suggested that a pure preparation of neutrophils is superior to mixed leucocytes for
in vivo studies using 1 "In-labelled cells [6]. The use of pure neutrophils also has the
advantage of avoiding the labelling of the radiosensitive lymphocytes [7-9].
A number of methods exist to isolate pure neutrophils from blood but at present
these are time consuming and involve several steps [10, 11]. Mono-poly Resolving
Medium is a commercially available medium which can be used to isolate neutro¬
phils from whole blood in a single step. In this paper we describe the isolation of
neutrophils by this technique and their subsequent labelling with '"In-oxine.
Kinetic data and positive clinical studies are also presented.
0143-3636/86 $03.00+ .12 © 1986 Chapman and Hall Ltd.
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Methods
Patients
Investigations with "'In-neutrophils were performed on 45 patients with a variety of sus¬
pected inflammatory clinical conditions. Neutrophil kinetics were studied in eight of the
patients with no evidence of active lung disease.
Cell separation
Venous blood (60 ml) was collected aseptically via a 19G infusion set into a syringe containing
300 units of preservative-free heparin. A full blood count and ESR were performed on 10 ml
blood. All subsequent procedureswere performed using aseptic technique. In duplicate, 25ml
blood was layered over 12 ml Mono-poly Resolving Medium (Flow Laboratories) in a sterile
tube and centrifuged at 400 g for 60 min. Differential migration during centrifugation results in
two distinct cell bands and a red cell pellet (Fig. 1). From the top plasma layer, 8 ml was
collected and centrifuged at 1000 g for 10 min to provide platelet-poor plasma (PPP). The
remaining plasma and upper cell band containing mononuclear cells were discarded. The
neutrophils were recovered from the lower cell band, resuspended in 40 ml phosphate
buffered saline pH 7.4 (PBS) and centrifuged at 400 g for 10 min. The supernatant was
discarded and the cell pellet was resuspended in 10 ml PBS. A 1 ml sample was taken to
determine total and differential white cell counts and assess red cell contamination.
Fig. 1. Diagnostic illustration of blood cell separation on Mono-poly Resolving Medium.
Labelling procedure
'"In-oxine solution (20-40 MBq) (Amersham International pic) was added dropwise to the
remaining suspension of neutrophils. After incubation at room temperature for 15min, 3ml of
PPP was added then the cell suspension was centrifuged at 250 g for 10 min. The supernatant
was transferred to a fresh tube. The cell pellet was resuspended to a volume of 5mlwith equal
parts of PBS and PPP. The activities of the cell suspension and supernatantwere measured in a
radioisotope calibrator and the labelling efficiency calculated. The cell suspension which
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Cell counting
All cell counts were performed manually using a new improved Neubauer chamber (0.100
mm). Blood films made from whole blood and the neutrophil suspension were stained with
May-Grunwald/Giemsa and a differential cell count determined. The percentage cell recovery
was calculated by comparing the neutrophil count in whole blood with that in the neutrophil
suspension.
Scintigraphic investigations
Imaging was performed using a large field of view gamma camera (GEC-400T Maxicamera)
interfaced to a PDP11-34 computer (Digital Equipment Corporation). Kinetic data were
obtained from eight patients in the following manner: the patient was positioned anteriorly to
visualize lungs, liver, spleen and heart and the 1 "In-neutrophil suspension was administered
intravenously by a fast running 5% dextrose infusion. A sequence of 64 x 64matrix images was
taken over 25 min at a varying frame interval starting at 5 s for the first six images and then
increasing stepwise to 60 s for the later images. The counts were normalized for frame length.
To assess "'In-neutrophil kinetics, the movie images were inspected and regions of interest
(ROI) created around the heart, lungs, liver, spleen and whole field of view. The whole field
frame showing the maximum count-rate was assumed to represent the total activity injected.
The count-rates from the other ROIs were expressed as a percentage of the maximum whole
field count-rate and a time-activity curve was created for each organ. This method of data
analysis allows direct comparison of the relative activity in each organ. In all patients, static
images were obtained at 6 and 24 h after injection.
From the 45 patients' blood samples on which separation was performed, the
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Fig. 2. 11 'In-neutrophil time-activity curves for lungs, heart, liver and spleen.
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Fig. 3. Gamma camera image (24 h) showing the anterior abdominal view obtained from a
patient with ischaemic colitis. Predominant uptake of 111 In can be seen in the sigmoid and
descending colon.
Fig. 4. Anterior chest image (24 h) showing marked uptake of 1 "In in the left upper lobe of a
patient with obstructive pneumonia in the left upper lobe.
Fig. 5. Reconstructed '"In transverse and coronal head images at 24 h obtained using single
photon emission computerized tomography in a patient with a right frontal cerebral abscess.
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neutrophil count less than 4.2x10'. All neutrophil suspensions were labelled with
'"In-oxine and a mean labelling efficiency of 72.1% (s.D.±12.9%) was achieved. In
addition, red cell contamination was calculated in the eight patients used for kinetic
data and was found to be 5.7% (s.D.±2.6). Lymphocyte contamination was found to
be less than 0.5%.
Fig. 2 shows the mean '"In-neutrophil kinetic data obtained from the eight
patients studied. The data are expressed as percentages of the maximum count rate
achieved in the whole field of view. Heart count-rate falls to 3% of the maximum
whole field count-rate within 90 s and after 5 min remains constant at 2% for the
remainder of the study. Similarly, lung count-rate falls to 19% within the first 90 s
and thereafter falls at a slower rate to 9% by 20 min indicating a small degree of lung
retention. The liver count-rate rises to 16% by 15 min and remains constant, whereas
the spleen count-rate continues to rise throughout the study.
Of the 45 studies, 18 showed positive uptake, three examples ofwhich are given in
Figs. 3 to 5. No patientwith a negative scan was subsequently demonstrated to have
a major site of infection.
Discussion
Leucocytes labelled with a variety of radionuclides have been used to locate infection
or inflammation since the early 1970s [12-14]. In recent years, '"In-chelates have
been used to label leucocytes for routine diagnostic purposes. While much of the
initial work has involved the labelling of mixed leucocytes with 1 "In, more recently
emphasis has been placed on two advantages of using pure neutrophils: (1)
avoidance of labelling radiosensitive lymphocytes [7-9]. (2) Reduction in the
labelling of non-specific cells principally erythrocytes and platelets [6].
A number of techniques have been developed to isolate and label pure neutrophils
with "'In. These methods are time consuming, requiring the preparation of a
discontinuous density gradient for the cell separation. In an attempt to retain cell
function it has been recommended that the neutrophils be isolated and labelled in a
plasma environment. To achieve this, a technique using a discontinuous density
gradient prepared with the patient's own plasma and subsequent labelling in plasma
with "'In-tropolonate has been developed [10], Isolation and labelling in this
manner does, however, prolong the procedure as the gradient can only be prepared
after cell-free plasma has been obtained.
The purpose of this study was not to evaluate the efficacy of' "In-labelled neutro¬
phils as a diagnostic tool as this has been well documented, but to describe a
technique for isolating neutrophils directly from whole blood without the need to
perform an initial sedimentation step using dextran, hydroxyethyl starch or methyl
cellulose as is the current practice [7, 10, 11]. Subsequent labelling of the separated
pure neutrophils is achieved with "'In-oxinate. This method does not require the
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preparation of a discontinuous density gradient but uses the commercially available
Mono-poly Resolving Medium. Good neutrophil recovery is achieved with little red
cell and virtually no lymphocyte contamination. Labelling efficiency is excellent and
agrees well with other published data for ' "In-oxinate [2,11, 15,16].
A number of studies has shown that poorly functioning or damaged 11 "In-labelled
neutrophils demonstrate lung retention or liver sequestration [2, 17-20]. It is
essential that 1 "In-labelled cells prepared by any new techniques of cell isolation be
assessed for lung retention. One method of achieving this is to compare the passage
through the lungs of a simultaneously injected !l!'Tcm-red blood cells and '"In-
neutrophils with simultaneous acquisition in the two energy windows [15], Using
this technique the !mTcm activity-time curve represents blood flow through the
lungs. Retention of '"In-neutrophils is therefore demonstrated by the difference in
the lung time-activity curves for the two radionuclides. We decided to use a simpler
technique, comparing the '"In activity-time curves for the lungs and heart, the
difference in the slope of the two curves demonstrating lung retention. Kinetic data
obtained from eight patients in this manner demonstrated early uptake in the
liver and spleen, with splenic activity continuing to rise throughout the period of
study consistent with functioning cells. Lung clearance of the "'In-labelled neutro¬
phils occurs rapidly, 80% clearing within 90 s. When the lung and heart clearance
curves are compared, retention of "'In in the lungs is seen, consistent with the
margination of neutrophils within the pulmonary vasculature. Evidence of retention
is minimal by 20 min. The difference in total lung and heart counts at 25 min can
largely be explained on the basis of differences in pulmonary and cardiac blood
volume and need not represent continuing lung retention of "'In-labelled neutro¬
phils. This corresponds well with the kinetic data reported in previous studies [15,
20], showing little lung hold-up with rapid pooling of neutrophils within the spleen.
Further confirmation that the cells are functionally viable is provided by the positive
scans obtained from a group of patients with a variety of infective and inflammatory
conditions, examples of which are given earlier.
In conclusion, we have demonstrated a rapid single-step separation procedure for
the isolation of pure neutrophils from whole blood using Mono-poly Resolving
Medium. This method is rapid and involves less handling of cells, thus reducing the
risk of mechanical damage and requiring less technical expertise. Pure neutrophils
separated by this technique have good in vivo kinetics and appear functionally
normal.
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